2015 ashp midyear clinical meeting resident poster listing by

2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Resident Poster Presenters: Congratulations! Below is your scheduled poster presentation time and board number. This list is sorted by the Last Name of the Primary Author —not by presentation time. You may also search the list by using your Submission ID. If you have trouble locating your poster, please send an email to [email protected]. Allow three business days for a response. Date, time, and board number cannot be changed. ASHP will not edit titles, abstracts, or presenters. If you wish to withdraw your poster, please contact [email protected]. Be sure to read the Poster Presenter Handbook located at http://www.ashp.org/Get_Involved for additional instructions. We’ll see you in New Orleans! Educational Services Division NEW***We have added a poster session on SUNDAY!*** This year, a special poster session has been added to the Federal Forum program. Presenters who disclosed an affiliation with the Department of Veterans Affairs, Department of Defense, or other Federal Agency, will present their poster during the “Federal Forum: Meet the Researchers Poster Presentations” session on Sunday, December 6, 2015. Presenters who are scheduled to present their poster during this session will receive an email with more detailed information. If you are affiliated with a federal agency and did not disclose this information during the submission process, please send an email to [email protected] with Federal Forum: Meet the Researchers Poster Presentations in the subject line. 1|Page
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 387672 Phuong Abbott 1‐062 388064 George Abdallah 1‐063 386650 Mohammed 10‐139 Abdulwahhab 386650 Mohammed 12‐090 Abdulwahhab 388525 Justine Abella 9‐057 389192 Paola Acevedo 9‐247 387449 Emily Acker 11‐031 388571 Catalina Acosta 10‐220 Impact of early initiation of hydrocortisone therapy in severe sepsis and septic shock patients Evaluation of clinical and safety outcomes in critical care patients treated with a phenobarbital based alcohol withdrawal protocol Impact of discharge counseling for chronic obstructive pulmonary disease (COPD) patients on 30‐day hospital readmission rate Impact of discharge counseling for chronic obstructive pulmonary disease (COPD) patients on 30‐day hospital readmission rate Association of sodium bicarbonate with return to spontaneous circulation (ROSC) in cardiopulmonary arrest patients at UC San Diego Health Evaluating the inpatient use of epoetin alfa in non‐
hemodialysis patients in a community teaching hospital Impact of Penicillin Allergy on Empiric Carbapenem Therapy in Patients with Community‐Onset Gram‐
Negative Bacteremia Utilization of meropenem at a multi‐center community health system Date Time Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. 2|Page
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386982 Michelle Adamczyk 1‐064 385421 Ashley Adams 10‐299 386161 Kathleen Adams 9‐031 386332 Rebekka Adamson 9‐099 388707 Manali Adani 9‐005 386614 Kate Adcock 12‐001 388974 Jennifer Addo 8‐074 388586 Aderonke Adeboye 11‐275 Implementation of an antimicrobial stewardship protocol for urinary tract infections in the emergency department (ED) and its impact on prescribing habits Implementation and evaluation of targeted interventions for reducing missing dose requests within an academic veterans affairs medical center Implementation of an inpatient pharmacist‐
managed warfarin dosing protocol Prevalence of drug‐drug interactions with the novel oral anticoagulants Assessing the effectiveness of a network pharmacy renal dose policy: a pharmacy resident analysis Development of institutional antibiotic dosing guidelines in critically ill patients undergoing continuous renal replacement therapy Bloodstream infections in patients with cirrhosis: etiologic agents, risk factors for multidrug resistant organisms, and patient outcomes Evaluating Georgia State Protocol Immunizations in the Community Pharmacy Date Time Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. 3|Page
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 387729 Mary Afrane 1‐065 388116 Clifford Aguele 388826 Nabeela Ahmed 8‐015 389424 Gresa Ajeti 1‐066 386172 Deanna Akinbajo 1‐067 389217 Tolulope Akinbo 9‐176 10‐053 387035 Ukwen Akpoji 1‐068 384578 Sultan Al Raddadi 8‐305 384504 Abdulrahman 10‐259 Al Turaiki Evaluating time to therapeutic vancomycin trough levels in a community teaching hospital Optimization of medication alerts Evaluation of immediate release (IR) nifedipine use at a large academic medical institution Evaluation of empiric treatment of urinary tract infections and urine‐
culture follow‐up Analysis of post‐operative outcomes with the use of continuous infusion local anesthetic in total knee arthroplasty and arthroscopic shoulder surgery Implementation and evaluation of end‐tidal carbon dioxide (EtCO2) monitoring for the prevention of respiratory depression in patients receiving opioid therapy. Impact of Antimicrobial Dosing Guide on Initial Inpatient Antimicrobial Dosing Errors Is atorvastatin 80 mg as safe as atorvastatin 40 mg in Saudi patients with cardiac disease? Assessment of safety and efficacy of the oral multiple sclerosis medications Date Time Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. 12:30 p.m. ‐ 1:30 p.m. 4|Page
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386098 Hana Alawy 8‐306 388986 Ryan Albers 1‐069 387853 Christina Aldrich 9‐032 389483 Jason Val Alegro 9‐033 388049 Osamah Alfayez 12‐190 386497 Ali Alharbi 9‐248 386517 Reem Alharbi 10‐221 Appropriateness of Antiplatelet Therapy in Patients on Oral Anticoagulation Medication use evaluation of ciprofloxacin for the treatment of urinary tract infections managed through an urgent care center in a Veterans Affairs outpatient setting Retrospective drug use evaluation of DVT prophylaxis in patients on continuous veno‐venous hemofiltration Multi‐year analysis of outcomes associated with a pharmacist‐managed outpatient parenteral antimicrobial therapy (OPAT) program within a Veterans Affairs Medical Center (VAMC) Pharmacist impact on diabetes management as a member of an interprofessional team Adherence to an ICU sedation protocol at a community teaching hospital: Identifying the pharmacist's role Assessment of evidence‐
based practice (EBP) among hospital pharmacists in Saudi Arabia: attitude, awareness and practice Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. 5|Page
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388798 Doaa Aljefri 1‐070 387198 Jennifer Allen 10‐024 389037 Monica Allen 8‐307 388083 Kristin Allmaras 1‐071 388342 Ohoud Almalki 1‐072 387238 Saleh Almekhloof 1‐073 386401 Nasser Al‐
Qhtani 10‐222 387077 Yousef Al‐
Rajhi 10‐054 Clinical Outcomes of Daptomycin Therapy Based on a Dosing Body Weight Calculation Versus Total Body Weight Implementing a pain protocol in the palliative care setting of a rural hospital Impact of an antimicrobial stewardship intervention on uncomplicated skin and soft tissue infection treatment in the emergency department Identify and explore potential opportunities for augmentation of pharmacy‐based clinical services within a tribal home‐based service (HBS) program Target‐specific oral anticoagulants for post‐
surgical thromboprophylaxis in orthopedic patients: A network meta‐analysis Implementation of clinical guidelines for the management of delirium in the intensive care unit of a community health system Comparison of voluntarily reported medication errors between the icu and non‐
icu setting in adult patients Weekly Assessment of the therapeutic efficacy of different doses of Eprex for managing anemia in Date Time Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. 6|Page
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. chronic kidney disease adult patients 385165 Abrar Alshehri 11‐057 386472 Khalid Alsulaiman 11‐098 388472 Abdulhmid Althaghfi 8‐213 387069 Ahlam Althobaiti 12‐027 387437 Luisa Alvarado 9‐249 386293 Kathryn Alver 1‐074 Evaluation of the use of granulocyte‐colony stimulating factor factors (G‐CSFs) as neutropenia primary prophylaxis in solid tumors at KAMC‐WR: retrospective study Evaluation of prescribing medication errors in pediatric outpatient pharmacy Hospital Readmission Rates Following Implementation of an Antimicrobial Stewardship Intervention on the Acute Inpatient Psychiatric Units Impact of antibiotic use on valve survival in rheumatic heart disease patients post‐valve replacement Impact of a pharmacist‐
driven antimicrobial de‐
escalation protocol on the duration of parenteral antimicrobials in community‐acquired pneumonia A retrospective review of ticagrelor versus clopidogrel after acute coronary syndromes in a veteran population 7|Page
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386432 Safa Alyamani 8‐214 385239 Saeed Alzghari 9‐058 383090 Erin Amadon 11‐276 382625 Kallie Amer 10‐025 389283 Priti Amin 8‐016 388286 Francine Amoa 1‐075 389514 Brandon Anderson 1‐076 385665 Holly Anderson 8‐017 Impact of a pharmacy driven antibiotics de‐
escalating guidelines as a part of antimicrobial stewardship program (ASP) in a community hospital health‐system. Retrospective comparison of low molecular weight heparin versus warfarin versus oral Xa inhibitors for the prevention of recurrent venous thromboembolism in oncology patients Venous thromboembolism (VTE) prophylaxis core measures: A retrospective medication‐use evaluation Evaluation of regadenoson versus dipyridamole evaluation in myocardial perfusion imaging Comparison of risk of readmission scoring tools and readmission rates Comparing time in therapeutic range (TTR) among patients on warfarin managed via face‐
to‐face (FF) or telephone based (TELE) at the VAPIHCS Investigation of a pharmacist led chronic pain clinic impact on pain management outcomes Utilization of pharmacist‐
driven penicillin skin testing protocol to reduce unnecessary use of broad Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 8|Page
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time spectrum antibiotics 389185 Jessica Anderson 1‐077 382595 Telyssa Anderson 9‐250 388077 Michelle Andress 9‐059 388864 Nadia Aneese 11‐188 389297 Hans Ang 8‐215 386376 Louise Jeremia (Jeri) Angelo 1‐078 385878 Nicole Anidiobi 11‐133 Safety, efficacy, and cost savings of low dose alteplase (1mg/1ml) versus standard dose alteplase (2mg/2ml) for occluded central venous catheters Incidence of coadministration of acid suppression therapy with tyrosine kinase inhibitors in patients with CML and Ph+ ALL Assessing 30‐day readmissions and interventions provided by community and hospital pharmacy residents collaborating with a provider in a transitions of care clinic Evaluation of a pharmacist managed diabetes clinic Inpatient management of hyperglycemia in post‐
operative kidney transplant recipients Observational lorazepam study: Prevalence of chronic lorazepam use at Seattle Cancer Care Alliance (SCCA) and risk factor identification Evaluation of hospital readmission rates of patients treated with rivaroxaban versus Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. 9|Page
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time warfarin in the treatment of venous thromboembolism 385285 Francisco Antigua 1‐079 387997 Nicole Apoian 1‐080 387075 Deylen Aponte‐
Rosario 1‐081 388059 Alenoush Aramian 12‐002 388881 Ashley Arenson 12‐191 385941 Gemma Arrufat Goterris 10‐006 388498 Allison Arterbury 1‐082 Retrospective performance review of HIV linkage and retention to care in American Indian and Alaska Natives at Phoenix Indian Medical Center (PIMC) Impact bedside delivery has on patient satisfaction and financial benefits Assessment of antibiotic prescribing patterns for pharyngitis in the ambulatory care clinics of a multi‐campus Veterans Affairs (VA) ambulatory care system Development of an antibiotic stewardship program in the outpatient setting to decrease inappropriate antibiotic prescribing Evaluation and improvement of resident and prescriber knowledge of hospital‐based guidelines Autoverification of medical order prescriptions: a strategy to improve pharmacists efficiency Evaluation of a pharmacist led mental health transitions of care program at a Veterans Affairs health care system Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 10 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 382938 Miranda Arthur 11‐001 389614 Kofi Asante 10‐140 389614 Kofi Asante 12‐091 389007 Steven Asbill 8‐216 386615 Saira Ashraf 8‐217 385133 Tahir Ashraf 8‐092 387180 Sara Asif 9‐177 386705 Zinkeng Asonganyi 1‐083 Implementing a clinical pharmacist‐led COPD service in a primary care clinic Impact of medication therapy management with an active follow‐up, on improving medication adherence in patients with diabetes Impact of medication therapy management with an active follow‐up, on improving medication adherence in patients with diabetes Evaluation of tolvaptan usage for the management of hyponatremia at a community health system Evaluation of efficacy of joint replacement pain management protocol using an intra‐op periarticular mixture at a large tertiary care hospital Bacteremia due to group viridans streptococci in neutropenic patients on fluoroquinolone prophylaxis Description and preliminary results of a managed care plan initiative to increase access and adherence Estimated financial benefit of opening a hospital‐
owned outpatient pharmacy Date Time Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 11 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388640 Lynnly Assavavallop 11‐214 388490 Amanda Atherton 1‐084 386818 Matthew Atkinson 11‐002 385709 Kimberly Augustyn 12‐171 387218 Whitney Aultman 8‐093 389135 Amy Aumann 11‐277 389118 Frances Aune 9‐006 387043 Phyo Aung 1‐085 Impact of a discharge concierge pharmacy service on high‐risk patients Evaluation of patient outcomes in a pharmacist‐
managed hypothyroid clinic Implementing and evaluating a pharmacist procalcitonin protocol for use in low acuity patients with concern for respiratory tract infection Medication use evaluation of activated prothrombin complex concentrate for direct oral anticoagulation reversal Evaluation of compliance to an intravenous insulin infusion protocol in the management of diabetic ketoacidosis Pharmacist owned discharge medication reconciliation and patient education in a community hospital setting Acute kidney injury associated with vancomycin and beta‐
lactams: piperacillin‐
tazobactam versus cefepime Impact of transitions of care pharmacy medication education on pneumonia readmissions Date Time Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 12 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 387328 Paul Avenoso 10‐007 389435 Sindhuri Avula 9‐251 388324 Amy Awker 1‐086 389171 Adepeju Awodipe 9‐252 385364 Mike Axelsen 11‐003 386676 Sara Ayele 1‐087 387240 Dina Azar 1‐088 Evaluation of newly implemented adult febrile neutropenia antimicrobial protocol in liquid tumor malignancy and bone marrow transplant patients Evaluation of the appropriateness and safety of intravenous nicardipine use at a large community hospital Evaluation of a protocol for management of periprocedural anticoagulation at the Minneapolis Veterans Affairs Health Care System (MVAHCS) Pharmacist‐Led Discharge Counseling vs. Nursing Discharge Education on Readmission Rates and Patient Hospital Experience Evaluation of long‐acting injectable antipsychotics and their impact on patient length of stay and readmission rates in an adult acute psychiatric care unit Characterization of budesonide/formoterol inhaler prescribing at hospital transitions of care in a Veteran population Factors that Influence Time to Start Oral Chemotherapy Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 13 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 387156 Andrew Aziz 8‐001 386740 Asal Azizoddin 12‐028 385406 Timothy Bach 8‐094 384563 Rachel Bacher 10‐055 386635 Justin Bagby 11‐134 388551 Jasmine Bailey 12‐214 387097 Kaitlin Baisden 1‐089 387619 Madeeha Baker 12‐029 389389 Danielle Ball 10‐300 Prescriber satisfaction with medication history technicians within a transitions of care program Comparison of additional oncology pharmacy counseling services through electronic interface versus only face‐
to‐face nurse counseling. Treating hepatitis c virus (HCV) genotypes 1‐4 in a large multisite ambulatory care practice setting: outcomes with oral direct‐
acting antiviral (DAA) regimens Evaluation of intravenous nicardipine at an academic medical center Reduction in potential medication errors through pharmacist collected medication histories in a community hospital Impact Of A Peer‐Led and Interprofessionally Developed Community‐
Based Weight Loss Intervention Program: A Pilot Study Evaluation of vasopressin use in patients with septic shock Implementing emergency department pharmacist‐
driven first antibiotic dose initiative Evaluation of hematuria in pediatric surgical patients Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. 14 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386822 Austin Ballew 11‐135 387980 Temitayo Banjo 11‐120 389272 Jason Barca 1‐090 387114 Russell Bardsley 8‐075 389500 Jennifer Baric 12‐030 386483 Sophia Barker 1‐091 384634 Ghazaleh Barkhordaria
n 11‐215 388475 Valerie Barnett 8‐308 Comparison of diabetes control in patients managed by Pharmacist Clinicians in a collaborative care model versus patients managed without Pharmacist Clinician collaboration. Guardian knowledge and perception of human papillomavirus vaccine at the community pharmacy Glycemic control in Native American patients: comparison of two insulin detemir delivery techniques Urinary tract infections in males: are shorter courses of therapy feasible? Evaluation of intravenous fosphenytoin versus intravenous phenytoin at a community health system Increasing the availability of decentralized clinical pharmacy services in a team‐based healthcare outpatient department Implementation and evaluation of a pharmacist‐
endocrinologist collaborative practice for outpatient diabetes management Inpatient monitoring of procalcitonin to determine appropriate antibiotic treatment of lower respiratory tract infections Date Time Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 15 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. in American Indians and Alaska Natives at a 72 bed hospital 388719 Jaime Baron 8‐309 388505 Erica Barr 11‐032 386179 Kyle Barron 1‐092 386034 Linda Barstow 8‐095 387312 Robley 8‐018 Bartholomew 384667 Stella Basalilov 11‐004 384798 Danny Basri 8‐310 Retrospective Review of the Treatment Rate of Asymptomatic Bacteriuria Effects of discharge counseling by a pharmacist on select HCAHPS scores Assessment of fish oil utilization within a multi‐
campus Veterans Affairs (VA) ambulatory care clinic Assessment of emergency department antibiotic discharge prescription dosing errors for pediatric patients in a community hospital health system Impact of antimicrobial stewardship program initiation on patients with healthcare‐associated pneumonia Assessment of the efficacy and saftey of fascia iliaca blocks for the treatment of pain associated with hip fractures in geriatric patients Evaluation of the use of intravenous antihypertensives in a tertiary care teaching hospital Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 16 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 387223 Andrea Bastiaanse 1‐093 389359 Matthew Batchelder 9‐100 387182 Jessica Bates 9‐178 388700 Madelyn Batey 9‐060 385380 Sundeep Bath 12‐031 385799 Simarjit Batth 8‐218 388273 Amanda Bauerle 9‐167 388273 Amanda Bauerle 11‐195 389586 Christopher Baughman‐
Oprica 1‐094 Development and Implementation of a Pharmacy to Dose Warfarin Consult Service: Part One: Evaluating Current Prescribing Habits An evaluation of pharmacokinetic dosing of vancomycin and aminoglycosides in obese adult patients Needs analysis for a rural drug information center Effect of direct acting oral anticoagulants (DOACs) on mortality in traumatic brain injury patients Evaluation of goal tacrolimus trough levels and impact on kidney transplant rejection. Impact of clinical pharmacists interventions on patients knowledge of direct oral anticoagulants Evaluation of injectable acetaminophen usage appropriateness and potential cost savings from using alternate therapy Evaluation of injectable acetaminophen usage appropriateness and potential cost savings from using alternate therapy Analysis of metabolic monitoring in patients prescribed antipsychotics at the Providence VA Medical Center: a pilot study Date Time Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 17 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386396 Thomas Baumann 1‐095 386972 Caitlin Beale 11‐216 386194 Danielle Beale 12‐172 387936 Andrew Beaty 12‐003 388362 Carson Bechtold 1‐096 387484 Jacob Beck 11‐217 Impact of pharmacist‐led methicillin‐resistant Staphylococcus aureus (MRSA) polymerase chain reaction (PCR) nasal screening on de‐escalation of empiric treatment for suspected MRSA pneumonia Transdiciplinary team approach to reduce 30‐day re‐hospitalization rate in chronic obstructive pulmonary disease patients: impact of pharmacist‐provided standard discharge initiative Safety and efficacy of anti‐
factor xa versus activated partial thromboplastin time monitoring in patients receiving intravenous unfractionated heparin therapy: a retrospective review Phenytoin versus levetiracetam as first‐line treatment for new onset seizures Assessing the impact of anticoagulation on atrial fibrillation patients with a CHA2DS2‐VASc score of 1 due to hypertension : Evaluation of Optimal Vancomycin Dosing in Young Children Date Sunday, December 6 Time 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 Wednesday, December 9 3:45 ‐ 5:15 p.m. 1:45 p.m. ‐ 2:45 p.m. 18 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386643 Abigail Becker 10‐280 388776 Eyerusalem Befkadu 10‐008 388066 Lauren Behrle 11‐058 388300 Ainhoa Belaustegui 1‐097 388312 Brian Bell 8‐096 389293 Kristin Bell 1‐098 387645 Morgan Belling 12‐215 385159 Kasie Bellmann 11‐099 Evaluation of the frequency of adverse events from dofetilide therapy in obese patients The effect of appropriate empirical therapy on hospital mortality in patients with candidemia in an urban teaching hospital Incidence and clinical outcomes of off‐label oral anticoagulant dosing in nonvalvular atrial fibrillation within a community hospital health system Long acting release octreotide in the treatment of recurrent bleeding from intestinal angiodysplasia: evaluation of safety and efficacy Targeted discharge counseling in high risk patient populations Assessment of psychotropic medication use in a veteran affairs nursing home pre and post pharmacist led intervention Incidence of documented administration stop times for IV infusions in an outpatient cancer center Evaluating the effect of an order set on the treatment of asymptomatic bacteriuria in the emergency department Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. 19 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386505 Victoria Belousova 8‐097 387817 Lauren Belt 12‐032 387851 Jason Bena 1‐099 387913 Grace Benanti 11‐005 386178 Lydia Benitez 11‐278 388602 Denise Bentley 1‐100 388411 Sarah Berger 8‐019 388840 Sean‐Paul Bergeron 10‐141 Sustainability of a pharmacist driven, practice‐embedded medication management service Pharmacist interventions for adherence and safety in patients being treated with oral chemotherapy agents at an outpatient cancer center Measuring value associated with end of life oncologic therapy A Single Center Evaluation of the ABCDE Bundle Implementation Olanzapine for the prevention of emesis in patients with multiple myeloma receiving high dose melphalan prior to autologous transplantation Impact of a pharmacy led pain management service with a focus on patient controlled analgesia in a community hospital Assessment of current prevention and treatment strategies for pediatric opioid‐associated constipation Implementation and Evaluation of Updated Severe Sepsis/Septic Shock Standing Orders: Effective Medication Therapy and Improvement in Patient Outcomes Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. 20 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388840 Sean‐Paul Bergeron 12‐092 389043 Delaney Berggren 10‐056 387427 Biniam Berhane 1‐101 387155 Brittany Berry 1‐102 385735 Holly Berry 11‐100 389599 Bethany Bersani 11‐218 388530 Elizabeth Bertran 1‐103 Implementation and Evaluation of Updated Severe Sepsis/Septic Shock Standing Orders: Effective Medication Therapy and Improvement in Patient Outcomes Rate of cefepime de‐
escalation in hospitalized patients with positive cultures Evaluation of fosphenytoin and valproate loading doses for status epilepticus patients in the emergency department at an urban community hospital Evaluation of long‐acting injectable antipsychotic medications in Medicare beneficiaries: a utilization review and cost analysis Work Flow Optimization of a Decentralized Pharmacy Technician to Increase Pharmacy Provided Medication Reconciliation in a Community Teaching Hospital Evaluating risks of harm in patients with atrial fibrillation on chronic warfarin who undergo temporary discontinuation of oral anticoagulation for a planned elective procedure Effects of dapagliflozin on energy intake and appetite in healthy subjects Date Time Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 21 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388879 Michael Beshir 12‐173 388499 Ena Besic 11‐279 385694 Ashley Besignano 11‐136 388625 Tatiana Betancor 8‐058 387544 Kristina Bettencourt 12‐296 389430 Jaimie Bhagat 9‐179 386386 Nisha Bhide 10‐026 387540 Stephen Bienemann 11‐280 388111 Anna Bieniek 8‐098 387658 Sebastian Biglione 9‐061 388458 Sarah Billman 9‐253 Necessity for Beta‐Lactam Allergy Guidelines at a Large Academic Medical Center Evaluation of pharmacy involvement in heparin infusion protocol Reversibility of Renal Dysfunction After Discontinuation of Tenofovir Total parenteral nutrition: do we accomplish the recommendations? Implementation of pharmacists in patients with congestive heart failure at hospital discharge Evaluation of the utilization of intravenous lipid emulsions in the treatment of drug overdose Leadership in Pharmacy Taking an antibiotic time out: impact of a seven day stop order on duration of antibiotic therapy Alaris library gap analysis: standardization in an expanding health‐system Outcomes of a steroid‐free protocol in living donor liver transplant recipients Pharmacoeconomic analysis of intravenous acetaminophen in colorectal surgery patients Date Time Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. 22 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 387099 Connor Birkel 11‐219 386603 Kylee Bitner 1‐104 387779 Courtney Black 11‐033 388325 Regina Blackley 9‐254 388778 Samantha Blackmon 12‐004 388401 Joshua Blackwell 10‐142 388401 Joshua Blackwell 12‐093 389367 Katherine Blain 8‐099 Development, implementation and evaluation of a perioperative blood glucose management protocol in diabetic general surgery patients. Role of bedside preparation in reducing door‐to‐drug tissue‐type plasminogen activator (tPA) administration times and association with patient outcomes Assessing the frequency in which medication is a reason for earlier than desired cessation of breastfeeding Effectiveness and safety of an inpatient clinical pharmacist‐managed warfarin consult service Initiation and evaluation of a standardized stroke protocol upon hospital admission Impact of utilizing technology to improve pharmacist‐driven medication reconciliation for transplant patients Impact of utilizing technology to improve pharmacist‐driven medication reconciliation for transplant patients Pharmacist dispensed naloxone in Kentucky: implementing services in a large chain community Date Time Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 23 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. pharmacy and measuring pharmacist perceptions 389396 Fernando Blanco 8‐100 385276 Kristina Blanquiz 11‐137 389256 Maria Blaze 1‐105 388025 Candace Bloomer 10‐143 388025 Candace Bloomer 12‐094 Prescriber adherence to intravenous acetaminophen drug use policy: a medication‐use evaluation Implementation and evaluation of a pharmacist‐run metabolic risk reduction clinic in the ambulatory care setting Effectiveness of the Inpatient to outpatient transition program (IOTP) in improving adherence to psychiatric pharmacotherapy and follow‐up appointment attendance at VAWNY Healthcare System Comparison of antimicrobial related interventions and acceptance rates between a pharmacist versus a pharmacist in collaboration with a physician specializing in infectious diseases. Comparison of antimicrobial related interventions and acceptance rates between a pharmacist versus a pharmacist in collaboration with a physician specializing in infectious diseases. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. 24 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 382703 Presley Blount 1‐106 386209 Bridget Blowey 8‐020 385945 Samantha Bochenek 9‐101 388422 Viola Bockenfeld 8‐101 388913 Joe Bodkin 9‐034 388672 Andrew Bohrer 10‐144 388672 Andrew Bohrer 12‐095 386569 Christina Bonanno 1‐107 Theoretical cost savings analysis through a formulary interchange between basal insulin products Characterization of antithrombin concentrate utilization at a pediatric hospital Evaluation of calcitonin utilization at a large, academic medical center applying lean thinking Evaluation of de‐escalation strategies for empiric intravenous vancomycin therapy in patients with healthcare associated pneumonia (HCAP) Comparison of pharmacist versus nurse managed heparin titration Daptomycin dosing based on ideal body weight versus actual body weight: a study on clinical outcomes and safety Daptomycin dosing based on ideal body weight versus actual body weight: a study on clinical outcomes and safety Clinical consequences of disruption in psychiatric medications upon hospitalization at Veterans Affairs Medical Center Date Time Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 25 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 389003 Maria Bondar 10‐145 389003 Maria Bondar 12‐096 388329 Angelica Borrero Olan 8‐219 387397 Michael Botros 11‐281 387431 Joshua Bouffard 12‐216 384392 Aimee Bower 8‐102 386885 Kathryn Bowerman 12‐005 Impact of pharmacist involvement on the utility of Verigene rapid identification assay on antimicrobial usage for gram positive blood cultures in a community hospital Impact of pharmacist involvement on the utility of Verigene rapid identification assay on antimicrobial usage for gram positive blood cultures in a community hospital Development of a quality metrics dashboard for clinical pharmacists intervention in ambulatory care Drug‐drug interactions among non‐vitamin K oral anticoagulants in geriatric patients, seventy‐five years and older Tobacco cessation treatment program: analysis of current practice in the behavioral health population Effect of a standardized order set on adherence to treatment guidelines in patients with clostridium difficile infection Impact of a resident pharmacist on medication reconciliation at admission in high‐risk patients Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. 26 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 385972 Riley Bowers 10‐146 385972 Riley Bowers 12‐097 389321 Brandi Bowman 12‐006 389027 Hilary Box 11‐034 386685 Anthony Boyd 10‐001 385886 Amanda Boykin 8‐076 387537 Crystal Boykin 10‐147 387537 Crystal Boykin 12‐098 Systemic glucocorticoid usage in acute COPD exacerbations in hospitalized patients: A retrospective medication‐
use evaluation Systemic glucocorticoid usage in acute COPD exacerbations in hospitalized patients: A retrospective medication‐
use evaluation Perioperative use of intravenous acetaminophen in pediatric adenotonsillectomies Access to Hepatitis C Medications in a Community Pharmacy Setting Risk factors for cefepime‐
non‐susceptible gram‐
negative infections in hematopoietic cell transplant (HCT) recipients Implementation of pharmacist‐provided chronic obstructive pulmonary disease (COPD) education in a community hospital Evaluation of medication adherence among veterans enrolled in an ambulatory intensive case management program Evaluation of medication adherence among veterans enrolled in an ambulatory intensive case Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. 27 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. management program 386608 Paul Boylan 9‐102 386788 Julia Boyle 1‐108 385830 Lynnea Braden 8‐103 385203 Melina Braly 10‐301 383304 Teia Brandenburg 10‐057 388394 Courtney Brandow 10‐002 Incidence of acute kidney injury in patients receiving intravenous vancomycin in combination with piperacillin‐tazobactam or cefepime Medication use evaluation of concomitant selective serotonin reuptake inhibitors (SSRIs) and serotonin norepinephrine reuptake inhibitors (SNRIs) at a Veterans Affairs hospital Evaluating the safety and efficacy of dornase alfa in non‐cystic fibrosis pediatric patients Development of a heparin induced thrombocytopenia (HIT) diagnosis and treatment algorithm for post open heart surgical and transcatheter aortic valve replacement (TAVR) patients. Effects of implementing delirium screening in a pediatric intensive care unit Impact of pharmacy interventions in glycemic control in patients receiving correctional insulin only in a community hospital setting 28 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 387861 Andrea Brandt 1‐109 385368 Caitlin Brant 8‐104 387139 Cynthia Brasher 11‐138 382634 Joseph Bratsch 9‐103 384650 James Braun 11‐139 389603 Thomas Brazeal 9‐180 389580 Kaitlin Bresnahan 8‐077 388457 Lindsey Briggs 8‐078 Impact of delay in treatment on clinical outcomes in patients with hepatitis C virus infection Dual anti‐platelet therapy after coronary stent placement: impact of duration on mortality, major cardiac events and adverse events Economic feasibility assessment for a specialty pharmacy in a not‐for‐
profit community health system Evaluation of tranexamic acid and the incidence of post‐operative thromboembolic events in hospitalized adult patients Benzodiazepine Use for Status Epilepticus in an Academic Medical Center Emergency Department Role of clinical pharmacists in managing chronic obstructive pulmonary disease (COPD) patients with multiple comorbidities Impact of an algorithm to guide medication therapy for acute agitation in behavioral health patients in the emergency department. Evaluation of acute kidney injury and hyperkalemia with trimethoprim/sulfamethox
azole in a community Date Time Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 29 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. hospital setting 388568 Emily Brinser 9‐181 385245 Celeste Briones 1‐110 386905 Sara Britnell 10‐302 386621 Michael Brocco 12‐217 388720 Kara Brockhaus 1‐111 385400 Daniel Broderick 8‐220 Identification and evaluation of current practices and opportunities of emergency department pharmacists using clinical surveillance software (EDPharm) Efficacy and safety of novel oral anticoagulants vs. warfarin in super geriatric patients with non‐valvular atrial fibrillation Evaluation of Clostridium difficile treatment outcomes based on the severity of illness and antibiotic treatment Analysis of insulin detemir versus insulin glargine in a community hospital Impact of a comprehensive approach for administration of surgical prophylaxis antimicrobials in patients with documented beta‐lactam allergies Characterization of pharmacologic interventions to prevent shivering during therapeutic hypothermia following cardiac arrest in adults Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 30 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 387696 Amy Brotherton 10‐058 386944 Ashley Brown 1‐112 387455 Christopher Brown 8‐311 385794 Emily Brown 10‐059 389461 Kellee Brown 1‐113 386243 Kristin Brown 9‐168 386243 Kristin Brown 11‐196 Evaluation of amiodarone and antifungal use: missed opportunities for antifungal stewardship Evaluation of enoxaparin use in pediatric patients requiring treatment dosing Medication use evaluation and cost minimization analysis of premixed nicardipine injectable solution versus compounded nicardipine injection in a community hospital Evaluation of vancomycin dosing for the treatment of Staphylococcus aureus infections in intravenous drug abusers Attainment of target anti‐
factor Xa levels in patients with acute kidney injury requiring continuous renal replacement therapy (CRRT) The effects of a pre‐
operative methicillin‐
resistant Staphylococcus aureus (MRSA) screening and decolonization protocol on post‐operative MRSA infection rates The effects of a pre‐
operative methicillin‐
resistant Staphylococcus aureus (MRSA) screening and decolonization protocol on post‐operative MRSA infection rates Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. 31 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388090 Ryan Brown 11‐220 387174 Sara Brown 1‐114 388832 Andrew Bruce 12‐218 383282 Andrew Brueckner 12‐192 385993 Kirsten Bruell 10‐148 385993 Kirsten Bruell 12‐099 387283 Adam Brumfield 1‐115 388467 Allison Brunsman 8‐105 384325 Theresa Brush 8‐106 Date Time Assessing sedation practices and the incidence of ventilator‐associated pneumonia (VAP) in intensive care units Poractant alfa versus beractant for neonatal respiratory distress syndrome: a retrospective pharmacoeconomic and outcomes analysis Evaluation of rasburicase use at a large community teaching hospital Predictors of successful conversion from tacrolimus to sirolimus in kidney transplant recipients on a steroid free immunosuppressive regimen Differences in type 2 diabetes medication intensification between a family medicine clinic and an endocrinology clinic Differences in type 2 diabetes medication intensification between a family medicine clinic and an endocrinology clinic Drug use evaluation of outpatient azithromycin prescribing at a Veterans Affairs Medical Center Daptomycin Stewardship at Transitions of Care Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Evaluation of phytonadione usage and appropriateness in a community hospital Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 32 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 385582 Heather Bryan 9‐255 385661 Allison Bryce 9‐256 387503 Carl Buchwald 10‐223 388152 Kara Buck 8‐221 389059 Anjuli Buechler 1‐116 386185 Janice Bueter 10‐281 387317 VIVIAN BUI 1‐117 386715 Daniel Bulger 1‐118 388797 Sarah Buranich 8‐222 Retrospective analysis of inpatient pneumonia treatment Evaluation of the clinical outcomes of Hepatitis C patients in a community owned healthcare setting Closing the gap: the impact of pharmacist intervention on forty‐eight hour ICU readmissions Efficacy of sodium polystyrene sulfonate for the treatment of acute hyperkalemia in hospitalized patients Pharmacy Presence in a Veterans Affairs Urgent Care Clinic Effect of computerized order entry on the process of inpatient chemotherapy order efficiency and medication error potential New metformin prescribing recommendation: evaluating metformin use based on estimated glomerular filtration rate over traditional serum creatinine contraindications Assessing the effectiveness of an automatic warfarin critical drug interaction consult Evaluation of pharmacist‐
led interventions in transition of care in an inpatient community Date Time Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 33 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time hospital setting 388516 Jordan Burdine 1‐119 386268 Chase Burkavage 9‐104 388454 Kelly Burke 8‐223 387185 Ruby Burks 9‐257 385424 Vincent Burns 12‐033 388808 Corey Burrelli 8‐021 389591 Sheena Burwell 11‐054 388648 Anna Bustin 1‐120 Inpatient palivizumab utilization post‐specialty pharmacy Evaluation of the management of enterococcal urinary tract infections (UTIs) and in‐
vitro susceptibility of isolates at an urban community hospital Hospital adverse drug event prevention: opioids and naloxone use Coded adverse drug events after real‐time clinical surveillance tool implementation for pharmacists Effect of sedation protocol revision on sedative use in the medical intensive care unit (MICU) Treatment outcomes with nafcillin versus cefazolin for methicillin‐susceptible Staphylococcus aureus bloodstream infections Implementation and evaluation of pharmacy services in an adult cystic fibrosis clinic Drug use evaluation of anakinra in a pediatric population Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 34 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386370 Caitlin Butler 11‐221 388734 Tierra Butler 11‐121 385366 Amy Butz 1‐121 387414 Hillary Buzby 8‐224 389439 Alexis Bylina 10‐060 386762 Nicole Caffiero 11‐140 388427 Bradley Cagle 11‐027 389234 Jessi Cahoon 12‐219 389383 Jocelyn Calado 8‐225 Evaluating the efficacy of liposomal bupivacaine in select surgical procedures at Boca Raton Regional Hospital (BRRH) The Impact of Pharmacy Resident‐Led Transitions of Care Service in an Urban Family Medicine Clinic Evaluation of stimulant use and prescribing patterns at the Salt Lake City VA Medical Center Clinical and economic outcomes associated with the utilization of a bedside prescription delivery service at discharge Use of continuous unfractionated heparin for venous thromboembolism in cirrhosis Implementation of a virtual renal care collaborative project (RCC) by an interdisciplinary nephrology team Creating reimbursement pathways for inpatient medication therapy management pharmacy services Implementation of a Hepatitis C point‐of‐care testing program in rural Montana Development of a process for privileging pharmacists as providers and its application for providing pharmacist diabetic Date Time Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 35 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. services 386566 Lauren Caldwell 12‐174 388995 Monique Calil 1‐122 387307 Austin Camp 9‐182 386760 Christopher Campbell 9‐035 388909 Rebecca Campbell 8‐107 387046 Eris Cani 1‐123 383297 Leann Cape 8‐226 Evaluation of the argatroban infusion protocol for systemic anticoagulation in adults with possible heparin‐
induced thrombocytopenia Evaluation of the impact of liposomal bupivacaine on postsurgical analgesia in spinal surgical procedures Postoperative blood glucose control in the cardiovascular intensive care unit after discontinuation of a continuous insulin infusion protocol Review of a hypoglycemia protocol at an academic medical center Working beyond the single‐disease state model: optimizing use of ambulatory care pharmacists in the primary care setting through use of collaborative drug therapy management agreements Urinary tract infections (UTIs) in diabetic versus non‐diabetic patients: prevalence, clinical and microbiological outcomes Evaluation of adherence to osteoporosis screening recommendations in women veterans. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 36 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 385786 Amanda Capino 11‐059 389328 Raquel Caporella 10‐009 387138 Todd Capron 9‐258 382624 Stephanie Cardinale 12‐034 388710 Dustin Carneal 10‐061 385723 Matthew Caron 1‐124 385396 Mary Carpenter 10‐027 Date Time Caregiver perception, self‐
efficacy, and knowledge of methadone tapers for children with iatrogenic opioid abstinence syndrome Assessment of a pharmacist‐led medication counseling program on patient satisfaction scores in a hospital unit Meds‐To‐Go Program in a Community Hospital Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Medication utilization evaluation of oral antihyperglycemic medications in the elderly Implementation of a Pharmacist‐Coordinated Transitions of Care Service and the Utilization of a Patient Specific Medication Timeline within a Small Independent Non‐Profit Planetree Community Hospital Evaluate the safety and efficacy of using lower doses of flumazenil for the reversal of benzodiazepine intoxication Impact of multidisciplinary care on readmission rates for patients discharged with congestive heart failure and chronic obstructive pulmonary disease Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. 37 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388916 Parrish Carpenter 1‐125 388861 Zachary Carrasco 11‐035 386796 Jessica Carrillo 8‐022 388321 Anne Carrington 11‐036 386834 Courtney Carroll 11‐282 386301 Eileen Carroll 1‐126 388466 Maxwell Cart 9‐169 Jet‐injected lidocaine compared to vapocoolant spray for local anesthesia prior to peripheral intravenous catheter insertion in pediatric patients Evaluating use of sub‐
dissociative ketamine in the ER at Mercy Health Muskegon Effects of interdisciplinary education on treatment outcomes for oral anticoagulant induced intracranial bleeding and traumatic head injury in three community hospitals Analysis of phytonadione utilization and prescribing patterns for appropriateness at a community teaching hosptial The impact of a pharmacy technician on the accuracy of a pediatric medication history at admission versus 24 hours post‐admission Comparison of continuous intravenous insulin order sets in the setting of hyperglycemic emergency Quality assurance assessment of peri‐
procedural enoxaparin bridging provided by anticoagulation pharmacists in Veterans undergoing elective gastrointestinal Date Sunday, December 6 Time 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. 38 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. procedures 388466 Maxwell Cart 11‐197 387945 Charles Carter 11‐141 385783 Kenneth Carver 11‐222 386739 Marissa Casagrande 8‐002 386726 Brian Case 10‐224 387315 Benjamin Casey 11‐142 Quality assurance assessment of peri‐
procedural enoxaparin bridging provided by anticoagulation pharmacists in Veterans undergoing elective gastrointestinal procedures Improvements in pharmacist‐driven medication reconciliation and patient counseling: preoperative outpatient setting versus postoperative inpatient setting Use of real‐time decision support to identify opportunities for clinical pharmacist intervention Impact of pharmacist‐
driven discharge medication reconciliation at a community hospital A retrospective review of an auto‐substitution of fosaprepitant for aprepitant in patients receiving highly or moderately emetogenic chemotherapy Procalcitonin‐guided discontinuation of antibiotic therapy in critically ill patients with 39 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. pneumonia: An institutional review 387079 Michael Casias 12‐035 389088 Sady Castane 10‐062 386553 Michelle Castelli 1‐127 387819 Jessica Cate 1‐128 388757 Drew Cates 9‐183 388449 Lillian Caton 10‐149 388449 Lillian Caton 12‐100 387039 Alanna Causebrook 1‐129 Impact of cepheid blood polymerase chain reaction (PCR) combined with antimicrobial stewardship intervention on Staphylococcus aureus bacteremia: A community hospital approach Impact of pharmacist post discharge follow up phone call program on adherence and medication related problems Implementation of the rivaroxaban patient assistance kit (R‐PAK): a one year update Establishing a pharmacist managed dementia medication monitoring clinic PrEPing with PrEP: Pharmacy‐based Collaborative Care Comparison of the use of methylnaltrexone bromide before and after protocol implementation Comparison of the use of methylnaltrexone bromide before and after protocol implementation Pharmacist run oral chemotherapy clinic Sunday, December 6 3:45 ‐ 5:15 p.m. 40 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 385407 Jillian Cavallari 1‐130 385871 Joseph Cavanaugh 8‐227 386808 Zakary Cerminara 8‐079 388229 Ashley Ceryance 1‐131 387386 Anwesa Chakrabarti 9‐184 388402 Alexandra Chambers 11‐006 387446 Lauren Chambers 8‐059 387430 Esther Chamorro‐
de‐Vega 9‐062 The effect of tranexamic acid on mortality, use of blood products and vascular adverse events in resuscitation of trauma patients Pharmacist impact on patient outcomes and ACLS compliance during in‐
hospital cardiac arrest A single center retrospective analysis of a protocol for high‐dose methotrexate and leucovorin rescue administration Implementation of a standardized process for dispensing medications from a specialized spinal cord pharmacy Medication use evaluation of metronidazole for double anaerobic coverage and appropriateness of therapy The clinical efficacy and cost effectiveness of Rasburicase, fixed dosing versus weight based dosing, in a multi‐
institutional healthcare system Evaluation of antimicrobial de‐escalation in patients with suspected sepsis at a community teaching hospital Direct‐acting antiviral agents for the treatment of chronic hepatitis c virus Date Time Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. 41 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. infection: effectiveness and safety. 385882 Carol Chan 9‐105 387306 Churg Chan 8‐023 387217 Jason Chan 12‐220 389618 Kay Chan 1‐132 388313 Mitchell Chan 9‐259 386091 Yazmin Chan 1‐133 Evaluation of adherence, safety, and efficacy of warfarin versus new oral anticoagulants in patients enrolled in a non‐profit health plan Evaluating a dosing protocol for tranexamic acid in a community teaching hospital Implementation and evaluation of a heparin dosing nomogram in a large urban healthcare system Feasibility study of implementing a pharmacist prescribed therapies program for acute conditions in community chain pharmacies Implementation of a pharmacy‐lead vancomycin dosing protocol in the intensive care unit (ICU) at a small community hospital Pharmacists' collaboration to optimize transitions of care: improving the transition from inpatient to outpatient settings for heart failure patients Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 42 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386326 Chia‐Lin Chang 9‐260 388128 Michelle Chang 10‐303 387294 Stephanie Chang 9‐261 385870 Ryan Chapin 1‐134 389405 Kimberly Chapman 8‐228 387422 Julia Chase 10‐063 387576 Nadiyah Chaudhary 1‐135 388841 Shakira Chavis 11‐101 387639 Daniel Chen 12‐221 Evaluating the impact of pharmacist intervention on Staphylococcal bacteremia utilizing real‐time surveillance technology Evaluation of phenytoin and fosphenytoin pharmacy dosing guidelines Impact of an antimicrobial stewardship program on discontinuation of empiric anti‐MRSA therapy Formalization of an antimicrobial stewardship program at a rural hospital Identification of neonatal exposure to medications via breast milk and impact of standardized medication recommendations on breast milk feeding rates in a pediatric hospital Hyperchloremic metabolic acidosis secondary to fluid resuscitation in patients diagnosed with sepsis in an intensive care unit setting Use of icatibant for ace‐
inhibitor induced angioedema (AIIA) Recombinant human regular insulin U‐500 medication use evaluation Evaluating the tolerability and efficacy of select dipeptidyl peptidase‐4 inhibitors compared to pioglitazone as optimal third agent of choice in Date Time Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. 43 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. veterans with type 2 diabetes 387716 Justin Chen 10‐225 387288 Victor Chen 11‐223 382962 Xinwei/Nancy 12‐222 Chen 387809 Mikalla Cheney 8‐229 387481 Rose Cheng 11‐224 384803 Serena Cheng 8‐024 388086 Eunah Cheon 8‐108 Evaluation of rabbit anti‐
thymocyte globulin for the treatment of acute renal allograft rejection in pediatric patients Double antifungal coverage with liposomal amphotericin B and voriconazole for persistent Candida parapsilosis fungemia Assessing the Appropriate Administration of Kcentra, Profilnine, and NovoSeven in a Community Hospital Assessing inpatient pharmacists role and competency in emergency codes. Comparing body surface area formulas in patients receiving cancer chemotherapy Influence of obesity on treatment outcomes in hospitalized patients with acute bacterial skin and soft structure infection Impact of pharmacists on the quality of anticoagulation management within a multidisciplinary healthcare team in a warfarin fast‐track service 44 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 384510 Ashley Cherniawski 9‐036 385155 Rachel Childers 1‐136 388903 Kelly Chillari 1‐137 386933 Jacinta Chin 8‐025 385264 Jamie Chin 12‐223 387030 Michael Chiou 9‐262 385977 Danielle Chipchura 9‐185 387617 Allen Chirackel 8‐109 Hemodynamic effects of dexmedetomidine compared to propofol in critically ill adults Utilization of electronic notifications as a reminder system to improve metabolic monitoring of patients on second‐
generation antipsychotics Assessment of the potential impact of dose rounding parenteral chemotherapy agents on cost savings and drug waste minimization Impact of antimicrobial stewardship pharmacist intervention using real‐
time rapid pathogen identification via MALDI‐
TOF MS on time to appropriate therapy for blood stream infections Single center experience with apixaban Assessment of clinical outcomes following implementation of a daily sedation interruption protocol in the intensive care unit at a community teaching hospital Infections post kidney transplant after low dose rabbit anti‐thymocyte globulin induction therapy Evaluation of use of intravenous ketamine in the emergency department for agitation Date Time Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 45 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. and pain control 386916 Brandon Chiu 8‐230 385148 Katie Chizmadia 9‐186 387705 Eun Jeong Choi 11‐225 385890 Miesoo Choi 9‐063 387309 Sebastian Choi 9‐187 385832 Dimpa Choksi 8‐080 388390 Vanessa Chong 10‐150 Demonstrate the impact of matrix‐assisted laser desorption ionization time of flight (MALDI‐TOF) on antibiotic stewardship, patient outcomes, and cost Exploring medication therapy management (MTM) in an inpatient setting Comparison of time to therapeutic international normalized ratio between vitamin K versus warfarin omission in absence of bleeding Propofol infusion syndrome (PRIS) safety initiative Assessing the impact of respiratory viral panel and rapid respiratory panel on antibiotic use and length of stay in an adult inpatient population Incidence of acute kidney injury in elderly patients receiving vancomycin with intermittent‐infusion piperacillin‐tazobactam versus extended‐infusion piperacillin‐tazobactam: a retrospective, cohort study Involvement of a hospital pharmacist in an outpatient physician office setting to perform medication management 46 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. and review 388390 Vanessa Chong 12‐101 387750 Nupur Chopra 10‐064 388765 Fabienne Chou 9‐188 387250 Parita Chowatia 8‐231 389553 Emily 8‐003 Christenberry Involvement of a hospital pharmacist in an outpatient physician office setting to perform medication management and review Effectiveness of a pharmacist implemented drug‐induced QTc‐
prolongation protocol for the prevention of torsades de pointes in an inpatient hospital setting Comparing treatment outcomes in patients with opioid use disorder treated with either extended‐
release naltrexone or buprenorphine at Veterans Affairs Western New York (VAWNY) Healthcare System Impact of pharmacists on carbapenem usage and integration of transitions‐
of‐care within an antimicrobial stewardship program in a community academic medical center Implementing a medical billing software to increase uptake of Tdap and herpes zoster vaccinations in Medicare Part D beneficiaries 47 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 389048 Alicia Christensen 1‐138 384759 Bryan Chudnow 8‐232 387711 Taylor Chuich 10‐151 387711 Taylor Chuich 12‐102 388495 Pamela Chukwuleta 10‐065 387824 Catherine Chun 12‐224 Proposed methicillin‐
resistant staphylococcus aureus treatment pathway: validation according to patient‐
specific treatment selections made by infectious disease physicians at Avera McKennan Hospital & University Health Center Effect of a pharmacist led post discharge visit and medication reconciliation on thirty day readmission rates and emergency room visits. Prospective initiation and implementation of a pharmacist and pharmacy student‐run medication reconciliation clinic for pre‐operative patients Prospective initiation and implementation of a pharmacist and pharmacy student‐run medication reconciliation clinic for pre‐operative patients Evaluation of nurse driven teaching during new medication administration: a hospital consumer assessment of providers and systems (HCAHPS) measure Conversion of enoxaparin to a direct oral anticoagulant (DOAC) for the treatment of venous thromboembolism (VTE): a Date Time Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. 48 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time retrospective analysis 389069 Christopher Chung 1‐139 388717 Vivian Chyan 1‐140 388858 Jason Ciaramitaro 12‐036 387769 Alana Ciolek 11‐037 385797 Nicole Cisler 1‐141 387536 Francesco Ciummo 8‐110 Development and evaluation of a pharmacist‐led vancomycin monitoring service for high risk patients at a tertiary care teaching hospital with limited clinical pharmacy staff Comparison of video to face‐to‐face education on patient knowledge in a newly established anticoagulation service in an internal medicine clinic with an underserved population Therapeutic substitution at a pediatric hospital: An evaluation Cost‐effectiveness of strategies aimed at reducing nitroprusside utilization and waste at an academic medical center Evaluation of system‐wide use of tranexamic acid and its potential safety concerns Multimodal pain management and high‐
dose liposomal bupivacaine for the treatment of postoperative pain in total knee replacement Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 49 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 389141 Alexander Clark 12‐225 388657 Dillon Clark 9‐189 389611 Jacqueline Clark 1‐142 386140 Kyle Clark 1‐143 389304 Christie Clauss 1‐144 387332 Brenna Clayton 1‐145 388659 Christina Clemens 9‐190 388726 Jenna Clemons 1‐146 Evaluating the performance of the pharmacy departments within three community hospitals. Inhaled insulin and chest pain related to second hand smoke Use of Intravenous Methadone in an Academic Medical Center Impact of a pharmacist‐
administered biometric screening on patient outcomes in an independent community pharmacy setting. Development of a pharmacist discharge medication review initiative within a children's hospital Retrospective review of appropriate stress ulcer prophylaxis discontinuation in the intensive care units and the impact of pharmacist education and interventions Evaluation of thromboprophylactic anti‐
Xa levels in morbidly obese patients receiving standard versus weight based doses of enoxaparin Impact of pharmacist intervention to improve appropriate proton pump inhibitor utilization Date Time Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 50 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 385645 Eduardo Clot 9‐001 388567 Brandon Clubb 1‐147 387500 Cory Coffey 12‐226 387518 Michael Cohen 9‐106 387339 Lauren Coker 9‐064 386535 Rose Colucci 10‐066 386257 Brette Conliffe 1‐148 Characterization of a Clinical Trials Unit Activity in a University Hospital Evaluating the effect of a pharmacist counseling service on medication‐
related HCAHPS scores and hospital readmission rates Evaluating the effect of a pharmacist‐led patient education program on chronic pain management in an underserved ambulatory care clinic. Drug utilization evaluation of sodium polystyrene sulfonate administered at the University of Rochester Medical Center Evaluation of Asthma Readmission Rates as Compared to the Joint Commission Standard Maintenance of patient international normalized ratio (INR) within therapeutic range at a pharmacist managed anticoagulation clinic Impact of an advanced pharmacy practice experience (APPE) student‐
run 'Meds 2 Beds' and discharge counseling program on quality of care Date Time Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 51 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 385413 Theresa Connelly 10‐152 385413 Theresa Connelly 12‐103 388963 Savannah Connolly 10‐304 387632 Kathryn Conti 8‐233 387254 Maureen Converse 1‐149 385273 Erin Conway 1‐150 387787 Monique Conway 9‐037 CMS guideline complicance at Saint Joseph Mercy Oakland for acute venothromboembolism treatment utilizing warfarin and a parenteral anticoagulant and its effect on length of stay CMS guideline complicance at Saint Joseph Mercy Oakland for acute venothromboembolism treatment utilizing warfarin and a parenteral anticoagulant and its effect on length of stay Evaluation of multiple dose dinoprostone for cervical ripening for induction of labor at a high volume community birth center Analysis of benzodiazepine and opioid co‐prescribing to Veterans at the Providence VA Medical Center: a pilot study Evaluation of dexmedetomidine use for sedation across a state‐
wide health system A retrospective review of outpatients treated for skin and skin structure infections in a VA hospital Evaluation of chromogenic factor X levels in the transition from argatroban to warfarin Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. 52 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388539 Allene Cook 8‐111 385747 Amy Cook 10‐305 385551 Elizabeth Cook 10‐260 387443 Emily Cooke 10‐226 389047 Brandy Cooper 9‐007 387623 Nathan Cope 9‐038 387812 Vanessa Copeland 10‐028 387731 Alexander Corboy 1‐151 Date Time Comparison of acute kidney injury in hospitalized patients with cellulitis when treated with broad‐spectrum antibiotics versus gram positive coverage alone Evaluation of current utilization of dornase alfa in the neonatal and pediatric populations in a community hospital Unit equivalency of insulin glargine to insulin detemir Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Evaluation of health literacy and knowledge of febrile neutropenia in parents and caregivers of pediatric hematology and oncology patients Impact of medication history collection by pharmacy students in the emergency department Evaluating the usage of TPN in adult patients at Carilion Roanoke Memorial Hospital Development of a value stream map for producing compounded sterile products using LEAN principles at a large academic medical center Assessment of safety outcomes with a pharmacist‐managed protocol for dosing and monitoring of vancomycin in a Veterans Affairs hospital Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 53 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386283 Ashley Core 8‐112 384734 Laura Cotiguala 8‐081 385881 Benjamin Cottongim 10‐067 385833 Stephanie Cotugno 9‐039 388349 Lindsey Coval 10‐029 389107 Kevin Cowart 10‐068 387521 Ann Cowden 8‐026 387654 Jacob Cox 11‐060 387515 Sarah Cox 8‐113 Timing of anticoagulation therapy in atrial fibrillation status post cardioembolic stroke Pharmacist‐led medication education service for cardiac transplant recipients Effects of ketamine on early extubation in postoperative mechanically ventilated coronary artery bypass graft patients Impact of pharmacist intervention on influenza vaccination rates in a psychiatric patient population Antibiotic consumption after implementation of a neutropenic fever guideline Evaluation of intravenous acetaminophen usage in bariatric surgery patients Impact of multiplex polymerase chain reaction (PCR) technology and automatic infectious disease consultation on clinical and economic outcomes Analysis of carbapenem utilization at a regional community hospital Factors associated with 30‐
day readmission avoidance after pharmacist‐led inpatient diabetes education Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 54 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 384380 Rachael Craft 9‐263 386538 Andrea Crahan 11‐102 386427 Adam Craig 9‐107 387205 Danielle Craig 11‐143 389449 William Crall 10‐153 389449 William Crall 12‐104 386516 Lindsay Crawford 11‐300 387318 Nicole Croyden 8‐114 Impact of proper allergy reporting of antibiotics for inpatients on a routine medical floor Prescribing cascades: the incidence of anti‐gout medications in patients taking thiazide diuretics Mock Signal Evaluation: A longitudinal project designed to enhance student understanding of how a clinical skill set can be transferred to a real pharmaceutical industry activity Evaluation of facility‐
specific risk factors for Clostridium difficile infection rates and implementation of strategies for subsequent rate reduction Evaluation of dyskalemia in pentobarbital‐treated patients with refractory status epilepticus or intracranial hypertension Evaluation of dyskalemia in pentobarbital‐treated patients with refractory status epilepticus or intracranial hypertension Evaluation of medication‐
related variables in heart failure readmissions at the Boise VA Medical Center Evaluation of antimicrobial de‐escalation for mechanically ventilated patients in a community Date Time Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 55 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. teaching hospital intensive care unit 386657 Emily Crum 10‐154 386657 Emily Crum 12‐105 388017 Keri Crumby 11‐061 388573 Sara Csont 8‐234 385147 Marissa Csovelak 1‐152 387454 Yan Cui 1‐153 Antibiotic therapy for the treatment of urinary tract infections in a long term care facility Antibiotic therapy for the treatment of urinary tract infections in a long term care facility Impact of pharmacist driven, multidisciplinary initiative to reduce antibiotic use for treatment of asymptomatic bacteriuria The impact of an inpatient medication therapy management (MTM) service at a community hospital Retrospective study to evaluate nausea, vomiting, and hypersensitivity reactions in patients receiving FOLFOX for colorectal cancer at an infusion center not routinely administering prophylactic dexamethasone Evaluation of the current monitoring process for patients receiving target specific oral anticoagulants (TSOACs) and its impact at the Cincinnati Veterans Affairs Medical Center (CVAMC) 56 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386110 Marissa Cullen 10‐282 385638 Melanie Cullen 10‐283 387304 Heidi Cung 8‐115 387925 Jeff Curless 12‐037 389241 Kelly Curran 11‐038 388678 Brent Curry 1‐154 386350 Breanna Curtis 8‐068 388935 Christa Curtis 9‐040 Intravenous infusion administration charge verification in a charge on administration environment Pharmacist consult for the conversion or initiation of direct acting oral anticoagulants Optimization of medication clinical decision support (mCDS) with focus on improving clinical relevance in drug‐
drug interaction (DDI) and duplication therapy Nitazoxanide for the treatment of Clostridium difficile infection in pediatric patients Evaluation of a pharmacist led admission medication reconciliation process with an effort to reduce medication errors in a community hospital setting. Assessing prescribing practices of clozapine before and after the implementation of an updated risk evaluation and mitigation strategy (REMS). Effects of the availability of CYP2C19 genotype on prescribing behavior for clopidogrel in primary care Hypoglycemia and its association with tighter glucose control in type two Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. 57 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. diabetics in a community hospital 385666 Jaclyn Cusumano 11‐226 Daptomycin non‐
susceptible methicillin resistant Staphylococcus aureus: a case report Evaluating the effect of insulin prescribing practices on blood glucose control in critically ill patients Pharmacist‐led transitional care program on 30‐day readmissions, medication appropriateness, and patient satisfaction within a community hospital Pediatric antithrombin III medication use evaluation 388759 Lindsay Cwynar 8‐082 386880 Akorede Dada 11‐039 383201 Matthew Dandino 10‐155 383201 Matthew Dandino 12‐106 Pediatric antithrombin III medication use evaluation Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. 387353 Daniel Dang 10‐156 Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. 387353 Daniel Dang 12‐107 Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. 387603 Divya Daniel 8‐116 Wednesday, December 9 10:00 ‐ 11:00 a.m. 389451 Ryan DasGupta 8‐069 Evaluation of fluconazole prescribing patterns in a non‐teaching community hospital Evaluation of fluconazole prescribing patterns in a non‐teaching community hospital Effect of lactobacillus on duration of ventilator therapy in critically ill patients Evaluation of intravenous phenytoin and fosphenytoin loading doses in obese patients Wednesday, December 9 10:00 ‐ 11:00 a.m. 58 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 387702 Aimee Dassner 8‐117 388385 Nhu Quyen Dau 11‐227 388782 Michelle Davids 9‐008 387938 Erin Davidson 1‐155 389319 Camellia Davis 10‐157 389319 Camellia Davis 12‐108 387961 Joseph Davis 12‐227 Evaluation of nephrotoxicity before and after implementation of vancomycin per pharmacist protocol Evaluation of rivaroxaban and apixaban prescribing patterns and associated outcomes in patients with atrial fibrillation at a large academic medical center A retrospective review of intensive versus conventional blood glucose protocols in critically ill patients The role of a pharmacist managed smoking cessation program in a community charity clinic: a retrospective review Utilization of multiplex polymerase chain reaction (PCR) technology and pharmacist involvement in the identification of gram negative blood stream infections Utilization of multiplex polymerase chain reaction (PCR) technology and pharmacist involvement in the identification of gram negative blood stream infections Impact of a pharmacist vancomycin dosing guideline on achievement of therapeutic trough levels Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. 59 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388732 Kevin Davis 12‐193 383722 N. Logan Davis 9‐065 384565 Tamara Davis 9‐041 388721 AMAYA DE BASAGOITI GORORDO 8‐118 388482 Alyssa De Castro 11‐144 388901 Jaymes Dean 9‐191 386752 Heather DeAtley Ratliff 11‐145 387614 Angela DeBerardine 1‐156 Medication use evaluation of budesonide/formoterol use in large community hospital system. Development of a peer‐
review quality improvement program for clinical pharmacy services Evaluation of time to first dose of antibiotics and appropriateness of antibiotic choice in PICU patients with suspected severe sepsis and septic shock Standardization of antineoplastic agents dosage in hepatic insufficiency Role of lorazepam in treating chemotherapy‐
induced nausea and vomiting after unsuccessful ondansetron treatment in pediatric population Improving the management of drug shortages through the development of a workflow checklist, intranet webpage, and telephone hotline Evaluating the efficacy of morphine protocols to treat neonatal abstinence syndrome for a level two nursery in a rural community hospital. Evaluation of the use of rivaroxaban in cancer Date Time Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 60 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. patients 385831 John Dechand 8‐119 388535 Andrew Decker 11‐062 387429 Kaitlyn DeHoff 11‐283 387946 Sarah Deitering 10‐069 386279 Kelly DeJager 8‐326 389053 Timothy DeJesus 12‐194 387293 Annalisa Delagarza 1‐157 Vasoplegic syndrome in patients undergoing coronary artery bypass grafting: an evaluation of pharmacologic management Stability of extemporaneously prepared sodium benzoate oral solution The effect of heparinization on outcomes of therapeutic hypothermia Comparison of iron dextran infusion times on safety, efficacy, and cost for the treatment of iron‐
deficiency anemia Evaluation of rivaroxaban, apixaban, dabigatran, and warfarin on hospital readmission rates following initiation of medication for non‐
valvular atrial fibrilation and venous thromboembolism Evaluation of intravenous immune globulin utilization and prescribing practices in a community health system Testosterone drug use evaluation with implementation of a medication use evaluation tool in a Veteran Affairs Medical Center Sunday, December 6 3:45 ‐ 5:15 p.m. 61 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 389061 Daniel Delaney 1‐158 387856 Hanna Delaney 8‐235 388330 Michael Deleener 9‐108 387891 Christopher 8‐236 DeLeersnyder 382943 Alexander Dellabella 1‐159 387640 Bethany Dellay 9‐042 387501 Lindsey DeLoach 11‐063 387616 Paige DeLuca 8‐120 Antimicrobial utilization and the effect of rapid methicillin‐resistant Staphylococcus aureus colonization detection on vancomycin discontinuation in pneumonia: a quality improvement evaluation Pharmacist impact in a patient‐centered medical home (PCMH): average hemoglobin A1C and co‐
morbidity reduction in patients with type 2 diabetes The impact of a points‐
based medication screening tool and pharmacist counseling on fall rates in a community hospital Impact of transfusion guidelines on the use of erythropoietin stimulating agents and parenteral iron Evaluation of ceftaroline and restricted use policy at a large, tertiary care institution Evaluating the use of intravenous hydralazine at a teaching institution Patient adherence in patient assistance programs Medication use evaluation of dexmedetomidine in adult intensive care unit (ICU) patients Date Time Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 62 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388295 Jason Dent 10‐306 388870 Lauren DeRespiris 1‐160 385682 Melissa Derner 1‐161 386522 Kathryn Derrig 10‐284 386426 Charles Gregor Derupe 8‐121 388637 Anand Desai 8‐312 385529 Bansri Desai 1‐162 386549 Hilary Devine 8‐122 385807 Lauren Devine 1‐163 Evaluation of comprehensive prospective pharmacist order verification in the emergency room Stewardship evaluation of anti‐infective use errors in hospitalized patients on hemodialysis The prevalence of adults 65 years and older presenting to a US ED with injury who are prescribed a skeletal muscle relaxant Impact of pharmacists in adherence to American Heart Association guidelines during advanced cardiac life support Igniting pharmacy advocacy: increasing Maine pharmacist and pharmacy student engagement in pharmacist provider status advocacy Measurement & improvement of intravenous antibiotic administration time in critically‐ill patients Impact of targeted adherence calls among a Marketplace population Assessing adverse bleeding events in patients taking rivaroxaban or warfarin Rate of appropriate statin therapy in HIV patients on a protease inhibitor antiretroviral therapy Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 63 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time regimen 386792 Jordan DeWitt 1‐164 387265 Tara Dicker 9‐109 387510 Sarah Dickey 8‐027 387286 Sarah DiDominick 8‐004 385733 Sandy Diec 12‐038 386856 Tyson Dietrich 1‐165 Negative predictive value of methicillin‐resistant staphylococcus aureus (MRSA) nasal polymerase chain reaction (PCR) in critical care patients with pneumonia Impact of pharmacist‐
driven discharge counseling and medication therapy management (MTM) on 30‐day hospital readmission rates in patients with chronic illnesses Transitional interventions from the emergency room: impact of clinical pharmacists and telehealth services on acute care utilization (TIER project) Retrospective assessment of efficacy, safety, and satisfaction of updated pain management order sets at a community hospital Evaluation of a mobile telehealth support for self‐
monitoring of blood glucose in primary care clinic patients with diabetes ‐ a pilot study Implications of carrier fluids in critically ill patients with a positive fluid balance Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 64 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 387477 Girish Dighe 8‐237 388788 Naomi Digiantonio 9‐009 387329 Roman Digilio 10‐070 385953 Sylvia Dikas 1‐166 385567 Heather Dillenbeck 1‐167 387549 Nicholas Dillman 12‐039 385237 Ryan Dillon 8‐123 387681 Mary Dimaano 10‐071 384755 Erica Dimitropoulo
s 1‐168 Development and implementation of a denials prevention program at two outpatient hospital‐based infusion centers Impact of a pharmacy‐led medication reconciliation program Impact of a hospital pharmacist coordinating transition of care in an assisted living facility The Impact of Intravenous Acetaminophen on Opioid Requirements in Postoperative Inpatients in a Veteran Affairs Health System Drug‐use evaluation: the treatment of intra‐
abdominal infections at Highland Hospital Evaluation of the effects of ventricular assist devices on vancomycin serum concentrations in pediatric patients Evaluation of intravenous chlorothiazide use at a large academic medical center Evaluation of hepatitis c virus cure rates in those receiving direct acting antiviral therapy Evaluation of concurrent oral and long‐acting injectable antipsychotic prescribing at the Minneapolis Veterans Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 65 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Affairs Health Care System (MVAHCS) 389348 Pavlin Dimitrov 9‐110 388202 Catherine Dinkins 11‐146 388487 Kyle DiPaola 11‐040 388336 Caitlin Dirvonas 10‐010 385614 Brianne Dixon 8‐238 389593 Tamara Dixon 1‐169 385272 Brian Do 11‐228 Understanding the impact of delirium on patients admitted to the ICU in a community‐based, level II trauma center: a retrospective analysis Designing a comparison of hospital length of stay in patients treated with direct oral anticoagulants or warfarin for venous thromboembolism Assessing the impact of a pain and sedation protocol revision on mechanically ventilated pediatric patients in the pediatric intensive care unit The prevalence and management of vitamin D insufficiency and deficiency in veterans admitted to an acute inpatient psychiatric unit Bad to the Bone: Ceftolozane/Tazobactam for Osteomyelitis. Two Case Reports Improving Diabetes Care at a Rural VA Outpatient Clinic Incidence of venous thromboembolism in oncology patients following major surgery Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. 66 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388257 Geeyeon Do 1‐170 387894 Jennifer Do 11‐301 389089 Timmy Do 8‐124 387358 Cortney Dodson 8‐028 388646 Nicholas Dodson 12‐040 384331 Kim Doerhoff 11‐302 386349 Philip Dollin 9‐043 386602 Kirsten Donnan 12‐007 Pharmacist development and implementation of multidisciplinary hypertonic saline administration policies, procedures, dosing algorithm, and education Effectiveness of a vancomycin dosing regimen utilizing adjusted body weight in obese patients versus non‐obese patients Medication use evaluation of intravenous fluids containing vitamins Accuracy of body weight obtainment in patients who receive alteplase in the emergency department for an acute ischemic stroke Evaluation of pharmacist‐
led discharge education in the emergency department: impact on 30‐
day emergency department revisits and hospital admissions Assessment of the continuation of antipsychotics prescribed for ICU delirium Analysis of use of procalcitonin assay in COPD exacerbations at an academic medical center Safety and efficacy of direct oral anticoagulant (DOAC) use in patients who completed catheter‐
Date Sunday, December 6 Time 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. 67 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. directed thrombolysis with the endowave system 387276 Kailee Donner 12‐228 386859 Sasha Dorzin 11‐122 388811 Emily Doss 12‐008 385302 Cassandra Dotson 12‐009 385684 Kierra Dotson 8‐239 389204 KariLynn Dowling 10‐072 388747 April Downey 11‐007 Evaluation of meningococcal vaccination rates in adolescents at one urban clinic Implementation of a pediatric antimicrobial stewardship program (ASP) targeted to decreasing the use of antibiotics in children during an asthma exacerbation. Prescribing patterns and follow‐up practices of target‐specific oral anticoagulants within VA‐
Tennessee Valley Healthcare System Evaluation of pharmacist views and safety aspects of house bill 2879 Evaluation of real life treatment outcomes among veterans with HCV genotype 1 treated with 12‐week regimens of newer direct‐acting antivirals Implementation of a two‐
phase intranasal naloxone initiative in a patient‐
centered medical home Seizure prophylaxis after traumatic brain injury: a retrospective analysis of antiepileptic use for post‐
traumatic seizure prevention 68 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386647 Lauren Downing 9‐264 386099 Zachary Drabick 8‐029 385211 Nadine Drago 8‐083 389289 Michael Drake 1‐171 388582 Anna Drapkin 9‐192 387478 Zachary Drawe 1‐172 386791 Annette Drobac 9‐018 387989 Amy D''Silva 8‐125 An Evaluation of Antimicrobial Exposure and Therapeutic Management in Patients Diagnosed with Clostridium Difficile at an organization with an Antimicrobial Stewardship Program Evaluation of a noninvasive cardiac output monitoring (NICOM)‐based protocol in patients with septic shock Intravenous acetaminophen use: a retrospective review of adherence to hospital restrictions Implementation of a pharmacist‐run outpatient oral chemotherapy clinic at a veterans affairs medical center Common themes in Clostridium difficile infection at a community teaching hospital Vancomycin‐associated nephrotoxicity: a retrospective review of the incidence and associated risk factors Optimizing empiric prescribing practices and outcomes in cellulitis patients seen in an urban community hospitals emergency department Venous thromboembolism prophylaxis point prevalence study Date Time Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 69 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 387053 Le Du 1‐173 388875 Maria Duarte 8‐126 388523 Kari Duckworth 9‐193 385744 Rachel Duffield 1‐174 384356 Katerine Dumais 1‐175 385154 Kellyn Duncan 12‐041 386129 Samantha Duncan 1‐176 389112 Abby Dunker 1‐177 Visual assessment tool to evaluate performance and improve pharmacy quality and productivity: clinical and financial measures Evaluating the use of non‐
vitamin k antagonist oral anticoagulants in a community hospital Description of antibiotic therapy in patients with healthcare‐associated pneumonia and a documented beta‐lactam allergy Expansion of a pharmacist‐
managed hypertension clinic within the patient aligned care team (PACT) model in the VA Central Iowa Health Care System Retrospective chart review assessing impact of weekly paclitaxel plus carboplatin and dose‐dense doxorubicin/cyclophospha
mide (ddAC) on relative dose intensity (RDI) in breast cancer patients Evaluation of vancomycin dosing in patients receiving high‐flux dialysis PTSD screening in underserved population in a primary care setting Development of a pharmacy response plan to prepare for a nursing workforce disruption Date Time Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 70 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 385643 Laura Dunlap 10‐261 383309 Sarah Dunn 11‐123 386541 Ian Dunne 1‐178 387615 Richard Duong 9‐111 387340 Marianne Dust 10‐011 387291 Elliott Duvall 12‐042 385897 Andrew Dwenger 1‐179 385432 Stephanie Dwyer 11‐229 Evaluation of tranexamic acid utilized in patients undergoing total knee arthroplasty Anticoagulation therapy in non‐valvular atrial fibrillation upon discharge from UTMC: an analysis of guideline compliance Evaluation of daptomycin dosage on clinical outcomes in vancomycin‐
resistant enterococcal infections at a Veterans Affairs academic teaching hospital Retrospective evaluation of disease modifying therapy utilization patterns and healthcare resource utilization in multiple sclerosis Implementation of pharmacist directed warfarin dosing in a community hospital Barcode scanning compliance within the antepartum unit and the impact of educational intervention Beta‐blocker review of agents in veterans with reduced ejection fraction (BRAVE) Evaluation of digoxin therapy in veterans with atrial fibrillation and time to first hospitalization related to a cardiac event Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 Wednesday, December 9 3:45 ‐ 5:15 p.m. 1:45 p.m. ‐ 2:45 p.m. 71 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386826 Caitlin Early 11‐147 386254 Chelsea Ebert 1‐180 385383 John Edelstein 10‐227 387941 Simone Edgerton 12‐297 386319 Lindsay Edmondson 9‐265 387710 Marc Edmundson 1‐181 385775 Ahmed Eid 10‐228 389525 Amber Elam 9‐112 386097 Megan Elavsky 8‐030 Pegging down risk factors for peg‐asparaginase toxicity in patients with acute lymphoblastic leukemia Impact of pharmacist‐run medication management clinic in a patient centered medical home Impact of an infectious disease consult on Staphylococcus aureus bacteremia management Implementation of the lean six sigma methodology to reduce pharmaceutical waste within an urban, government funded, tertiary care hospital Efficacy of 6mg single fixed‐dose rasburicase for prophylaxis and treatment of tumor lysis syndrome in a hospital network of adult and pediatric hematology/oncology patients Predictors of tobacco cessation success among VA participants Medication use evaluation: prescribing indications of levetiracetam for adult mixed intensive care unit patients. Central Alabama Veterans Healthcare System Date Time Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Medication use evaluation Wednesday, of argatroban for heparin December 9 induced thrombocytopenia 10:00 ‐ 11:00 a.m. 72 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. at a tertiary care institution 387746 Yasmine Elbaga 8‐327 389266 Katie Elder 10‐307 385224 Zane Elfessi 11‐230 389093 Emily Elftman 1‐182 386794 Amy Eliason 12‐175 385592 Kaitlyn Elliott 1‐183 Implementation of a pharmacist‐driven antimicrobial stewardship service for general medicine adult inpatients receiving piperacillin/tazobactam or cefepime ‐ a pilot study Evaluation of empiric antifungal treatment in patients with thermal or inhalational injury Impact of push‐dose phenylephrine to prevent hemodynamic instability during rapid sequence intubation Assessment of referrals initiated and facilitated in a pharmacist‐led transition of care outpatient clinic Evaluation of the implementation of a new neonatal gentamicin dosing regimen based on the pharmacokinetic parameters in neonates with early onset sepsis Evaluation of vancomycin dose calculators in predicting empiric dosing and steady state trough levels in the adult veteran patient population Sunday, December 6 Wednesday, December 9 Sunday, December 6 3:45 ‐ 5:15 p.m. 3:00 p.m. ‐ 4:00 p.m. 3:45 ‐ 5:15 p.m. 73 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 385587 Amanda Eloma 12‐229 386200 Sarah El‐
rachidi 1‐184 388709 Steven Elrod 9‐170 388709 Steven Elrod 11‐198 385376 Eric Elsasser 10‐285 384746 Osama Emara 11‐064 389138 Elizabeth England 8‐127 Evaluation of clinical institute withdrawal assessment‐alcohol, revised (CIWA‐Ar): correct initiation in the presence or absence of documented risk factors for alcohol withdrawal Retrospective review of fosaprepitant for prophylaxis and treatment of nausea and vomiting in patients undergoing autologous stem cell transplant How to Optimize Polypharmacy Services that are Integral to Patient Centered Medical Home (PCMH) How to Optimize Polypharmacy Services that are Integral to Patient Centered Medical Home (PCMH) Assessment of patient benefits and follow‐up for commonly approved non‐
formulary medications at a single veterans affairs medical center Analysis of pharmacist involvement in management of urinary tract infections in a long‐
term care facility Dexmedetomine adjunct therapy compared to benzodiazepines alone for the treatment of alcohol withdrawal syndrome in Date Time Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 74 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. critically ill trauma patients 386131 Corinne English 10‐229 386273 Erin Eriksson 10‐073 386896 Aaron Ernstberger 1‐185 388555 William Erwin 1‐186 387204 Belen Escudero 11‐148 384756 Vicente Escudero‐
Vilaplana 11‐189 387590 Fernando Estrada 8‐328 388258 Raymond Estrada 9‐194 Dexmedetomidine versus usual care for treatment of severe alcohol withdrawal in the medical intensive care unit Evaluation of sotalol monitoring at a community teaching hospital Evaluation of a dosing strategy for therapeutic enoxaparin for acute venous thromboembolism at the Cincinnati Veterans Affairs Medical Center Medication use evaluation (MUE) of apixaban in a Veterans Affairs Medical Center (VAMC) Optimization of antiretroviral theraphy in HIV patients Structured guide for pharmacist interviews and onco‐hematologic outpatients education Implementation of pharmacy‐driven evaluation of intravenous antibiotics before hospital discharge Reduction of healthcare‐
associated Clostridium difficile readmission rates through pharmacist antimicrobial stewardship review of discharge Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. 75 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. antibiotics 383587 Ashley Evans 9‐195 389475 Kellie Evans 10‐158 389475 Kellie Evans 12‐109 389487 Stacy Evans 8‐313 388029 Michael Ezebuenyi 12‐298 384412 Nuha Fairaq 12‐043 Impact of implementation of a layered learning model on pharmacy‐led warfarin patient education Effects of a pharmacy technician‐driven admission medication reconciliation program for psychiatric patients boarding in the Grant Medical Center Emergency Department Effects of a pharmacy technician‐driven admission medication reconciliation program for psychiatric patients boarding in the Grant Medical Center Emergency Department Implementation of an electronic order template to prevent the spread of fluoroquinolone resistance in an outpatient setting Evaluation of physician prescribing patterns for antibiotics in the treatment of cellulitis Impact of medication reconciliation by pharmacist during transition of care from adult intensive care unit (ICU) to regular hospital wards. 76 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 383481 Savana Fairchild 1‐187 386586 Nicole Farabaugh 10‐159 386586 Nicole Farabaugh 12‐110 386464 Nada Farhat 10‐160 386464 Nada Farhat 12‐111 386867 Nicholas Farina 9‐019 389159 Kevin Farrow 11‐204 386235 Esther Fasanmi 8‐314 Impact of the implementation of Project Re‐Engineered Discharge (RED) for chronic obstructive pulmonary disease (COPD) patients at a Veterans Affairs hospital Impact of pharmacy intervention on Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) medication communication scores Impact of pharmacy intervention on Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) medication communication scores Risk factors for pseudomonas aeruginosa in diabetic foot infections Risk factors for pseudomonas aeruginosa in diabetic foot infections Evaluation of fidaxomicin use for Clostridium difficile infections across a state‐
wide health system Evaluation of a newly implemented diabetic ketoacidosis (DKA) protocol in a community teaching hospital Determination of medication possession ratio thresholds for viral suppression in HIV‐
infected patients Date Time Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 77 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388435 Veronica Fassio 1‐188 387563 Shane Fassnacht 11‐231 387211 Nayyra Fatani 1‐189 384314 Joseph Faulhaber 1‐190 385836 Mollie Fearing 9‐113 387226 Ryan Feeney 9‐114 Trends in non‐steroidal anti‐inflammatory drug prescriptions before and after an opioid safety initiative in the Veterans Health Administration Comparing error rates of a newly implemented electronic health record (EHR) to previous paper record orders in an outpatient oncology setting Evaluation of the use of non‐vitamin‐K‐antagonist oral anticoagulants (NOACs) in a community teaching hospital and the impact of medication reconciliation on medication discrepancies Evaluation of the treatment of alcohol withdrawal before and after implementation of a new alcohol withdrawal treatment protocol at a community teaching hospital Evaluation of opioid education in post‐
operative orthopedic patients Evaluation of pharmacologic agents for the management of atrial fibrillation in hemodynamically unstable patients Date Sunday, December 6 Wednesday, December 9 Time 3:45 ‐ 5:15 p.m. 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. 78 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 389358 Jessica Fennelly 9‐266 385206 Amanda Fenstermach
er 10‐030 386524 Kirsten Ferguson 10‐074 389322 Ryan Ferren 9‐066 387273 Kelsey Fink 8‐128 388755 Meggie Finley 11‐149 387969 Danielle Finn 1‐191 388433 Michela Fiori 8‐031 Evaluation of a comprehensive medication review service in a patient‐
centered medical home Medication use evaluation of calcitonin injection within the St. Luke's University Health Network Targeted temperature management following cardiac arrest: Outcomes of cooling to 33 degrees celsius versus 36 degrees celsius Impact of the Verigene Gram‐positive blood culture assay on time to appropriate antibiotic therapy for Staphylococcus aureus bacteremia at an academic medical center Compliance with oxytocin protocol in laboring patients Evaluating the utilization of tbo‐filgrastim and pegfilgrastim in adult patients with solid tumors and non‐myeloid malignancies Effectiveness of a psychiatric pharmacy resident intervention in reducing benzodiazepine use in elderly veterans Outcomes of a pharmacist‐
driven education program for residents discharged from a skilled nursing facility Date Time Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 79 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 384738 Lindsey Firman 12‐195 388558 Daniel Fischer 9‐267 388175 Diana Fischer 1‐192 387407 Allison Fisher 8‐240 385810 Scott Fitter 10‐075 386519 Alyssa Fixl 10‐003 386276 Meghan Fletcher 11‐150 388896 Rebecca Fletcher 1‐193 Development of a pharmacist driven medication review process to address polypharmacy in patients within a neurology clinic Prothrombin complex concentrate compared to fresh frozen plasma for the emergent reversal of warfarin related intracranial hemorrhage Pharmacist resident implementation of a transitions of care system in a community hospital Assessment of prophylactic antibiotics on surgical site infections in elective colorectal surgeries Comparison of outcomes in patients receiving four factor prothrombin complex concentrate for reversal of warfarin vs. other coagulopathies Risk factors for adverse events during hypertension management in the emergency department: a comparison of intravenous antihypertensive therapies Effect of education on tetanus vaccinations administered in an emergency department Low‐dose methotrexate induced hematologic toxicity after acute kidney Date Time Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 80 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Injury and concomitant diflunisal 387409 Elizabeth Flippin 1‐194 384577 Marcus Flores 9‐196 387613 Kelsie Flynn 1‐195 387376 Kevin Flynn 1‐196 386894 Lauren Flynt 12‐044 389422 Christopher Foley 1‐197 389263 Heather Folz 1‐198 Characterizing antidiabetic prescribing in hospitalized patients at a Veterans Affairs Medical Center Bariatric surgery in patients receiving oral cancer treatment at MetroHealth Medical Center Comparison of venlafaxine and duloxetine: measuring clinical impact of time to therapeutic effect among patients achieving therapeutic dosing for pain. Effect of decentralization of as needed and one‐time hospital medication dispensing on pharmacy workload and timeliness of medication administration in a Veterans Affairs hospital To cap or not to cap? The effects of dose‐capping unfractionated heparin for venous thromboembolism. Correlating uncontrolled depression with worsening control of diabetes using HbA1c and PHQ9 scores Course redesign of the my first patient program into the clinical assessment course Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 81 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386299 Garrett Foo 1‐199 385144 Farnaz Foolad 11‐151 385411 Ashley Ford 8‐241 388819 Maria Foreman 9‐268 382641 Jeanne Forrester 9‐171 382641 Jeanne Forrester 11‐199 388865 Emily Foster 9‐115 Impact of a clinical pharmacist at reducing anticholinergic medication burden in older, medically complex Veterans Impact of a stewardship intervention on duration of therapy and associated Clostridium difficile infection among patients with community acquired pneumonia Evaluation of patient safety when using U‐500 insulin in an acute care setting Implementation and evaluation of a pharmacist‐based vancomycin dosing protocol in a rural, community hospital Incidence of hyponatremia and hypovolemia in pediatric patients receiving standard intravenous maintenance fluids Incidence of hyponatremia and hypovolemia in pediatric patients receiving standard intravenous maintenance fluids Time to resolution of SIRS criteria in patients with acute pancreatitis receiving lactated ringer's solution versus normal saline for fluid resuscitation Date Sunday, December 6 Time 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. 82 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386128 Ashley Fox 8‐032 387697 Jill Frament 8‐129 386489 Jeannie Francis 1‐200 387141 Julie Francisco 1‐201 383584 Richard Francisconi 10‐076 387314 Taylor Franckowiak 10‐077 385856 Elizabeth Franco 10‐308 389524 Matthew Franke 11‐232 Prescribing patterns at discharge after an acute coronary event in a state with high rates of coronary heart disease mortality Medication dosage form adjustment prior to bariatric surgery: partnering with patients and providers before admission The impact of a clinical oncology pharmacist in the management of oral chemotherapy Evaluation of specialty pharmacy services and outcomes for hepatitis C at a large academic medical center Overview of antiemetic use in pediatric oncology patients at a children's hospital Derivation and validation of a 30 day hospital readmission risk index Duration of mechanical ventilation in patients in the intensive care unit (ICU) treated with benzodiazepine vs nonbenzodiazepine based sedation Implementation of a community‐outreach program to increase usage of intrauterine devices (IUD) in women less than 18 years old Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. 83 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 385168 Andria Frazier‐
Brantley 12‐010 385595 Amy Frederick 12‐230 386433 Anna Claire Freeman 9‐269 382939 Mallory Freeman 8‐242 387600 Caitlin Frohnapple 12‐231 389378 Madeline Fry 10‐161 389378 Madeline Fry 12‐112 Bridging gaps in care through direct pharmacist involvement in admission, discharge, and transitions of care Effect of visit frequency of pharmacist‐led medication management program (MMP) visits on diabetes clinical outcomes Optimization of daptomycin: assessing prescribing habits after criteria‐for‐use implementation Evaluation of confounding factors prior to hyperglycemic events in adult hospitalized patients The Use of tPA for Acute Ischemic Stroke in Patients with low NIHSS scores Impact of an innovative patient communication tool on a pharmacists identification of medication related problems and the patient‐
pharmacist relationship in a high‐risk Medicaid population Impact of an innovative patient communication tool on a pharmacists identification of medication related problems and the patient‐
pharmacist relationship in a high‐risk Medicaid population Date Time Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. 84 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386592 Vanessa Gaerig 9‐270 388536 Alexis Gaggini 11‐103 386356 Patrick Galdun 1‐202 387650 Stormi Gale 1‐203 388460 Joseph Galipean 1‐204 387737 Anthony Gall 12‐232 388436 Sara Gallardo 12‐045 Borge 387527 Alyssa 12‐233 Gallipani Early steroid withdrawal and graft rejection in kidney transplant patients Impact of a pharmacist‐
directed insulin management collaborative practice agreement on diabetes care in a patient‐
centered medical home Establishment of a pharmacist managed hepatitis c clinic in a rural Indian Health Service hospital New protocol using unfractionated heparin for radial‐access percutaneous coronary intervention in acute coronary syndrome patients Use of coformulated ledipasvir/sofosbuvir for hepatitis C virus genotype 1 in patients coinfected with HIV‐1 being treated with concomitant boosted HIV protease inhibitors and tenofovir Analyzing the feasibility of a pharmacy managed anemia clinic Acute intermittent porphyria case report Cost analysis of single, low‐
dose rasburicase for the management of tumor lysis syndrome in adult cancer patients Date Time Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. 3:00 p.m. ‐ 4:00 p.m. 85 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 389659 Jeffery Galyon 11‐104 386343 Angela Gamwell 9‐044 386551 Kevin Gan 1‐205 387505 Geetika Gandhi 12‐234 388456 Erin Gandrud 9‐067 385864 Jessica Ganschow 1‐206 388228 David Garbarz 10‐230 Title: Effectiveness of adjunct dexmedetomidine therapy on decreasing benzodiazepine administration in the treatment of alcohol withdrawal syndrome (AWS) in the intensive care unit (ICU) Severe sepsis or septic shock upon arrival to the emergency department (ED)‐ are ED pharmacists improving outcomes? Development of a protocol for the prevention of deep vein thrombosis/pulmonary embolism for patients admitted in an acute care setting Evaluation of heparin and enoxaparin monitoring in patients with doses adjusted for obesity Medication utilization evaluation of imipenem/cilastatin at a northern Colorado community hospital Optimization of aldosterone antagonists for heart failure at hospital discharge from the Portland VA Healthcare System Clinical and financial impact of a pharmacist coordinated penicillin allergy testing program Date Time Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. 86 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 387602 Graham Garcia 10‐162 387602 Graham Garcia 12‐113 386911 Katelynn Garcia 8‐130 385866 Xandra Garcia‐
Gonzalez 10‐309 385232 Jessica Gardea 9‐271 389380 David Gardner 8‐005 386143 Stephanie Gartrell 11‐152 389083 Mike Gassmann 1‐207 Impact of antibiotic dispensing and counseling by a pharmacist at the time of hospital discharge on readmission rates for patients with pneumonia Impact of antibiotic dispensing and counseling by a pharmacist at the time of hospital discharge on readmission rates for patients with pneumonia Evaluation of therapeutic enoxaparin dosing and corresponding anti‐Xa levels in obese hospitalized patients: a prospective observational study Adverse events associated with genetic variations in colorectal cancer patients treated with capecitabine Evaluating glycemic control for patient‐aligned care team Clinical Pharmacy Specialists at the Michael E. DeBakey Veterans Affairs Medical Center Efficacy of educational videos on health related topics and its correlation with health literacy Implementation of a patient self‐testing program within a pharmacist‐managed anticoagulation clinic Quality assessment of admission medication reconciliation process at a Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 87 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. VA medical center 386687 Katie Gauen 12‐299 387564 Elizabeth Gavioli 8‐243 387597 Aubrey Gawron 10‐163 387597 Aubrey Gawron 12‐114 388791 Brian Gawronski 12‐176 387596 Elizabeth Gearhart 10‐264 Effect of Advanced Pharmacy Practice Experience (APPE) students on preceptor productivity on general medicine floors in a large, academic medical center Prevention of granulocyte‐
colony stimulating factors(G‐CSF) induced bone pain using a double histamine blockade Assessment of vasopressin utilization for distributive shock in the intensive care unit population Assessment of vasopressin utilization for distributive shock in the intensive care unit population Effect of the implementation of a transition of care pharmacy service on readmission rates, emergency department visits, and inpatient care costs Incorporating matrix‐
assisted laser desorption ionization time‐of‐flight (MALDI‐TOF) rapid identification into a pharmacy clinical on‐call program 88 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 385275 Megan Gee 10‐078 387767 Gina Gelonese 8‐244 389556 Steven Geltzer 11‐233 387319 Stefanie George 8‐245 383591 Teresa George 10‐079 388382 Nicole Anne Gerardo 1‐208 385156 Alexander German 1‐209 Analysis of the Diagnosis and Treatment of Urinary Tract Infections in the Veterans Affairs Western New York Healthcare System Home Based Primary Care Population Impact of pharmacist‐led diabetic ketoacidosis education provided to intensive care unit and emergency department nursing staff on utilization of diabetic ketoacidosis order set Utilization of a telehealth smartphone application to improve medication adherence and reduce hospital readmission rates in pneumonia patients Comparison of phenobarbital and lorazepam treatment for alcohol withdrawal syndrome Combining pharmacy expertise with asthma educator certification: assessing the impact on inner‐city asthma patients Scaling the tissue plasminogen activator (tPA) dose: the effect of weight variance on the tPA dose for acute ischemic stroke patients Impact of a Diabetes Shared Medical Appointment in Patients with Poorly Controlled Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 89 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Type 2 Diabetes Mellitus 385131 Alicia Gesenhues 10‐080 388936 Amina Ghalyoun 1‐210 386498 Erika Giblin 1‐211 389374 Shannon Giddens 1‐212 382942 Stacey Giles 11‐008 387424 Colin Gillis 12‐196 388612 Allison Gilmore 1‐213 Comparison of fungal prophylaxis strategies in pediatric patients undergoing hematopoietic stem cell transplantation: a retrospective review Evaluation of the veterans health administration (VHA) opioid safety initiative (OSI) daily morphine equivalent dose cutoff in relation to mortality Insulin titration per protocol versus standard care for management of hyperglycemic crises Evaluation of inpatient narcotic waste at a large pediatric hospital Retrospective evaluation to determine appropriate use of statins based on current guidelines within a multi‐specialty outpatient practice Risk evaluation and mitigation strategy prevalence among new drug application (NDA) and biologic license application (BLA) submissions and implications for regulatory strategy Evaluation of overtreatment of diabetes in a veteran population at high risk for hypoglycemia Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 90 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386699 Brianna Glynn 1‐214 388544 Meghan Glynn 10‐012 387289 Charleen Gnisci 9‐272 387176 Wyatt Gold 9‐010 388398 Erika Goldberg 1‐215 387842 Rebecca Goldsmith 10‐081 385902 Leigh Gomez 11‐284 388638 Aurea M Gomez‐
10‐272 Development and evaluation of a pharmacist‐managed telehealth GRECC Connect clinic to optimize medication regimens in recently hospitalized rural geriatric Veterans Impact of medication adherence in underinsured renal transplant recipients assisted by an outpatient pharmacy based medication assistance program Evaluating the safety and efficacy of using actual versus ideal body weight for daptomycin dosing Improving lipid measures at the Boise VA Medical Center through pharmacy interventions Evaluation of extravasation of peripherally infused vasopressors in the intensive care units of a veterans affairs medical center Infection‐related readmission rates following traumatic splenic injury at a level‐1 trauma center Association between the incidence of venous thromboembolism and body mass index classification PREVALENCE OF MALNUTRITION IN Date Time Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. 91 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Marquez Date Time Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. INSTITUTIONALIZED PATIENTS 388975 David Gonzalez 9‐197 387723 Kendra Gonzalez 12‐197 388956 Loliet Gonzalez Martinez 12‐310 384324 Kellie Goodlet 1‐216 387722 Brittany Gorden 11‐041 389394 Emma Gorman 1‐217 Impact of a pharmacist‐led discharge education program on reducing medication errors and readmission rates in a 360‐
bed acute care community teaching hospital Impact of a pharmacist directed risk assessment discharge tool (RADT) on hospital readmissions Impact of implementing an antimicrobial stewardship program on the appropriateness of antimicrobial utilization in a 360‐bed community teaching hospital Necessity of carbapenem use when prescribed per infectious diseases specialists Application of the 2013 American College of Cardiology/American Heart Association blood cholesterol guidelines in HIV patients in an ambulatory care setting Antibiotic selection in the treatment of acute bacterial skin and skin structure infections in the emergency department setting Sunday, December 6 Wednesday, December 9 Sunday, December 6 3:45 ‐ 5:15 p.m. 1:45 p.m. ‐ 2:45 p.m. 3:45 ‐ 5:15 p.m. 92 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 389587 Jenna Gorrell 8‐329 382716 Ted Grabarczyk 8‐131 388871 Nista Gracien 9‐116 385825 Robert Granett 1‐218 386025 Kimberly Grant 9‐045 388663 Glenn Grantner 12‐311 385200 Brandon Green 9‐002 388354 Christopher Green 11‐285 Evaluation of outcomes in orthopedic surgery patients receiving liposomal bupivacaine with historical patients who have not. Comparison of the effectiveness of FDA approved weight loss medications utilized by the Veterans Affairs population, a retrospective cohort study Design and implement an e‐consultation for medication fall risk evaluation for pharmacists Safety and efficacy of the standard intensity heparin dosing nomogram at Mercy Health Saint Mary's AAT‐Falls: Adherence to antihypertensive therapeutic guidelines and association with falls in a long‐term care facility Implementation and evaluation of a pharmacist‐led patient‐
controlled analgesia rounding service at a community hospital Effects of liposomal bupivacaine, for periarticular pain control post total knee arthroplasty, a retrospective cohort study. Evaluation of appropriate use of 4‐factor prothrombin complex Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. 93 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. concentrate at a large tertiary care hospital 388133 Sarah Green 10‐164 388133 Sarah Green 12‐115 387575 Stephanie Gregg 11‐234 386767 Amanda Grego 9‐068 382593 Lindsey Greiner 12‐235 386843 Chelsea Gresham 10‐082 387303 Morgan Greutman 8‐070 386574 Alexandra Grieco 10‐165 Evaluation of Nephrotoxicity Associated with Intravenous Colistin or Polymyxin B Evaluation of Nephrotoxicity Associated with Intravenous Colistin or Polymyxin B Development and implementation of system‐
wide staff education modules of medications with risk evaluation and mitigation strategy (REMS) programs Impact of pharmacist‐
delivered discharge counseling on heart failure readmissions The effects of ranolazine on hemoglobin A1c in a veteran population Assessing the impact of pharmacist‐delivered transition of care services at the time of discharge from a community teaching hospital Implementation of outpatient naloxone pharmacy services to at‐
risk patients Impact of targeted pharmacist outreach on increasing smoking cessation efforts among Medicaid managed care members 94 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Impact of targeted pharmacist outreach on increasing smoking cessation efforts among Medicaid managed care members Retrospective chart review of prothrombin complex concentrate utilization Date Time Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. 386574 Alexandra Grieco 12‐116 389311 Emily Griesbach 10‐166 389311 Emily Griesbach 12‐117 Retrospective chart review Wednesday, of prothrombin complex December 9 concentrate utilization 3:00 p.m. ‐ 4:00 p.m. 389016 Reid Griffin 8‐132 Wednesday, December 9 10:00 ‐ 11:00 a.m. 389530 Sonja Grinfeld 10‐083 Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. 389251 Diana Gritsenko 11‐065 Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. 387017 Reid Grobe 1‐219 387898 Marti Groeneweg 9‐198 386352 Brittany Gross 9‐273 388794 Joel Grussendorf 1‐220 Evaluation of Myeloid Growth Factor Use at a Community Hospital Medication use evaluation of ceftaroline at Erie County Medical Center (ECMC) in Buffalo, NY Evaluation of the safety and efficacy of catheter directed thrombolysis in a community teaching hospital Evaluation of anti‐xa level use in adult patients on enoxaparin Measuring the value of utilization management: a cost analysis of a regional health plan prior authorization program Retrospective review of pediatric hypertension and management in Mississippi medicaid population Evaluation of metabolic monitoring in patients with obesity receiving olanzapine at a Veterans Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 95 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Affairs medical center 388805 Jessica Guastadisegn
i 8‐006 385742 Gabriel Guerra 9‐199 388849 Valerie Guerrier 10‐084 387865 Courtney Guinn 9‐020 389277 Adam Gummershei
mer 10‐167 389277 Adam Gummershei
mer 12‐118 386630 Wenting Guo 12‐236 Incidence of acute kidney injury with vancomycin and beta‐lactam antibiotics in adult hospitalized patients Analyzing and universalizing the components of a clinical decision support project prioritization tool Evaluation of a pharmacist‐led basal bolus insulin protocol in a community hospital Evaluation of the appropriateness of use and adverse effects of proton pump inhibitors for stress ulcer prophylaxis Evaluation of a pharmacist‐led thromboembolism prophylaxis protocol on an adult mental health unit in a rural hospital Evaluation of a pharmacist‐led thromboembolism prophylaxis protocol on an adult mental health unit in a rural hospital Evaluation of a pharmacist‐managed vancomycin consult service versus standard of care at a large academic medical center 96 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 389540 Natalia Gut 11‐042 388232 Kristyn Gutowski 8‐246 385634 Michael Ha 10‐085 389180 Katie Haas 8‐315 386593 Jamie Haase 1‐221 386261 Anthony Haberstroh 10‐168 386261 Anthony Haberstroh 12‐119 Converting twice daily tacrolimus to the once daily extended‐release tacrolimus formulation in renal transplant recipients Pharmacist‐led patient education: the impact of managing chemotherapy‐
induced nausea and vomiting in ambulatory oncology patients in a prospective study Evaluation of an electrolyte repletion protocol in patients receiving therapeutic hypothermia for sudden cardiac death Evaluation of sedation practices in mechanically ventilated intensive care unit (ICU) patients across metro hospitals of a health system Evaluation of the appropriateness and tolerability of formulary second‐generation, long‐
acting injectable antipsychotics at the James J. Peters VA Medical Center Advancement of pharmacy services for pediatric and neonatal patients at two acute care regional community hospitals Advancement of pharmacy services for pediatric and neonatal patients at two acute care regional Date Time Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. 97 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. community hospitals 388658 Melanie Hackney 11‐066 386207 Kyra Hagan 9‐200 387568 Maureen Hagedorn 10‐169 387568 Maureen Hagedorn 12‐120 388328 Kyle Hagen 1‐222 386176 Emily Haggard 11‐286 385722 Aya Haghamad 12‐011 Utilization of a procalcitonin level to identify and appropriately treat critically ill sepsis patients Cost evaluation of physician‐selected versus pre‐defined intravenous electrolyte fluid replacement for the treatment of diabetic ketoacidosis Impact of health‐system pharmacist‐driven interventions on the care of patients followed by hospitalist teams at a community teaching hospital Impact of health‐system pharmacist‐driven interventions on the care of patients followed by hospitalist teams at a community teaching hospital Characteristics of patients prescribed naloxone kits in a Veterans Affairs medical center Retrospective analysis of risk factors associated with linezolid‐induced thrombocytopenia Quality improvement project to improve pain relief in pediatric patients Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. 98 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 385562 Jenelle Hall 9‐274 386196 Joshua Hall 10‐031 387986 Lela Hall 9‐172 387986 Lela Hall 11‐200 388723 Brandi Hamilton 10‐170 388723 Brandi Hamilton 12‐121 388681 Lakisha Hamilton 10‐310 389695 Walid Hammoud 12‐237 Impact of provider education on high risk patient utilization of outpatient pharmacy services within a community teaching hospital Impact of enhanced external counterpulsation on VO2MAX: an update Retrospective evaluation of immune thrombocytopenia treatment in an adult population Retrospective evaluation of immune thrombocytopenia treatment in an adult population Evaluation of the impact of a new patient‐centered pharmacist staffing model at a large academic medical center Evaluation of the impact of a new patient‐centered pharmacist staffing model at a large academic medical center Evaluation of a pharmacy antibiotic streamlining program in a community hospital Evaluation of pharmacist‐
prescriber communication preferences at a community teaching hospital Date Time Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. 99 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388237 Joseph Han 11‐105 388962 Sarah Hand 1‐223 387330 Paul Hanley 8‐247 385164 Rashad Hanna 11‐153 389126 Jessica Hanson 8‐133 387768 Joshua Hapney 11‐303 389046 Allison Hardy 10‐171 Comparing high‐dose dexmedetomidine (HD) versus standard‐dose dexmedetomidine (SD) for sedation of adult patients in the intensive care unit (ICU) Retrospective evaluation of the impact of selective serotonin reuptake inhibitors on the incidence of bleeding events in Veterans receiving new oral anticoagulants Comparison of the incidence of nephrotoxicity with vancomycin plus piperacillin‐tazobactam versus an alternative beta‐
lactam: A retrospective, non‐inferiority, cohort study Impact of a Pharmacist‐Led Transition of Care Telephone Service on 30‐
day Hospital Readmissions and ED Visits in Patients with Recent Discharge Molecular epidemiology of carbapenem resistant Enterobacter cloacea isolates from a Mississippi hospital Retrospective analysis of patients with reported penicillin allergy Evaluation of fluconazole prophylaxis for invasive candidiasis in a neonatal intensive care unit: developing a successful Date Time Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. 100 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. standardized protocol 389046 Allison Hardy 12‐122 386557 David Harriman II 1‐224 388724 Amanda Harrington 8‐134 388158 Kiydra Harris 9‐069 388381 Kiya Harrison 1‐225 389692 Stephanie Hart 11‐009 Evaluation of fluconazole prophylaxis for invasive candidiasis in a neonatal intensive care unit: developing a successful standardized protocol Examining the Clinical and Economic Impact of a Hyperglycemia Management Protocol Implemented at the VA of Southern Nevada Healthcare System: A Three Month Observational Study. Development of a direct oral anticoagulant guideline for pharmacist‐
led patient education Experience with IBRANCE (palbociblib) at the UT Health Memorial Hermann Cancer Center Impact of a pharmacist‐led vancomycin dosing and monitoring service at an academic medical center Implementation of a pharmacist‐driven, transition‐of‐care program to reduce readmission rates for certain CMS diagnosis‐related groups at an Indian Health Services hospital Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. 101 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 384416 Somer Harvey 8‐248 389634 Alycia Hatashima 1‐226 385229 Jessica Hatton 1‐227 389518 Kathryn Hauenstein 1‐228 384642 Tara Haworth 10‐231 389544 Alastair Hay 12‐238 385153 Cara Hay 12‐046 382969 Michelle Hayes 9‐070 389491 Sarah Hayes 12‐177 387770 Jay Hazelcorn 8‐316 Evaluation of antibiotic use in uncomplicated appendectomies Clinical and Pharmacoeconomic Impact of Extended Infusion Cefepime and Meropenem Patient Satisfaction with Clinical Video Teleconferencing versus Conventional Care Impact of a pharmacist‐run telehealth anticoagulation service in a rural hospital setting Prevalence of fractures in pediatric patients on an antiepileptic drug The evaluation of pharmacy technician readiness to engage in and discuss medication therapy management services with patients Alteplase for catheter clearance: a retrospective review on utilization Comparison of time to achieve rate‐control in atrial fibrillation between esmolol and diltiazem Inpatient use of intravenous immune globulin for the treatment of hematologic and neurologic disorders in a tertiary care hospital Evaluation of daptomycin prescribing patterns in a large tertiary care, teaching hospital Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 102 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 387821 Dana He 8‐135 385289 Ann Heble 9‐021 386148 Cory Hedin 1‐229 388430 Jessica Hedvat 11‐287 385681 Alyssa Heiden 10‐232 386135 Krista Heinrich 11‐010 387621 Matthew Heinsen 9‐201 386990 Ronald Heisel 11‐235 389203 Lauren Held 9‐275 Date Time Impact of a pharmacy resident on inappropriate treatment of asymptomatic bacteriuria in a community teaching hospital Characterization of rituximab use at a pediatric hospital Prevalence of spurious systolic hypertension in an active young adult population Evaluation of new oral anticoagulants for the treatment of venous thromboembolism in the oncology population Lung cancer disparities in rural United States Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Impact of telehealth on warfarin education on patient retention: a quality improvement study Evaluation of adjunctive tigecycline use for clostridium difficile Impact of vancomycin utilization on VRE colonization among acute myeloid leukemia patients undergoing intensive induction chemotherapy Incidence of Invasive Fungal Infections in Newly Diagnosed AML Patients Based on TRM score and Choice of Prophylactic Antifungal Regimen Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. 103 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 383485 Lindsey Helm 9‐202 387275 Olivia Henderson 11‐304 388921 Nicole Henige 9‐046 387772 Kevin Henke 10‐273 384503 Christina Henkel 10‐265 388320 Sarah Hennemann 10‐032 387247 Stacy Henthorne 8‐136 Reconciling common medication reconciliation discrepancies in a community hospital setting: what are the most common mistakes made and how can we improve upon accuracy? Evaluation of the appropriate use of rabies immunoglobulin and the rabies vaccine for post exposure prophylaxis in the emergency department Evaluation of 4‐factor prothrombin complex concentrate (4F‐PCC) use in a community teaching hospital Impact of clinical pharmacy services through collaborative drug therapy management in diabetes patients receiving subcutaneous insulin Evaluate the use of 23.4% vs. 7.5% hypertonic saline in patients in the ICU setting: a systematic chart review Evaluation of system‐wide use of cefazolin for surgical prophylaxis Impact of frequency of psychiatric medication administration on time to psychiatric readmission and adherence in patients with schizophrenia and schizoaffective disorder Date Time Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 104 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388113 Zachay Henz 1‐230 386801 Ashley Herlihy 12‐198 387269 Luis Hernandez 9‐117 387341 Vata Hernandez 1‐231 384789 Omaida Hernandez‐
Ray 9‐276 386741 Brooke Herndon 1‐232 389607 Andrew Hibbard 10‐172 Assessing the impact of an internal "Pharmacist Intervention Tool" in a tertiary academic medical center Evaluation of stimulant use in the treatment of Attention‐Deficit and Attention‐Deficit Hyperactivity disorders at a Veterans Affairs Medical Center: Utilization of diagnostic criteria, appropriate monitoring and follow‐up. Developing a hazardous drugs training module to educate pharmacy personnel and assess their competency throughout a health system Medication Use Evaluation of Posaconazole The effect of personalized letters on pneumococcal‐ 13 valent vaccination rates in community pharmacies Evaluating differences in mortality within the susceptible minimum inhibitory range: comparison of patients with positive Pseudomonas aeruginosa cultures who are treated with piperacillin/tazobactam or cefepime The upstream solution to the prior authorization process: observations from Date Sunday, December 6 Time 3:45 ‐ 5:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. 105 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. a pharmacist led innovation team 389607 Andrew Hibbard 12‐123 386406 Lauren Hickman 12‐178 386810 Joshua Hille 1‐233 388376 Andrew Himsel 11‐154 384627 Abigail Hines 10‐233 385719 Randall Hinojosa 8‐137 388532 Charles Hinton 8‐249 The upstream solution to the prior authorization process: observations from a pharmacist led innovation team Standardization of intervention documentation for pharmacists in the outpatient setting Evaluation of the appropriate and safe use of parenteral nutrition in an institutional setting Effect of the history of ethanol or cannabinoid use on sustained virologic response rates following direct‐acting anti‐viral treatment in hepatitis C virus infected veterans. Comparison of two anti‐
emetic regimens and their effectiveness in patients treated with highly and moderately emetogenic chemotherapy Pharmacy role in the primary management of total parenteral nutrition in a single institution Outcomes of pharmacist led medication management in care transitions pilot program on resolution of drug therapy problems for heart failure patients Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 106 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 385915 RaeAnn Hirschy 9‐118 388156 LETIANA HITOALIAJ 1‐234 388254 Christina Ho 8‐250 389072 Courtnee Ho 12‐199 387557 Quynh Ho 12‐239 388125 Brenda Hoang 9‐071 387047 Hoan Hoang 11‐067 388365 Caitlin Hoar 11‐106 387763 Jessica Hochstetler 9‐277 387127 Jennifer Hockings 11‐155 Venous thromboembolism prophylaxis in obese patients Evaluation of cannabis use in veterans with posttraumatic stress disorder at VA Connecticut Healthcare System Evaluation of antibiotic administration for early sepsis management in the emergency department Benefits of implementing a pharmacy education referral service Evaluation of compliance and safety of standardized heparin protocol Comparing the effectiveness of apixaban and rivaroxaban educational videos through tablet to written education Evaluation of low‐dose hydrocortisone continuous infusion versus intermittent boluses in septic shock Long‐term outcomes of weight and metabolic outcomes after gastric bypass in a large patient‐
centered medical home Impact of electronic pop‐
up alerts on antibiotic therapy duration Evaluation of a three‐tier sliding scale insulin protocol based on insulin sensitivity Date Time Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. 107 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 384476 Sarah Hoerner 12‐240 388882 Marissa Hoffman 1‐235 387175 Brendon Hogan 1‐236 385198 Mary Caroline Hogue 11‐236 384326 Kylie Holland 1‐237 386247 Adam Hollingswort
h 10‐311 387263 Amanda Holyk 11‐043 385865 Kristin Hong 11‐190 Evaluation of caffeine citrate usage in the neonatal intensive care unit during a medication shortage Pediatric safety and formulary compliance with parenteral hydantoin anticonvulsant agents Adherence rates of target specific oral anticoagulants (TSOACs): comparison of once daily versus twice daily dosing among Central Texas Veterans Healthcare System patients Impact of pharmacist involvement in admission medication reconciliation in a long‐term acute care hospital Maintenance of glycemic control in Veterans discharged from pharmacy medication management clinics The effectiveness of using a case‐based card game verses traditional study methods to learn pharmacological treatment guidelines Evaluating outcomes of poractant alfa versus calfactant in neonates Evaluation of national sepsis protocol driven antibiotic initiation in the emergency department Date Time Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. 108 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386723 Katelyn Hood 10‐312 385766 Jessica Hoover 8‐138 387864 Teri Hopkins 8‐251 385777 Caleb Hopkinson 11‐124 389099 Liane Horiuchi 10‐086 388596 Justin Horowitz 11‐237 388708 Spencer Horst 1‐238 Retrospective review of prazosin use for the treatment of post‐
traumatic stress disorder (PTSD)‐related nightmares in pediatric and adolescent patients Risk factors for respiratory syncytial virus‐associated lower respiratory illnesses in the pediatric population Cefazolin plus metronidazole versus cefoxitin for the prevention of surgical site infections in elective colorectal surgery Length of hospital stay and outcomes in patients with venous thromboembolism: comparison of different anticoagulant regimens Evaluation of patient outcomes after implementation of an enhanced recovery after surgery (ERAS) protocol for laparoscopic gynecologic procedures Nephrotoxicity associated with concomitant vancomycin and standard versus extended infusion piperacillin‐tazobactam Evaluation of subcutaneous versus intravenous erythropoietin administration in hemodialysis patients Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 109 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 384497 Sherry Hou 11‐068 386678 Andrew Houck 9‐119 387523 Alison Houng 12‐012 385713 Anna Howard 11‐156 389640 Kristin Howard 12‐047 384400 Kimberly Howe 1‐239 388112 Adam Howell 10‐087 386309 Emalee Hribick 1‐240 387889 Tiffany Hsu 9‐203 Impact of pharmacy students in the utilization of patient assistance programs (PAP) for qualified patients: a rural hospitals experience Dexmedetomidine medication use evaluation in a community pediatric hospital Optimization of antimicrobials to promote antimicrobial stewardship in a childrens hospital Carboplatin dosing strategies in patients with obesity Ketamine versus propofol or benzodiazepines for continuous sedation in critically ill patients Comparison of the effectiveness of FDA approved weight loss medications utilized by the Veterans Affairs population, a retrospective cohort study : Empiric Dose‐Reduction Strategy for Tacrolimus After Initiation of IV and Oral‐tablet Formulations of Posaconazole Implementation of a pharmacist‐managed telehealth anticoagulation clinic Identifying high risk hypertension patients using a population health strategy Date Time Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. 110 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388287 Tracy Hsu 9‐278 388096 Huiyuan Hu 9‐120 386999 Linda Huang 11‐011 387324 Samuel Huber 9‐121 385835 Kayla Hubrich 8‐330 385999 Chelsea Hudak 11‐205 388874 Joel Huffman 12‐200 Predictors of direct antiviral agent treatment failure in a Veteran population with hepatitis C infection Assessment of fructosamine and glycated albumin tests as an alternative to hemoglobin A1C test in managing diabetes for HIV and hepatitis C patients on antiviral therapy Value and design of pharmacy residency research programs Retrospective evaluation of pharmacist interventions on optimal use of antimicrobials using a clinical decision support tool Evaluation of quality and cost‐related outcomes from implementing prior authorization criteria for specialty medications Overcoming barriers of medication adherence to antihypertensive therapy through pharmacist intervention in an employer sponsored healthcare clinic Retrospective review of surgical intervention versus medical management for the treatment of infective endocarditis in injection drug users Date Time Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. 111 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 387882 Adrian Hughes 1‐241 388492 April Hughes 11‐206 389402 Jonathan Hughes 1‐242 389065 Mitchell Hughes 9‐072 387105 Lauren Hundley 12‐241 386509 Allyson Hunt 9‐279 385903 Hannah Hutchinson 1‐243 Development and evaluation of a transitions‐
of‐care referral process from inpatient clinical pharmacists to outpatient clinical pharmacists for heart failure patients Impact of community pharmacist education through the use of a patient friendly handout on statin adherence Effect of the 2012 American College of Rheumatology Management of Gout Guidelines on Monitoring of and Adherence to Urate Lowering Therapy Association between tacrolimus concentrations and hypertension in allogeneic hematopoietic stem cell transplant recipients Assessment of outcomes with bisphosphonates as secondary prevention for recurrent osteoporotic fractures in a veterans affairs community Impact of auto‐verification of high‐risk medications in an emergency department Evaluating extended sterility of single dose vials attached to an automated IV compounding device Date Sunday, December 6 Wednesday, December 9 Time 3:45 ‐ 5:15 p.m. 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 112 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388608 Carolkim Huynh 8‐317 388977 Hoang Huynh 9‐280 389160 Yuna Huynh 10‐088 386087 Cara Iacobellis 8‐139 387896 Carlo Iasella 12‐242 386674 Christine Ibarra 10‐089 388337 marisol ibarra 12‐048 386624 Christine Ibrahim 12‐179 Enhancing the delivery of clinical services to specialty patients in the community pharmacy setting Assessment of antimicrobial use in the infant special care unit utilizing the Centers for Disease Control and Prevention 12 step campaign Evaluation of the utilization of a clinical decision support system to expand antimicrobial stewardship interventions by pharmacists in the hospital setting Evaluating the efficacy of fecal microbiota transplantation in patients with recurrent clostridium difficile infection Clinical factors predicting variability in drug response with the target‐specific oral anticoagulants Quality of elder care: a study to determine possible treatment related sleep interruptions Clinical outcomes of the new Hepatitis C drugs in the veteran population at VACHS Development of a primary care pharmacist practice model in the patient centered medical home (PCMH) Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. 113 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388686 Tamara Idlibi 12‐243 388822 April Ingason 11‐012 386903 Kelly Ishizuka 8‐252 387334 Daniel Israel 12‐180 387752 Marissa Israel 1‐244 389144 erika issler 10‐090 385384 Nicholas Jackson 10‐173 Impact of pharmacist counseling and discharge clopidogrel on acute coronary syndrome 30 day readmission rate Evaluation of vecuronium dosing and subsequent neostigmine utilization in surgical patients Association between procalcitonin levels and clostridium difficile infection A prospective, observational study of novel oral anticoagulant prescribing: A pharmacy resident review Pharmacist‐led inquiry during an outpatient counseling session to increase influenza vaccination rates in a veteran population Evaluation of bolus versus continuous infusion neuromuscular blocker administration in the management of therapeutic hypothermia Assessment of current VA practices regarding chronic heart failure patient management to analyze role and implementation of a pharmacist‐managed clinical service Date Time Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. 114 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 385384 Nicholas Jackson 12‐124 387706 Jeena Jacob 8‐331 386679 Carissa Jacobs 9‐204 386800 Jaleena Jacobs 11‐238 387101 Sonja Jacobsen 10‐174 387101 Sonja Jacobsen 12‐125 387473 Brandon Jacoby 11‐288 385689 Nilofar Jafari 9‐122 Assessment of current VA practices regarding chronic heart failure patient management to analyze role and implementation of a pharmacist‐managed clinical service Incidence and analysis of infectious complications in patients with left ventricular assist devices Evaluation of a multimodal approach to education provided to pediatric pharmacists on resuscitation events Implementation of inhaled epoprostenol in neonatal and pediatric intensive care units (NICU/PICU) Improving oral chemotherapy fulfillment processes and implementation of a pharmacist‐managed oral chemotherapy follow‐up program Improving oral chemotherapy fulfillment processes and implementation of a pharmacist‐managed oral chemotherapy follow‐up program Efficacy of topical versus oral tranexamic acid in total knee arthroplasty: a retrospective chart review Evaluation of duplicate medication orders at a tertiary care hospital Date Time Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. 115 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Identification of an optimal steroid tapering schedule for treatment of acute graft‐versus‐host‐disease following allogeneic hematopoietic stem cell transplantation Relapse rate of complicated urinary tract infections in inpatient rehabilitation patients treated with cefuroxime at a tertiary teaching hospital Developing a shortage and recalls program Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. 387112 Katherine Jahng 8‐033 387438 Joy Jakubek 8‐253 385710 Jennifer James 10‐175 385710 Jennifer James 12‐126 Developing a shortage and recalls program Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. 388346 Amna Jamil 11‐055 Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. 387584 Whitney Jandreau 1‐245 389050 Stephen Jankovic 8‐140 386195 Jennifer Jankovsky 8‐254 387755 Adrienne Jantzi 12‐201 Clinical impact of pharmacist intervention in the maintenance of glycemic control at a community teaching hospital Expanding access to hepatitis C care for rural Maine veterans using pharmacist‐driven education Evaluation of Post Intubation Analgesia and Sedation in the Emergency Department Evaluation of atropine efficacy for symptomatic bradycardia in the emergency department The Impact of a Multidisciplinary Pain Group on Disease Understanding and Quality of Life in Chronic Pain Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. 116 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Patients 388451 Kristin Janzen 8‐034 385978 Elizabeth Jasper 11‐305 388609 Gurbinder Jassar 10‐013 387928 Gregory Jaszczur 9‐281 386234 Tara Jawaro 10‐234 384486 Bryan Jennings 1‐246 Implementation of continuous quality improvement program for assessing success of residency program graduates. Physical compatibility and chemical stability of the combination of ziprasidone mesylate 20mg/mL with lorazepam 2mg/mL Evaluating the impact of the implementation of an operational dashboard on inpatient pharmacy productivity in a veterans affairs medical center Optimizing electronic health record patient lists to improve pharmacist efficiency: a time motion study Evaluation of the propensity and prevalence of drug‐drug interactions in patients discharged from an academic emergency department Risk of proton‐pump inhibitors and clostridium difficile in the veteran population: a retrospective review 117 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386844 Poonam Jewani 10‐176 386844 Poonam Jewani 12‐127 387668 Christine Ji 9‐011 389086 Jennifer Jiang 12‐244 384494 Lauren Jindracek 1‐247 385906 Juliana Jing 8‐141 385593 Matthew Jirasek 11‐157 Incidence of venous thromboembolism (VTE) in hospitalized medically ill patients receiving fixed‐
dose unfractionated heparin prophylaxis in three weight cohorts Incidence of venous thromboembolism (VTE) in hospitalized medically ill patients receiving fixed‐
dose unfractionated heparin prophylaxis in three weight cohorts Evaluating the effectiveness of intravenous acetaminophen for pain relief Evaluating the effectiveness of a national hypoglycemia safety initiative at a Veterans Affairs health care system Identifying missed opportunities for the pneumococcal conjugate vaccine (PCV13) in outpatient veterans 65 years and older Sirolimus use in heart transplant patients Evaluation of an institutionally‐approved guideline for the management of anticoagulants in the perioperative setting at an academic medical center Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. 118 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 384710 Janet Job 10‐014 387062 Hala Joharji 9‐047 386913 Billee John 1‐248 384766 Natalie John 1‐249 387985 Amanda Johnson 8‐142 386463 Bess Johnson 11‐158 386632 Christopher Johnson 12‐245 388815 Edwin Johnson 12‐202 Predicting tolerability of leucovorin, fluorouracil, irinotecan, and oxaliplatin (FOLFIRINOX) in the treatment of pancreatic cancer Use of rituximab in the management of antibody mediated rejection (AMR) post heart transplant: A 9‐
years single center experience Evaluating the impact of implementing a penicillin skin testing protocol to guide antimicrobial therapy selection Evaluation of antimicrobial surveillance software on systemic antibiotic use in a community teaching hospital Association of cumulative epinephrine dose and mortality in patients with in‐hospital cardiac arrest Impact of dispensing no cost discharge antibiotics on pneumonia readmission rates Evaluation of physician responsiveness to procalcitonin results and compliance with evidence based recommendations Daptomycin usage at an academic medical center: patterns in indication for use and prescribing tendencies Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. 119 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 385691 Heather Johnson 8‐255 386666 Jessica Johnson 1‐250 388310 Kelley Johnson 9‐003 386646 Laura Johnson 8‐035 387698 Laura Johnson 12‐246 385860 Nancy Johnson 8‐256 388426 Tonya Johnson 10‐091 Impact of pharmacist involvement during inpatient hospitalization: interventions required for discharge medication reconciliation on patients with congestive heart failure for teaching services versus hospitalist services Implementation of alert tool for antibiotic initiation in veterans on warfarin therapy Management of acute pain in sickle cell patients experiencing a vaso‐
occlusive crisis: comparing the safety and efficacy of patient‐controlled analgesia versus intermittent intravenous push Impact of a pharmacist‐
driven culture follow‐up program in the emergency department Patient knowledge and utilization of medicare assignment of benefits for diabetic testing supplies in a community pharmacy Evaluation of pain management post‐
tonsillectomy Potential Benefits of Developing a Collaborative Practice Agreement to Establish a Pharmacist‐Run Outpatient Clinic for Monitoring, Evaluating, Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. 120 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time and Treating Unipolar Depression 387244 William Johnson 1‐251 387751 Jackie Johnston 11‐069 386387 Whitney Johnston 8‐084 386669 Dylan Jones 12‐049 385162 Gerrick Jones 1‐252 388054 Gina Jones 9‐205 Association of outpatient inhaled corticosteroid use in hospitalized pneumonia patients The Evaluation of Nystatin Compared to Low‐Dose Fluconazole on Tacrolimus Levels in Renal Transplant Patients Impact of missed prophylaxis doses on the incidence of venous thromboembolism (VTE) in hospitalized surgical patients: a case‐control study Treatment Outcomes among Patients with Methicillin‐Susceptible Staphylococcus aureus Bloodstream Isolates Possessing mecA by Commercial PCR compared to Patients with Methicillin‐Resistant S. aureus (MRSA) Bloodstream Isolates. Improving hypertension control: Million Hearts campaign at Gallup Service Unit Evaluating the effect of a pharmacist‐run post myocardial infarction program on 30 day readmission rates Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. 121 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388588 Hillary Jones 1‐253 386244 Katharine Jones 11‐239 387667 Kyle Jones 9‐073 387122 Laney Jones 8‐143 388353 Aaron Joseph 9‐206 386652 Roy Joseph 11‐125 388647 Karin Josephson 1‐254 387807 Malena Jost 8‐144 Impact of various interventions on medication therapeutic duplication orders Evaluation of a nurse‐
driven protocol using early dose escalation of benzodiazepines in the treatment of alcohol withdrawal syndrome Evaluation of sliding scale insulin for glycemic control in medical intensive care patients The role of continuous subcutaneous insulin infusions for uncontrolled type 2 diabetes mellitus (T2D) with or without clinical pharmacy management Utilization of albumin solutions in hospitalized patients Evaluation of pharmacist impact on standardized extended‐interval aminoglycoside dosing strategy Transitions of care discharge follow‐up: effect on readmissions and emergency department visits Retrospective study comparing combat related post‐traumatic stress disorder treated with a selective serotonin reuptake inhibitor/serotonin‐
Date Sunday, December 6 Time 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 122 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. norepinephrine reuptake inhibitor (SSRI/SNRI) with or without prazosin 389691 Mishna Joy 8‐060 384749 Kayla Joyner 8‐036 386724 Ellen Jung 1‐255 388069 Hemi Jung 8‐145 385419 Sarah Jung 8‐318 389465 Amber Kabrick 9‐282 Evaluation of dexmedetomidine‐based sedation compared to non‐
dexmedetomidine‐based sedation following cardiac surgery Comparison of Bleeding and Thrombosis between Dual and Triple Antithrombotic Therapy in Post‐Stent Patients with an Indication for Anticoagulation Therapy Community pharmacy utilization of evidence‐
based interventions for increasing medication adherence: a survey study Tigecycline as adjunctive treatment for Clostridum difficile infections Evaluation of dexmedetomidine in the intensive care unit for development of a new protocol addressing pain, agitation, and delirium in critically ill patients Pharmacy evaluation of inhaler education to reduce chronic obstructive pulmonary disease readmission rates 123 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 385179 Ekaterina Kachur 9‐283 387846 Onchuma Tanya Kaenkumchor
n 387351 Cristina Kaifer 10‐092 388092 Cindy Kaing 1‐256 389413 Babafunlola Kalejaiye 1‐257 386327 Brittany Kalemkarian 10‐235 12‐247 385259 Charissa Kam 12‐181 388048 Linda Kamakuru 11‐044 385811 Bonnie Kaminsky 12‐248 Date Time Evaluation of the efficacy and safety of high dose tigecycline in 3 critically ill patients Retrospective review of alvimopan usage at a community health system Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Antibiotic management in patients with severe sepsis and septic shock Retrospective review of prescribing and monitoring practices of antiarrhythmics using a pharmacy‐driven protocol at a veterans affairs medical center Evaluation of adherence to medications for the management of chronic cardiovascular conditions in HIV positive patients Impact of antibiotic stewardship program driven antibiotic timeouts on non‐intensive care unit patients with sepsis Mycophenolic acid levels and rejection rates one year post‐lung transplant in pediatric patients Oral midodrine to wean off intravenous vasopressors in the intensive care unit Evaluation of an ongoing medication use evaluation of four‐factor prothrombin complex concentrate Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. 124 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386136 cibi ann kandammalil 1‐258 386488 Rebecca Kandilian 1‐259 385843 Clare Kane 9‐123 387744 Hyeon Hye Kang 1‐260 387599 Kristen Kannel 1‐261 389597 Daisy 1‐262 Kannukkaden 387742 Daniel Kapp 12‐249 Measuring the reversals of opioid overdose achieved by prescribing and dispensing naloxone rescue kits Evaluating the impact of implementing decision support tools on the clinical outcomes of patients at high risk for hypoglycemia Outcomes in obese versus non‐obese kidney transplant recipients that receive basiliximab induction immunosuppression Managing peri‐procedural bridging during warfarin interruptions in a veteran population prescribed chronic warfarin therapy Effect of pharmacist and nurse practitioner diabetes focused clinic visits on diabetic outcomes and statin use within an internal medicine department Impact of a pharmacist discharge service on hospital readmission rates Non benzodiazepine hypnotic use in older adults: evaluation of adherence to the 2012 Beers Criteria and the impact of a collaborative medication safety intervention program Date Time Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. 125 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386035 Masa Karanovic 11‐240 385789 Katie Karkowski 8‐257 385381 Celeste Karpow 10‐266 389312 Madison Karr 11‐126 387403 Joanna Kasper 8‐085 389505 Stephanie Kasten 1‐263 385223 Lauren Kato 11‐045 389038 Daniel 1‐264 Katzenberger Emergent uridine triacetate for fluorouracil overdose Risk factors for the development of new‐onset congestive heart failure with gemcitabine Evaluation of intravenous prostacyclin initiation for patients with pulmonary arterial hypertension in an intensive care unit Retrospective analysis of outcomes associated with labeled versus off‐label use of a four‐factor prothrombin complex concentrate within a three‐hospital system Empiric antibiotic use in oncology patients with febrile neutropenia Use and safety of metformin in veterans with renal dysfunction Effectiveness of stochastically controlled versus standard vancomycin dosing in adults. Reduction of niacin and gemfibrozil therapy for hyperlipidemia and optimization of HMG‐CoA reductase inhibitors (statins) at a Veterans Affairs Medical Center Date Time Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 Sunday, December 6 1:45 p.m. ‐ 2:45 p.m. 3:45 ‐ 5:15 p.m. 126 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 383188 Brianne Kaufman 9‐207 387490 Harpreet Kaur 10‐177 387490 Harpreet Kaur 12‐128 385215 Haley Kavelak 10‐093 388828 Chance Keddington 10‐094 388934 Peter Keddis 8‐061 388036 James Keeler 9‐284 389075 Kaylen Keen 9‐208 Tranexamic acid use in the total hip and total knee arthroplasty population at an academic medical center: a retrospective review of postoperative outcomes Evaluation of Pediatric Medication Safety Initiatives in the Emergency Department of a Community Hospital Evaluation of Pediatric Medication Safety Initiatives in the Emergency Department of a Community Hospital Retrospective evaluation of patients with primary diagnosis DVT for earlier discharge or outpatient treatment eligibility Implementation and evaluation of a community pharmacist led diabetes education program. Retrospective review of the combination of mannitol and hypertonic saline for the treatment of cerebral edema Evaluation of two prandial insulin dosing strategies in hospitalized patients with diabetes mellitus Evaluation of patient characteristics as predictors of drug‐related problems in a community pharmacy Date Time Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. 127 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388652 Rebecca Keeton 10‐015 388878 Jessica Kehm 9‐285 388351 Katrina Lee Keith 11‐013 382597 Jennifer Kelleher 8‐037 387508 Sara Keller 11‐241 387008 Sean Kelly 12‐250 Evaluation of low molecular weight heparin (LMWH) use for bridge therapy in a Veterans Affairs population Evaluating the efficacy and tolerability of ledipasvir and sofosbuvir at 8, 12, and 24 weeks in hepatitis c virus infected genotype 1 veterans Determination of susceptibility of Pseudomonas aeruginosa and extended spectrum beta‐lactamase Enterobactericeae bacterial isolates to ceftazidime/avibactam as compared to ceftazidime: an internal MIC distribution study Effect of a vancomycin dosing protocol for obese patients with renal impairment on goal trough levels in a community hospital setting Impact of pharmacist‐
driven baseline metabolic monitoring of antipsychotic medications in an inpatient behavioral health unit Association between home anticholinergic medications and delirium onset in trauma patients Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. 128 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388976 Shannon Kelly 10‐313 386641 Alyssa Kelsch 12‐050 388630 Madeline Kelzenberg 1‐265 389041 Benjamin Kematick 9‐124 389134 Alexander Keppel 9‐125 388922 Daniel Kerner 1‐266 387197 Amanda Kernodle 8‐007 386218 Jacob Kesner 1‐267 384559 Ryan Keul 9‐286 Implementation of depression screening into the clinical pharmacy services workflow at a federally qualified health center Selective serotonin reuptake inhibitor (SSRI) use in pregnancy and neonatal withdrawal Developing a protocol for pharmacist intervention during transitions of care in high risk patients Changes in chronic pain management therapy after sleeve gastrectomy Lean evaluation of first dose preparation from pharmacy automation within an inpatient central pharmacy at an academic medical center Implementing interventions to improve patient primary non‐
adherence Implementation of persuasive messages to increase participation in comprehensive medication reviews in a community pharmacy setting Outcomes of Enterobacteriaceae urinary tract infections treated with cephalosporins based on new susceptibility breakpoints Dipping into the Clostridium difficile pool Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. 129 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388722 Emily Kilber 10‐095 388575 Megan Kildea 9‐287 383583 Daniel Kim 8‐146 386546 David Kim 1‐268 386769 James Kim 11‐159 388741 Janet Kim 10‐096 387582 Maryanne Kim 9‐074 Hypoglycemia incidence following insulin administration for the treatment of hyperkalemia Evaluation of the use of bupivacaine elastomeric infusion technology in post‐operative adults for inpatient pain management Identifying the Key Features of a Pharmaceutical Industry Postdoctoral Fellowship that Impact Career Paths A retrospective review of an increased risk of hemorrhage and elevated INR during the initiation of duloxetine in patients taking warfarin therapy in a veteran population Establishing and Expanding Pharmacy Clinical Services in the Acute Care Setting SVR12 rates in genotype 1 hepatitis C patients treated with ledipasvir/sofosbuvir: the experience of a regional HMO Evaluation of the incidence of pre‐defined morbidity and mortality outcomes in post‐orthotopic heart transplant patients after implementation of the tacrolimus monotherapy protocol Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. 130 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388650 Priscilla Kim 8‐258 389302 Soyoung Kim 1‐269 384754 Susan Kim 1‐270 386163 Heather Kindermann 1‐271 389071 Alexandra King 11‐160 387440 Ashley King 12‐251 388837 Jacqueline King 1‐272 386660 Jaimie King 12‐051 Evaluation of chronic musculoskeletal and joint pain management for geriatric patients in the emergency department Use of antipsychotics for the management of delirium in the intensive care unit Evaluation of the institutional economic impact of a pharmacy implemented protocol for stress ulcer prophylaxis (SUP) discontinuation Appropriateness of procalcitonin guided antimicrobial therapy utilization in hospitalized veteran patients Evaluating the appropriate use and tolerability associated with plerixafor in autologous hematopoietic stem cell transplant patients. Implementation and outcome of a person‐
centered medication pass schedule in a long term care facility Medication utilization evaluation of recombinant factor VIIa in a large community hospital Retrospective review of the prescribing and management of gene‐
targeted oral chemotherapeutics in non‐
small cell lung cancer Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 Wednesday, December 9 3:45 ‐ 5:15 p.m. 3:00 p.m. ‐ 4:00 p.m. 131 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. (NSCLC) 388445 Morgan King 8‐259 385589 Jessica Kinstler 9‐126 389296 Justin Kirby 1‐273 387161 Cain Eric Kirk 12‐203 388208 Vanessa Kirkwood 1‐274 389117 Michele Kislan 9‐209 Comparison of the incidence of side effects of high‐dose vs. low‐dose dexmedetomidine in the intensive care unit of a community hospital Reduction of chronic obstructive pulmonary disease (COPD) exacerbations and 30 day readmission rates via implementation of a pharmacist‐led COPD clinic. Effect on therapeutic values for previously non‐
adherent patients with diabetes enrolled in a medication synchronization and education program at a community pharmacy Medication use evaluation of citalopram prescribing and monitoring practices at a Veterans Affairs health care center Assessing the number and types of close calls at the VISN 11 pharmacy call center Establishment Of Pain Clinic Pharmacy Improves Patient Care Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. 132 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386653 Ashraf Kittaneh 11‐070 389338 Sarah Klembith 12‐052 388570 Andrew Klick 11‐161 385675 Zachary Klick 1‐275 387162 Katy Klinefelter 12‐252 387458 Chantal Kneifel 1‐276 387543 Sara Knoll 11‐028 Clinical pharmacist impact on antibiotic treatment for sepsis in the Emergency Department Evaluation of the impact of a national opioid safety initiative on suicide rates among Central Texas Veterans Healthcare System patients on concurrent opioids and benzodiazepines A retrospective analysis of fixed versus weight‐based dosing of four‐factor prothrombin complex concentrate. Evaluation of factor product use perioperatively in cardiovascular surgery in non‐hemophiliac patients Adherence to guideline based treatment for patients admitted to the hospital with community acquired pneumonia; focus on duration and transition to oral therapy Effects on antibiotic prescribing rates after physician and nurse education on upper respiratory infections Impact of a standardized intravenous vancomycin loading dose protocol on therapeutic outcomes Date Time Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 Wednesday, December 9 Sunday, December 6 Wednesday, December 9 3:45 ‐ 5:15 p.m. 3:00 p.m. ‐ 4:00 p.m. 3:45 ‐ 5:15 p.m. 1:45 p.m. ‐ 2:45 p.m. 133 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388924 Emir Kobic 10‐097 389257 Gerard Kokett 10‐178 389257 Gerard Kokett 12‐129 386240 Chelsea Konopka 1‐277 387073 Laura Koppen 9‐288 384399 Bianca Korkis 12‐253 387082 Benjamin Korman 9‐127 387555 Karin Koseck 9‐289 Leveraging a community level one trauma hospital's electronic health record for antimicrobial stewardship by pharmacists Implementation and assessment of an opioid withdrawal protocol in an adult inpatient behavioral health setting Implementation and assessment of an opioid withdrawal protocol in an adult inpatient behavioral health setting Evaluation of management of acute bacterial skin and skin structure infections prior to the implementation of an Antimicrobial Stewardship Program initiative Conservative management of pediatric appendicitis in a community hospital setting Periprocedural bridging in patients with atrial fibrillation: practice patterns and outcomes from an urban pharmacist‐
run anticoagulation clinic Reduction of near miss occurrence through process improvement Fluoroquinolone use and development of Clostridium difficile infection post autologous hematopoietic stem cell Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. 134 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time transplantation 389467 Jaclyn Kotula 1‐278 388749 Megan Koyle 9‐210 387677 Sarah Kraus 1‐279 384318 Megan Kroll 10‐179 384318 Megan Kroll 12‐130 Impact on blood glucose readings after implementation of electronic health record clinical decision support tools for basal bolus insulin dosing Improving medication reconciliation through implementation of a technician‐centered medication reconciliation program in the primary care setting at the Boise VA Medical Center Impact of a melphalan dose rounding protocol on efficacy and cost in patients with multiple myeloma undergoing autologous stem cell transplantation Evaluation of the incidence of post‐operative wound infection in neonates and infants receiving stress dose hydrocortisone prior to gastrointestinal surgery Evaluation of the incidence of post‐operative wound infection in neonates and infants receiving stress dose hydrocortisone prior to gastrointestinal surgery Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. 135 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386594 Laura Kroon 12‐053 386220 Tiffani Krzywda 1‐280 387775 Jenna Ksiazkiewicz 10‐180 387775 Jenna Ksiazkiewicz 12‐131 387921 William Kuan 11‐306 386536 Kara Kubli 9‐290 385696 Ashlie Kucera 12‐054 385278 Wesley Kufel 12‐254 Pharmacist review of medication reconciliation completed by physicians and nursing staff at hospital discharge Review of pharmacist intervention in reducing cardiovascular risk in women Veterans Total versus adjusted body weight dosing of vancomycin in obese patients: a retrospective review of safety and efficacy Total versus adjusted body weight dosing of vancomycin in obese patients: a retrospective review of safety and efficacy Evaluation of treating elevated pulmonary arterial pressures with phosphodiesterase‐5 inhibitors in patients with left ventricular assist device Compliance of darbepoetin use in hospitalized patients Patient satisfaction with an appointment‐based medication synchronization program in community pharmacy Impact of Pre‐mix Antibiotic Formulations and Time to Administration in Sepsis Patients Date Time Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. 136 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 385748 Stephanie Kuhl 9‐291 388222 Ivie Kumura 8‐147 388604 Binni Kunvarjee 8‐038 388933 Julia Kuroski 8‐039 385586 Kari Kurtzhalts 11‐107 386421 Eliana Kurzum 8‐148 388552 Amy Kyle 1‐281 385741 Kelly Kyrouac 1‐282 Incidence of adverse events with full dose enoxaparin in moderate renal impairment Digoxin Dose (>0.125mg Daily) Reduction in Patients Age 64 with Chronic Atrial Fibrillation (Beers Criteria 2013 and CMS High Risk Medication in the Elderly) Efficacy and safety of tbo‐
filgrastim versus filgrastim in patients with acute myeloid leukemia and patients post hematopoietic transplant with melphalan conditioning Utilization of eculizumab for atypical hemolytic‐
uremic syndrome within a large, academic health center Optimum duration of antibiotic therapy for males admitted with urinary tract infections Evaluation of the use of new oral anticoagulants for the treatment of venous thromboembolism in patients with active malignancy Effect of the cumulative dose of testosterone on adverse cardiovascular events in a Veteran population Description of a newly instituted teaching Date Time Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 137 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. certificate program 385393 Yvonne Labram 12‐255 384639 Cameron LaChappelle 1‐283 389210 Emily Lachiewicz 10‐098 385290 Joseph Ladd 12‐256 387280 Margaret Ladlie 8‐040 389477 Jenni‐lyn Ladutko 1‐284 388192 Joshua Ladwig 8‐149 387095 Samuel LaFollette 11‐127 Medication Use Evaluation of Phytonadione within the St. Lukes University Health Network Efficacy and patient satisfaction of medication synchronization at Crownpoint Healthcare Facility Medication use evaluation of denosumab for the management of bone metastases in an outpatient oncology clinic Use of Low‐Dose Ketamine for Pain Management in an Emergency Department Insulin therapy in type 2 diabetes mellitus: standard management versus pharmacy titration protocol Redefining peri‐procedural bridging during warfarin interruptions: a quality improvement project at the Salt Lake City Veterans Administration Health Care System (VASLCHCS) Incorporating home clinical video telehealth into a pharmacy medication therapy management clinic at a rural Veterans Affairs healthcare system. Comparison of timely oseltamivir therapy to delayed therapy in hospitalized patients Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. 138 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388740 Marie Lafosse 9‐075 385172 Sophia Lai 1‐285 389271 Christina Laird 1‐286 382599 Benjamin Laliberte 8‐150 387085 ELENA LALLANA 9‐292 385930 Megan Lam 12‐257 385178 Mindy Lam 1‐287 Medication use evaluation of calcitonin injection for the treatment of hypercalcemia Value of a rounding pharmacist on an internal medicine team Canagliflozin as adjunct therapy in type 1 diabetic patients receiving continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring (CGM) in an outpatient setting Pilot observation of the intended discharge diuretic regimen in patients with acute decompensated heart failure at risk for rehospitalization Staff of the Hospital Pharmacy Service: key point of success towards Excellence Retrospective analysis of vitamin K usage for reversal of anticoagulation in a quaternary care teaching hospital Evaluating change in hemoglobin A1C after addition of a TZD, DPP4‐
inhibitor, or GLP‐1 agonist to metformin and sulfonylurea therapy in patients with type 2 diabetes Date Time Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 139 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386963 Thomas Lancaster 9‐076 386255 Macayla Landi 1‐288 387126 Susan Lane 8‐151 386291 Shelby Lang 1‐289 385829 Nicholas Lange 8‐260 386229 Katie Langley 9‐293 387382 Wendy Lantaff 9‐022 389309 Julie Large 11‐162 Transitions of care team in a primary care clinic: a unique answer to a common problem Evaluation and standardization of current practices for reinitiation of warfarin therapy post‐
procedurally at a VA healthcare facility Impact of pharmacy‐driven interventions on time to antibiotic administration in febrile neutropenia patients Implementation of a Pharmacist‐Run, Multidisciplinary Tobacco Cessation Shared Medical Appointment for Veterans Prescribing practices of peripherally administered vasoactive medications Hemodynamic effects of propofol versus dexmedetomidine for sedation during mechanical ventilation in adult medical and surgical intensive care units Pharmacy students perspectives on the introduction of a medication synchronization lecture based on the theory of planned behavior Evaluating the impact of pharmacist intervention on pneumococcal vaccination rates in a community Date Time Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. 140 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. pharmacy setting 386018 Ashley Larson 11‐163 386275 Andrew Lau 1‐290 389456 Gary Lau 12‐182 386533 Brian Lauer 9‐128 388814 Alyssa Laurich 8‐041 Development and implementation of a risk assessment tool for patients receiving oral chemotherapy to continually offer enrollment in a specialty pharmacy therapy management program Evaluating implementation of VA opioid overdose education and naloxone distribution (OEND) program within a primary care clinic at San Francisco Veterans Affairs Health Care System Evaluation of a pharmacy technician as a process navigator in obtaining oral anticancer agents in an outpatient oncology clinic Clinical outcomes in Human Immunodeficiency Virus (HIV) positive individuals using an on‐site outpatient pharmacy compared to off‐site pharmacy options Pharmacist impact on high risk medication use and adherence in a senior health center Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 141 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386622 Alexandra Lavoie 9‐077 387492 Fern Lawson 10‐181 387492 Fern Lawson 12‐132 388774 Nicholeah Lay 8‐152 385569 Brian Le 10‐236 385920 Elizabeth Le 9‐294 385641 Giang Le 1‐291 Evaluation of adherence to the dofetilide Risk Evaluation and Mitigation Strategy (REMS) program: a pre‐ and post‐
implementation analysis of quality improvement initiatives Implementation of a discharge medication reconciliation review protocol in a non‐teaching community hospital Implementation of a discharge medication reconciliation review protocol in a non‐teaching community hospital Assessment of pharmacists' knowledge of oral chemotherapy agents before and after completion of a continuing education (CE) program Risk factors for Clostridium difficile‐associated diarrhea in adult cancer patients without recent antibiotic exposure Evaluation of the current management of chronic obstructive pulmonary disease (COPD) at a federally qualified health center Innovative pharmacy practice model: development and implementation of pharmacy‐initiatives into measurable performance Date Time Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 142 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. metrics 388205 Huong Le 11‐289 388944 Jennifer Le 10‐237 389612 Jennifer Le 11‐128 389423 Phuong Le 10‐182 389423 Phuong Le 12‐133 385926 Rachael Le 9‐129 388590 Thang Le 8‐153 Assessment of appropriate use of anti‐methicillin resistant Staphylococcus aureus (MRSA) agents in patients with pneumonia Implementation of a pharmacy‐driven pediatric vancomycin safety monitoring service. Appropriateness of empiric antibiotic therapy for the treatment of severe sepsis and septic shock in the emergency department Pharmacy residents role as a liaison in hospital practice settings: an evaluation of associated outcomes from clinical pharmacy interventions Pharmacy residents role as a liaison in hospital practice settings: an evaluation of associated outcomes from clinical pharmacy interventions Wholesale acquisition cost‐containment strategies for inpatient drug purchasing at a county hospital Evaluating the risk of arthralgia in United States Veterans on dipeptidyl peptidase‐4 (DPP‐4) inhibitors 143 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 384656 Tiffany Le 8‐319 386221 Lisa LeCleir 11‐071 387887 Sheena LeClerc 1‐292 388694 David Lee 8‐154 386703 DongOuk Lee 9‐023 389415 Joshua Lee 9‐211 387949 Jung Sun Lee 9‐130 Single center evaluation of three antifungal strategies in post lung transplant recipients and their efficacy in reducing the occurrence of invasive fungal infections Optimizing automated dose‐rounding and dose range checking protocols for acetaminophen and hydrocodone‐
acetaminophen in a pediatric population Impact of achieving virologic response from hepatitis c direct‐acting antivirals on diabetes control Comparison of safety outcome between iron sucrose and ferumoxytol in iron deficiency anemia Comparison of pharmacist‐
managed versus physician‐
managed vancomycin dosing in a large academic medical center Evaluation of safety and efficacy outcomes in warfarin reversal using 3 versus 4‐factor prothrombin complex concentrate in a hospital system Study on the Demand of Investigators and Clinical Trial Subjects Regarding Medication Counseling Categories for Drugs Used in Clinical Trials Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. 144 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 384621 Monica Lee 9‐078 385247 Orlaine Lee 8‐062 383204 Phyllis Lee 8‐155 386898 Sarah Lee 12‐258 387692 Sharon Lee 10‐183 387692 Sharon Lee 12‐134 384724 Stephanie Lee 8‐332 Detecting the frequency and severity of paroxysmal sympathetic hyperactivity in traumatic brain injury patients using assessment measurement tools Measuring the impact of a transitional care pharmacist on reducing readmission rates and increasing cost savings for Medicare patients Evaluating regulatory timelines of companion diagnostics and oncology therapies Community‐acquired pneumonia (CAP) and the effect of a transitional care program on 30‐day readmission rates Evaluation of the relationship between proton pump inhibitor use and Clostridium difficile infection in a community hospital Evaluation of the relationship between proton pump inhibitor use and Clostridium difficile infection in a community hospital Hospitalization risk with concomitant benzodiazepine or opioid use in veterans with posttraumatic stress disorder Date Time Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 145 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388206 Steven Lee 11‐290 386288 Susan Lee 1‐293 385600 Yeun‐Ju Lee 8‐091 386228 Michaela Leffler 10‐099 387653 Elizabeth Legros 12‐259 387786 Matthew Lei 11‐014 388605 Brittany Leiba 12‐300 Multidisciplinary approach to improve vancomycin dosing and monitoring practices Evaluating adherence to a probiotic drug use criteria to reduce hospital‐
acquired Clostridium difficile infections at the San Francisco Veterans Affairs Health Care System Evaluation of 4T's scoring system in the identification of heparin‐induced thrombocytopenia in patients with mechanical circulatory support Total benzodiazepine dosage in alcohol withdrawal patients treated with scheduled dosing versus symptom triggered dosing Patient characteristics associated with avoidance of hospital admission in adults receiving intravenous magnesium sulfate for an asthma exacerbation in the emergency department Evaluation of the initiation of rapid infusion rituximab at an academic medical center Use of omalizumab in patients with allergic asthma at the Bay Pines Veterans Affairs Healthcare System Date Time Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. 146 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388538 DeAnna Leiba 11‐108 386605 Carrie Leichtweis 12‐055 387123 Caitlin Lemmer 10‐262 386011 Janelle Lenz 8‐008 387506 Chelsea Leonard 1‐294 386782 Sean Leonard 11‐291 386003 Philip Leong 8‐063 Use of direct‐acting antiviral agents (DAA) for the treatment of hepatitis C virus (HCV) in a veterans population: a medication use evaluation Evaluation of empiric antibiotic therapy and resistance of catheter‐
associated urinary tract infections (CAUTI) versus non‐catheter‐associated urinary tract infections (non‐CAUTI) in a level II trauma center Medication management by a pharmacist for patients with diabetes in a patient‐centered medical home Development of a risk score for major bleeding associated with novel oral anticoagulants Impact of an automated outbound call system on influenza vaccine administration in a community pharmacy Proactive prevention of hypoglycemia in ICU and CICU patients Use of quantitative bronchoalveolar lavage and procalcitonin to decrease antimicrobial use in patients suspected to have ventilator‐associated pneumonia (VAP). Date Time Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 147 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 387104 Julie Lernihan 1‐295 389174 Elizabeth Lessmann 9‐131 388760 Daniel Leszczynski 10‐184 388760 Daniel Leszczynski 12‐135 388848 Stephanie Lewis 8‐009 387712 Temeka Lewis 10‐238 388383 David Li 12‐260 Dual antithrombotic therapy in non‐valvular atrial fibrillation patients at the VA Maine Healthcare System Assessment of cytomegalovirus prophylaxis in a liver transplant population at a large academic medical center Procalcitonin as a Biomarker in Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Lower Respiratory Tract Infection Procalcitonin as a Biomarker in Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Lower Respiratory Tract Infection Implications of pharmacist‐
initiated medication therapy management and a medication synchronization program upon medication adherence outcomes Retrospective review of crotalidae polyvalent immune fab (Crofab) use at a tertiary care hospital prior to implementation of a protocol Streamlining pharmacy tray preparation with radio frequency identification technology Date Time Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. 148 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386820 Jueli Li 9‐212 384349 Kenric Li 11‐109 384531 Rosanna Li 10‐314 389566 Siyue Li 1‐296 388907 Tracey Li 9‐213 388388 Michael Licari 10‐004 388139 Christina Lichtinger 8‐156 Assessment of outpatient rituximab use post‐
implementation of cost‐
savings guideline Comparison of oral aspirin to other chemoprophylaxis agents for venous thromboembolism prophylaxis in hospitalized patients status post total knee arthroplasty Post‐Cardiothoracic Surgery Atrial Fibrillation Rates After Implementing Perioperative Prophylaxis Guideline Identification and reduction of concomitant therapy of benzodiazepine and opioid through implementation of an opioid surveillance program within a rural VA Health Care System Evaluation of fentanyl transdermal patch prescribing practices before and after pain management education by a pharmacist Prescribing trends of antibiotics in patients with documented beta‐lactam allergy or intolerance Evaluate the effect of structured orientation sessions on fourth year pharmacy students on rotation in an ambulatory care clinic Date Time Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 149 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386501 Michael Light 11‐015 382596 Eric Likar 9‐295 387620 Rachel Lim 11‐072 384982 Shannon Lim 1‐297 383486 Ken Lin 1‐298 389539 Lauren Linder 12‐261 387703 Marley Linder 9‐214 385125 Desirae Lindquist 1‐299 Date Time Evaluation of Epoetin Use in Chronic Kidney Disease Patients Management of a positive Candida urinary culture in hospitalized patient Efficacy of single dose vancomycin for treating cellulitis in the emergency department Medication de‐escalation in Veteran cancer patients within the last 90 days of life Impact of penicillin allergy on appropriateness of treatment in veterans Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Impact of implementing a parenteral nutrition algorithm on prescribing patterns Evaluation of clinical outcomes for multiple myeloma patients treated with lenalidomide and managed via an integrated health‐system specialty pharmacy Comparison of post‐
operative bleeding events in patients undergoing total hip or total knee arthroplasty and receiving enoxaparin, rivaroxaban, or aspirin for thromboprophylaxis Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 150 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388400 Dylan Lindsay 12‐013 383946 Sara Lindsay 1‐300 386841 Savannah Lindsey 10‐274 387365 Ashley Lindstrom 9‐048 385279 Courtney Linhart 9‐049 385132 Juliana Lipetzky 1‐301 388368 David Liu 1‐302 Increasing Mississippi pharmacist awareness about cessation (IMPAC): a statewide needs assessment for community pharmacist tobacco cessation services Assessing safety, efficacy and tolerability of novel, direct‐acting antivirals in treatment of Veterans with chronic Hepatitis C Implications of the presence of an emergency medicine pharmacist during critical care patient resuscitation Naloxone for management of pediatric clonidine ingestions Prevalence of inappropriate prescribing of non‐benzodiazepine hypnotics for patients 65 years and older in the United States Cefazolin versus nafcillin for the treatment of complicated methicillin‐
sensitive staphylococcus aureus (MSSA) bacteremia in a veteran patient population Evaluation of Compliance to Beta‐Blocker Therapy for Prevention of Postoperative Atrial Fibrillation in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery Date Time Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 151 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 387550 Derek Liu 1‐303 386385 Ken Liu 12‐204 386417 Roger Liu 1‐304 385834 Shimeng Liu 10‐033 387442 Sonia Liu 10‐315 387592 Nicholas Lockhart 10‐267 389154 Kashelle Lockman 11‐110 388358 Drew Lockstein 10‐100 Implementation of redesigned non‐formulary drug request adjudication process and evaluation of pharmacist workload and decision making at VA Puget Sound Effect of single and repeated doses of rifampin on eliglustat pharmacokinetics in healthy subjects Estimating return on investment of a mobile application providing supplementary, audio medication counseling in a rural, Native American healthcare setting: a pilot survey study. Clinical and economic evaluation of oritavancin use in the emergency department at a community hospital Target serum magnesium concentration for asthma exacerbation in pediatric patients Implementation of an automatic pharmacy stop for granulocyte colony stimulating factors: a retrospective chart review Knowledge, skills, and attitudes of pain management among first‐
year pharmacy students Utilization of ertapenem for surgical prophylaxis in a tertiary care institution Date Sunday, December 6 Wednesday, December 9 Time 3:45 ‐ 5:15 p.m. 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. 152 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388766 Emily Lodwick 10‐016 386719 Leah Loeffler 12‐056 389399 Tawny Loera 8‐333 385205 Katherine Loiacono 1‐305 386294 Mary Lomberk 8‐064 386677 Brittany Long 10‐185 386677 Brittany Long 12‐136 385564 Holly Long 1‐306 Evaluation of intravenous acetaminophen and its effects on opioid use following surgery Developing a pharmacist‐
driven transitions of care program for nursing facility patients within the continuum of care Review of inhaler use in hospitalized patients to implement a cost‐effective inhaler‐to‐nebulizer conversion protocol and discharge plan for patients with chronic obstructive pulmonary disease A prospective evaluation of compliance to a newly implemental VA hospital policy regarding dual PRN pain medication orders Impact of pharmacist‐
driven employer‐
sponsored diabetes management initiative on medication adherence for patients with uncontrolled diabetes Effectiveness of a university on‐campus pharmacist directed tobacco cessation program Effectiveness of a university on‐campus pharmacist directed tobacco cessation program Review of potentially inappropriate benzodiazepine use in elderly Veterans at a Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 153 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Veterans Affairs Medical Center 385394 Danielle Longo 8‐157 386969 Samantha Loutzenheise
r 11‐016 385274 Amanda Lovell 9‐296 386425 Brittany Loy 11‐207 386518 Caitlin Lozorak 9‐215 388928 Carmen Lu 10‐316 Assessment of inpatient granulocyte‐colony stimulating factor (G‐CSF) utilization at a tertiary care academic medical center Retrospective cohort analysis comparing proportions of patients prescribed statin therapy with or without diagnosis of hepatitis C after myocardial infarction, stroke, or transient ischemic attack Evaluation of QTc interval prolongation among hospitalized cancer pain patients on oral methadone Description of pharmacist recommendations in the caring for older adults and caregivers at Home (COACH) program and impact on potentially inappropriate medication prescribing Evaluation of an evidence‐
based pediatric acute hematogenous osteomyelitis treatment protocol Comparison of Intravenous (IV) Vancomycin Therapy Management Before and After Pharmacy Protocol Implementation at a Large Academic Medical Center 154 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 389215 Crystal Lu 12‐057 389409 Kylie Lucas 8‐334 383184 Caitlyn Luecke 1‐307 384404 Courtney Lujan 8‐261 386315 Laura Lum 8‐262 388553 Liliana Lunares 1‐308 388713 Tim Lundberg 9‐132 389232 Christer Lundblad 9‐173 389232 Christer Lundblad 11‐201 Evaluating prescribing habits for non‐formulary psychiatry‐related medications in inpatient psychiatry units Evaluation of effect of chemical restraint with ziprasidone compared to physical restraint on patient ambulation Acetaminophen for PDA Closure: Does It Work? Standardization of initial emergency department management and inpatient pediatric community‐
acquired pneumonia antibiotic prescribing practices in order to align with current national guidelines Decreasing the use of chronic Zolpidem in our High Risk Elderly Medication use evaluation of warfarin management by usual medical care at Virginia Garcia Memorial Health Center Effect of probiotic bundle and education to reduce proton pump inhibitor use on Clostridium difficile infection Pharmacist‐initiated discontinuation of empiric vancomycin therapy in patients with pneumonia Pharmacist‐initiated discontinuation of empiric vancomycin therapy in Date Time Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. 155 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. patients with pneumonia 388852 Traci Lundeen 11‐164 385277 Kristina Luo 8‐158 387040 Alexander Luong 1‐309 386382 Kristie Luu 1‐310 388214 Thanh Ly 10‐034 387343 Alessandra Lyman 9‐133 Evaluating the efficacy of kefir in preventing antibiotic‐associated diarrhea and Clostridium difficile infection in hospitalized patients receiving systemic antibiotic therapy Evaluating the impact of a multidisciplinary team approach to caring for patients with type 2 diabetes Comparison of Daily 2 GM and 1 GM Ceftriaxone for the Treatment of Methicillin‐Sensitive Staphylococcus Aureus Bloodstream Infections vs. Standard of Care Evaluating the impact of clinical pharmacists on oncology performance measures at the San Francisco Veterans Affairs Health Care System Medication delivery service to Emergency Department patients: a pilot study to reduce wait time from discharge to medication dispense A comparative evaluation of the incidence of aspiration pneumonia requiring hospitalization between clozapine and risperidone: A Pilot Study 156 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 385221 Katherine Lyndaker 10‐186 385221 Katherine Lyndaker 12‐137 387869 John Lyons 1‐311 386590 Adrienne Ma 9‐297 385976 Laura MacCall 1‐312 388075 Sandy Mach 8‐159 385397 Lauren Machell 10‐101 Single‐center retrospective cohort study on the treatment of asymptomatic bacteriuria and urinary tract infection, the impact on subsequent urinary tract infection outcomes Single‐center retrospective cohort study on the treatment of asymptomatic bacteriuria and urinary tract infection, the impact on subsequent urinary tract infection outcomes An evaluation of the incidence and management of BK virus within an academic medical center Retrospective Review of Sustained Virologic Response Rate with Hepatitis C Medications in the Era of Direct Acting Antivirals Approval Impact of a care process model on antibiotic prescribing for urinary tract infection in an emergency department Evaluation of a pharmacokinetic‐driven vancomycin dosing protocol to achieve therapeutic vancomycin trough concentrations Evaluation of acute hyperkalemia treatment at a tertiary care academic Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. 157 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. medical center 385048 Jade Machin 10‐035 387998 Molly Mack‐
Mortenson 8‐263 386259 Eric MacPherson 8‐160 388988 Ashley MacWhinnie 10‐102 389212 Melanie Madorsky 8‐161 387982 Uchechukwu Maduako 9‐134 386336 Tristan Maiers 10‐017 Surviving sepsis campaign bundles of care: implementation and effect on mortality rate Evaluation of time to therapeutic anticoagulation before and after implementation of a modified heparin drip protocol Comparing the effectiveness of single fixed‐dose versus weight‐
based dosing of rasburicase in patients with tumor lysis syndrome Evaluation of the prescribing patterns of quetiapine for delirium in the intensive care unit Impact of a pharmacy‐
managed anticoagulation consult service in a community hospital setting Safety and efficacy of target specific oral anticoagulants (TSOACs) versus long‐term enoxaparin use for prophylaxis and treatment of cancer‐related venous thromboembolism Evaluation of vancomycin‐
induced renal toxicity in hematology and oncology patients 158 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388692 Trisha Major 1‐313 389397 Anne Louise Male Ervik 1‐314 386150 Jody Mallicoat 8‐162 385820 Kendra Malone 9‐050 385672 Liana Mandel 1‐315 386010 Lauren Manganiello 1‐316 387579 Nicholas Manion 12‐058 385249 Francis Manuel 8‐010 385998 Kristin Mapes 11‐073 Date Time Effects of a pharmacist managed online warfarin dosing algorithm on time to reach therapeutic anticoagulation Pharmacist Competency in Total Parenteral Nutrition Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Evaluation of provider prescribing practices related to patient‐
controlled analgesia in adult surgical/trauma patients at a large academic medical center Development of an ambulatory care pharmacist‐managed transitions of care service within a Veterans Affairs Medical Center Evaluation of daptomycin use in a 445‐bed community hospital Evaluation of patient vaccination rates in a veteran population enrolled in a home‐based primary care program Quality improvement project: development and pilot of a clinical pharmacy productivity model Evaluation of a low‐dose 4F‐PCC dosing strategy for acute warfarin reversal Evaluation of an Emergency Department Sepsis Screening Tool and Code Sepsis Protocol in the Treatment of Sepsis Patients Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. 159 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386580 Katherine March 9‐024 388423 Pablo March Lopez 1‐317 384661 AMA MARFO 8‐042 385219 Carrie Margeson 11‐307 387132 Lindsay Mark 1‐318 386937 Marija Markovic 11‐165 389115 Megan Marsh 11‐046 Management of Amiodarone‐Induced Thyrotoxicosis in a Patient with Underlying Cardiac Abnormalities: A Challenging Therapeutic Endeavor Medication review in a spanish primary care center Computerized physician order entry implementation in a hematology and oncology outpatient clinic: effect on the quality and safety of chemotherapy orders Impact of pharmacist led interdisciplinary review using pre‐determined criteria on parenteral nutrition practices Evaluating the impact of a pharmacist‐managed anticoagulation clinic versus physician‐managed warfarin therapy in a rural outpatient healthcare system Evaluating the potential cost‐savings associated with implementing an intravenous immune globulin dose rounding and body weight adjustment policy Impact of post graduate year‐1 (PGY‐1) pharmacy residents on attending pharmacists productivity Date Time Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. 160 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 385260 Jennifer Marshall 1‐319 388634 Jennifer Marshall 11‐242 385204 Lindsay Martin 11‐292 384555 Corinn Martineau 10‐268 386542 Tiffany Martinez 10‐317 389191 Matthew 8‐335 Martin‐Souza 388835 Casey Mashl 1‐320 388203 Jocelyn Mason 11‐308 Evaluation of a transitional care pharmacist pilot program; assessing quality, feasibility, and outcomes on high risk patient populations Expansion of a pharmacist‐
driven protocol in the emergency department to optimize treatment of urinary tract infections Evaluation of melatonin use for sleep management and delirium prevention in the critical care setting Risk factors for emergency department visits amongst diabetes patients from a family medicine clinic Evaluation of the Appropriateness of Antibiotic Prescribing at the Time of Hospital Discharge Evaluation of prescribing practices of inhaled dornase alfa in non‐cystic patients Survey of 2015 postgraduate year one (PGY1) residents concerning the North American Pharmacist Licensure Examination (NAPLEX) and the Multistate Pharmacy Jurisprudence Examination (MPJE) licensing process Impact of an infectious disease physician‐led cellulitis treatment Date Sunday, December 6 Time 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. 161 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. pathway on hospital length of stay 389298 Erin Massarello 12‐205 385984 Michael Massmann 12‐301 388651 Cathleen Mathew 8‐163 383723 Emily Mattson 1‐321 388684 Revika Matuknauth 8‐264 386402 Scott May 1‐322 388859 Katelynn Mayberry 9‐079 Evaluation of sedation in mechanically ventilated patients after implementation of a pain, agitation and delirium protocol in the intensive care unit Evaluation of aprepitant use in the prevention of post‐operative nausea and vomiting (PONV) Assessment of pain management through opioid use at an urban community teaching hospital Non‐steroidal anti‐
inflammatory drug deprescribing after hospitalization in patients with ischemic heart disease: a Minneapolis Veterans Affairs Health Care System (MVAHCS) medication use evaluation Sliding scale insulin use in the long term care (LTC)/community living center (CLC) Evaluation of intravenous potassium replacement in the critically ill patient Mental health of pharmacy and medical residents: incidence of clinical depression 162 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386702 Katrina Mayr 10‐286 387498 Brittany Mazur 12‐262 389142 Renee McAlister 1‐323 387493 Claire McClain 11‐111 383185 Seth McCleary 1‐324 388416 Christine McCluskey 8‐265 388831 Michael McCormick 8‐164 Use of telavancin for the treatment of methicillin‐
resistant Staphylococcus aureus‐associated pulmonary exacerbations in patients with cystic fibrosis: a retrospective case series Impact of centralized pharmacist‐assisted medication reconciliation during transition of care between facilities within a multi‐site health system Retrospective chart review of urinary tract infection management for positive urine cultures in a Veterans Affairs population after discharge from an emergency department Pharmacogenomic association with neurotoxicity in Hispanic children with acute lymphoblastic leukemia (ALL) Discontinuation of Delirium Medications in the Intensive Care Units Beyond surgery: post‐
surgical impact of intra‐
operative liposomal bupivacaine use in a community hospital setting Patient risk stratification in an outpatient primary care clinic: a medication use evaluation Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 Wednesday, December 9 3:45 ‐ 5:15 p.m. 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 163 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386545 Shae McCowan 11‐129 388319 Grace McCoy 1‐325 387320 Jenna McCoy 8‐266 387594 Shelbie McCoy 12‐059 385736 Kathryn McDaniel 12‐263 388210 Kyle McDaniel 8‐165 385959 Kaitlyn McDonald 1‐326 386819 Marc McDowell 9‐298 Impact of benzodiazepine use on length of intensive care unit stay and time on the ventilator in patients with delirium Analysis of clinical pharmacy specialist integration within patient‐
aligned care teams to provide diabetes management services to Veterans Optimizing the automated dispensing cabinet refill process at a large community hospital Assessment of the use of Dual Antiplatelet Therapy in Acute Ischemic Stroke or TIA Effect of conversion to a qualified health plan on antiretroviral medication adherence in a HIV population Introduction of a Pharmacy Driven Culture Review for Outpatient Treatment of Urinary Tract Infections in the Emergency Department Development of an antimicrobial formulary review process Thromboelastography utility in the management of traumatic hemorrhage within the setting of direct oral anticoagulants Date Time Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. 164 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386527 Mary Martin McGill 1‐327 386979 Julie McGinley 11‐191 386751 Kayla McGrath 8‐336 388772 Cathryn McIntosh 8‐267 387529 Lindsey McIver 1‐328 388872 Albert McKee 1‐329 386668 Kristen McLain 10‐018 385991 Mary McMillan 8‐043 Comparative evaluation of a vancomycin dosing nomogram versus manual dose calculation in a veteran population Initiation of a pharmacist‐
managed venous thromboembolism prevention service and the impact on adherence and appropriateness of therapy Implementation and assessment of drug‐
specific chemotherapy preparation checklists Assessing the impact of pharmacy resident‐guided medication reconciliation on medication therapy appropriateness at an urban teaching institution Evaluation of dextrose utilization as a surrogate for insulin‐induced hypoglycemic events among hospitalized patients Retrospective quality assurance review of patient outcomes post gemfibrozil discontinuation in simvastatin treated patients Clinical pharmacist impact on sepsis core measure bundle compliance and clinical outcomes in the emergency department. Evaluation of enoxaparin anti‐xa levels in obese vs. Date Sunday, December 6 Time 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 165 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. morbidly obese patients 385283 Kathleen McNamara 10‐103 389609 Molly McNaull 11‐166 385818 Chelsey McPheeters 9‐216 387252 Michael McQuade 1‐330 385308 Shannon McVeigh 1‐331 386012 Jeffrey Meadows 8‐011 388983 Angela Mechelay 12‐014 387883 Katherine Mechtel 8‐166 Testing the ability of warfarin treated patients to predict their INR Postoperative abscess rates in children with perforated appendicitis: a direct comparison of piperacillin/tazobactam and ceftriaxone plus metronidazole Implications of statin use on vasopressor therapy in the setting of septic shock Evaluation of enoxaparin based venous thromboembolism prophylaxis in critically ill, obese patients at an academic medical center Impact of a polypharmacy initiative: reduction in unnecessary and inappropriate medications in an elderly veteran population Oritavancin versus vancomycin in ABSSI: clinical and economic outcomes Assessment of an outpatient hyperglycemia protocol in an academic primary care clinic Evaluation of the incidence of acute kidney injury with extended‐infusion piperacillin‐tazobactam and vancomycin compared to standard infusion 166 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. piperacillin‐tazobactam and vancomycin. 386204 Jacqueline Medina 8‐012 388802 Meera Mehta 1‐332 389280 Selam Melka 10‐104 385395 Lindsay Menard 11‐293 383289 Angela Mensah 1‐333 384645 Darren Mensch 12‐060 388857 Michael Menzel 8‐268 Development and implementation of heparin‐induced thrombocytopenia protocol and impact on patient care and cost Survey of residency program directors (RPD) attitudes and perceptions of non‐traditional pharmacy residency applicants Evaluation of alteplase utilization at two community hospitals Therapeutic drug monitoring and dose adjustments of calcineurin inhibitors in pediatric patients for hematopoietic stem cell transplant Development, implementation and evaluation of the effectiveness of computer‐
based core critical care competencies for pharmacists Short‐term effect of pharmacist's education on insulin administration technique Assessment of meropenem utilization at SSM Health St. Mary's Hospital ‐ St. Louis. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 167 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386186 Alison Merkel 9‐299 387782 Jason Mersek 8‐269 384358 Melodie Merzier‐
Michel 11‐309 387336 Rachel Meyer 1‐334 387064 Nightingale Meyou 10‐019 387462 Derek Michalski 9‐012 Continuous versus intermittent pantoprazole infusion therapy for nonvariceal gastrointestinal bleed: a retrospective study of an institutional drug shortage management plan Comparison of efficacy and safety outcomes between warfarin and target specific oral anticoagulants (TSOACs) in patients on concomitant amiodarone Assessing the impact of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on the development of proteinuria in patients receiving vascular endothelial growth factor inhibitors Rivaroxaban utilization at a Western Michigan community teaching hospital Reducing chronic pain symptoms in clinically depressed patients with first time use of serotonin norepinephrine reuptake inhibitors (SNRI): venlafaxine and duloxetine Assessing the impact of propofol duration, rate, and cumulative dose on the incidence of hypertriglyceridemia in intensive care unit patients Date Time Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. 168 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386597 Christina Miele 12‐061 388186 Sarah Mike 8‐167 389019 Katie Miklavcic 10‐105 387655 Lena Mikolas 1‐335 386742 Sarah Milkovich 1‐336 385599 Deven Millay 11‐167 387083 Andrea Miller 11‐074 Assessment of direct oral anticoagulant dosing and monitoring pre‐ and post‐ implementation of a per‐
pharmacy protocol at a community teaching hospital Evaluating effects of newly implemented emergency department pharmacist on patient safety, quality improvement, and cost avoidance Impact of mobile medication reminder applications for medication adherence on 30‐day hospital readmission rates Implementing a pharmacist‐managed medication monitoring clinic for hepatitis C treatment Serious mental illness and its impact on diabetes care in a nurse/pharmacist managed population within a veterans affairs primary care clinic Appropriate Use of Intravenous Antihypertensive Medication During Hypertensive Crises in a Community Teaching Hospital Medication use evaluation of analgesic use with intubation in the emergency department Date Time Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. 169 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 387469 Annilee Miller 11‐243 385739 Bethany Miller 10‐187 385739 Bethany Miller 12‐138 388982 Gerald Miller 12‐264 385996 Maelee Miller 9‐300 386725 Micah Miller 8‐065 387685 Rachel Miller 11‐244 383166 Susan Miller 1‐337 Impact of a pain, agitation, and delirium protocol in mechanically ventilated patients within a community hospital Treatment of community acquired pneumonia (CAP) in pediatric patients at a level I trauma center Treatment of community acquired pneumonia (CAP) in pediatric patients at a level I trauma center Efficacy of current hyperkalemia management strategies at a community teaching hospital Efficacy and safety of 3‐
factor prothrombin complex concentrate versus fresh frozen plasma in a major or life threatening bleed on warfarin, apixaban, and rivaroxaban A didactic curriculum analysis of informatics subjects in the University of Montana Skaggs School of Pharmacy program in preparation for ACPE's Evaluation of a protocolized algorithm for resistant alcohol withdrawal in the medically critically ill Evaluating chronic obstructive pulmonary disease (COPD) readmission rates Date Time Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 170 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 387942 Lindsey Minnick 11‐168 388513 Nalisha Minors 9‐301 385727 Kendall Mintus 8‐168 388714 Arya Mishra 9‐135 389125 Andrea Miskimins 12‐265 384880 Jagoda Misniakiewic
z 9‐302 387109 Ardath Mitchell 1‐338 382554 Kayla Mitchell 11‐310 387577 Sarah Mitchell 1‐339 388379 Priyam Mithawala 12‐062 Customized versus standardized commercial parenteral nutrition: a community hospital perspective Evaluating the appropriate use of meropenem in adult patients in a community health system Evaluation of blood factor product utilization and policy adherence in a tertiary care hospital Analysis of protocol‐based enoxaparin dosing at a tertiary care teaching institution Naloxone Kit Distribution from the ED of a Community Hospital: Identifying Patients at Risk for Opioid Overdose Effect of dose‐reduced paclitaxel pre‐medication regimen on rates of hypersensitivity and corticosteroid‐related adverse reactions Impact of dolutegravir use in a veteran population Evaluation of tobramycin use in cystic fibrosis patients Comparison of time to first dose of oral morphine in the treatment of neonatal abstinence syndrome Appropriateness of tirofiban use in accordance to current ACC/AHA guidelines Date Time Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 Sunday, December 6 Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. 3:45 ‐ 5:15 p.m. 3:00 p.m. ‐ 4:00 p.m. 171 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388656 Shogo Miyagi 11‐192 388174 Nicole Moersch 12‐015 385929 Bella Mogaka 8‐270 388278 Sara Mohamed 9‐136 386639 Insaf Mohammad 10‐239 384741 Kyle Mohler 1‐340 386210 Alika Moitra 8‐271 Impact of re‐warming after therapeutic hypothermia on gentamicin pharmacokinetics in neonates with hypoxic‐
ischemic encephalopathy Compliance of dosing insulin based on internal guidelines at a community health system Medication reconciliation in the emergency department performed by pharmacy personnel: a prospective cohort comparison study. Development of a pharmacist driven intravenous to oral medication conversion protocol at a childrens hospital Evaluation of a venous thromboembolism (VTE) transitions of care process involving the direct oral anticoagulants (DOAC) in the emergency department and observation unit (EVACUATE) Exacerbation rates of veterans diagnosed with chronic obstructive pulmonary disease (COPD) in the primary care setting Patient characteristics impacting understanding, retention and demonstration of inhaler technique in an Date Time Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 172 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time underserved population 389176 Laura Molander 1‐341 386587 Juan Molina 9‐303 389468 Suzanne Molino 1‐342 387526 John Mondin 10‐240 389085 Jessica Monitz 10‐287 387195 Beatriz Monje 9‐137 Impact of treatment guidelines on antibiotic use for urinary tract infections (UTIs) in the emergency department (ED) Medication utilization evaluation (MUE) on patients receiving chronic opioid medication therapy at Veterans Affairs Caribbean Healthcare System in 2015 Implementation and evaluation of a pharmacist managed transitions of care service within a Veterans Affairs Healthcare System Outcomes associated with perioperative management of oral antithrombotic therapies following cardiac surgical intervention Review of protocol adherence for opioid usage in critical care delirium at a community hospital Effectiveness and safety of belimumab in the treatment of Systemic Lupus Erythematosus Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. 173 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 389647 Megan Monteen 9‐004 386241 Courtney Montepara 8‐169 386790 Robyn Moodt 10‐036 386658 Michael Moody 8‐337 389152 Kyle Moomey 11‐245 386146 Danielle Moore 9‐138 Impact of an Inpatient Medication Therapy Management (MTM) Billing Process on Patient Satisfaction Through HCAHPS Scores in a Rural Community Hospital Evaluation of the appropriate use of stress ulcer prophylaxis during admission and upon discharge at a community teaching hospital Determining the appropriateness and safety of discontinuing metformin upon admission in the inpatient non‐
critically ill setting: a retrospective study The use of ketamine in the peri‐intubation period to facilitate rapid post‐
intubation sedation and analgesia in the Emergency Department Retrospective chart review of the effect of amantadine on cognitive outcomes in the acute treatment of traumatic brain injury patients Evaluation of protocol compliance and patient outcomes in mild traumatic brain injury on antiplatelet or anticoagulant therapy Date Time Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. 174 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 387699 Heidi Moore 10‐020 386329 Jordan Moore 10‐106 386734 Elisa Morgan 12‐016 388923 Rachel Morgans 8‐066 384730 Brooke Morris 1‐343 385940 Courtney Morse 1‐344 388452 Whitney Mortensen 10‐037 Retrospective evaluation of sirolimus in allogeneic stem cell transplant patients with steroid‐
refractory graft‐versus‐
host‐disease at a large regional transplant center. Efficacy and safety analysis of P2Y12 antagonists in patients with acute coronary syndrome Frequency of Pseudomonas aeruginosa (P. aeruginosa) in cultures obtained from patients admitted with diabetic foot infection (DFI) Impact of pharmacy participation on number of discrepancies identified during admission medication reconciliation process: a pilot study The MOBS Trial: A Retrospective Study on Medication Optimization after Bariatric Surgery at the Huntington Veterans Affairs Medical Center Impact of pharmacist discharge prescription delivery and medication counseling on 30‐day hospital readmission rate Implementation and evaluation of an academic detailing pilot program in a large, integrated health system Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. 175 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388589 Timothy Morton 8‐338 386853 Benjamin Moskoff 10‐188 386853 Benjamin Moskoff 12‐139 389658 Chandana Mulamalla 10‐107 383159 Allison Mulberry 1‐345 386507 Kimberly Mulcahy 1‐346 386211 Mallory Muller 9‐139 387581 Ashley Mulvey 8‐067 Investigation of factors influencing rates of hypoglycemia among inpatients receiving insulin Confirmation of the equianalgesic conversion of methadone to oral morphine equivalents Confirmation of the equianalgesic conversion of methadone to oral morphine equivalents Root Cause Analysis of glycemic events and pharmacist role in the management of glycemia in hospitalized patients at a teaching community medical center Evaluation of Progressive Tinnitus Management: An Interdisciplinary Study Antibiotic Use and Implications of Drug Therapy in Psychiatric Inpatients Evaluation of rifaximin utilization in hospitalized patients Prevalence of methicillin‐
resistant Staphylococcus aureus nasal carriage among long‐term care facility residents directly admitted to the intensive care unit at an urban, non‐
teaching community hospital Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 176 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 384785 Arlette Munoz 8‐044 384489 Lindsey Munsch 11‐047 384638 Maida Muratagic 8‐170 386358 Matthew Murphy 1‐347 388601 Ryan Murphy 10‐189 388601 Ryan Murphy 12‐140 Evaluation of disease state management and impact of incorporating a chronic illness management (CIM) diabetes clinic to the Veterans Affairs patient aligned care team (PACT) Creation of a pharmacy rotation to improve patient satisfaction, understanding of high risk medications, and Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores Impact of pharmacist‐led physician education on adherence to methylprednisolone dosing for pediatric patients with asthma exacerbations. A Safety Profile of Allopurinol Use in Chronic Kidney Disease: A Veterans Affairs Perspective Implementation and assessment of an antimicrobial stewardship program in a centralized pharmacy servicing multiple facilities within a health system Implementation and assessment of an antimicrobial stewardship program in a centralized pharmacy servicing multiple facilities within a health system Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. 177 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 387734 Joshua Musch 1‐348 387714 Maureen Muthoni 8‐171 388578 Erika Myers 12‐017 382714 Doaa naeem 11‐311 389262 Mary Naeger 11‐294 386865 Athar Naif 9‐140 387689 Agnieszka Najger 1‐349 385299 Halee Namanny 1‐350 Effect of implementing a stress ulcer prophylaxis clinical tool on prescribing habits and associated institutional drug acquisition cost Impact of pharmacists counseling oncology patients on oral chemotherapy agents Characterization of the use of prophylactic antiepileptics for post traumatic brain injury at an academic medical center Empiric Antibiotic Prescribing Practice in Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines Treatment of Staphylococcus aureus bacteremia pre‐ and post‐
implementation of rapid diagnostic testing Predicting citrate accumulation during continuous renal replacement therapy using a calcium total to calcium ionized ratio Evaluation of an antimicrobial stewardship program at a community hospital Incidence of methicillin‐
resistant Staphylococcus aureus (MRSA) and nephrotoxicity in patients Date Time Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 178 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. empirically treated with vancomycin 386618 Erin Napier 9‐304 386310 Michael Napoleon 1‐351 385823 Sylvia Narciso 11‐075 388144 Whitney Narramore 11‐076 389161 Clara Nassif 9‐217 388450 Sean Navin 1‐352 384505 Hilary Navy 11‐312 Potential risk factors for the development of clostridium difficile infection at a community hospital Pump up the hospital: implementation of inpatient continuous subcutaneous insulin infusion Evaluating the appropriateness of double gram‐negative coverage in severe septic patients Implementation and evaluation of annual wellness visits (AWV) and chronic care management (CCM) conducted by a pharmacist in a primary care clinic Impact of standardized transitions of care medication education material on pharmacist‐
initiated patient education Bubble packaging medications and adherence outcomes in American Indian patients at Albuquerque service unit Evaluating the Impact of Mandatory Prescription Drug Monitoring Program Requirements on Opioid Prescribing Patterns Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. 179 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 385679 Vijay Nayar 11‐169 387486 Pierre Ndje 1‐353 389080 Jessica Neal 8‐272 386930 Joslyn Neal 10‐108 386667 Breaer Neff 8‐172 389364 Luke Neff 9‐051 389001 Joseph Nekola 12‐302 386744 Keyvan Nekouei 8‐013 389442 Zachary Nelson 11‐017 Assessing the risk of failure with oral antibiotics for the treatment of urinary tract infections after discharge in children less than 24 months of age. Sofosbuvir/Ledipasvir Efficacy in Patients with genotype 1 at the Washington DC. Veterans Affairs Medical Center (DCVAMC) Improving adherence to a severe alcohol withdrawal protocol through targeted order‐set interventions Retrospective evaluation of renal risk index and acute kidney injury in liver transplant patients Use of procalcitonin as a biomarker of bacterial infections in neuro‐insult patients Levetiracetam versus (fos)phenytoin for early onset post‐traumatic seizure prophylaxis in pediatric patients Containment assessment by opening the Closed‐
System Transfer Devices utilized for hazardous drug preparation Implementation of a full‐
time perioperative pharmacist in a level 1 trauma center Successful Treatment of an Intentional Overdose of Capecitabine with Uridine Date Time Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. 180 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Triacetate 387189 Kristen Neumeister 1‐354 387001 Deidra Newbrough 9‐141 384478 Sarah Newman 10‐109 388546 Kristie Newsom 12‐089 387649 Cheyenne Newsome 9‐080 384714 Michelle Newton 1‐355 389452 Jennifer Ngan 10‐190 389452 Jennifer Ngan 12‐141 Evaluation of concomitant benzodiazepine and opioid prescribing at the Minneapolis Veterans Affairs Health Care System (MVAHCS) Evaluation of smart pump technology implementation at an academic medical center Retrospective review of auto‐verified orders in a pediatric emergency department before and after pharmacist‐driven provider education Development of criteria for ertapenem use in the emergency department based on a retrospective evaluation in a level one trauma center Evaluation of association between health literacy and diabetes control in a pharmacist‐run medication management clinic Evaluation of pregabalin usage in veterans with painful diabetic peripheral neuropathy Impact of pharmacy transitions of care services on key patient outcomes Impact of pharmacy transitions of care services on key patient outcomes Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. 181 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 387419 Marie Ngan 9‐142 382600 Ijang Ngando 1‐356 389129 Ai Thi Nguyen 8‐273 387059 Annie Nguyen 8‐045 386951 Darlene Nguyen 11‐130 386986 Duy Nguyen 1‐357 387471 Lynh Nguyen 8‐274 387957 Michelle Nguyen 10‐038 Effects of paroxetine on mortality, hospital admissions, and emergency room visits in heart failure patients Evaluating serum sodium levels in intensive care unit patients requiring 3% hypertonic saline therapy for the management of elevated intracranial pressures at a large rural medical center Appropriate usage and dosage of vancomycin in neutropenia Pharmacist impact on appropriateness of insulin infusion and effective transitioning for patients presenting with diabetic ketoacidosis in the acute care setting Community pharmacists' role in care transitions for transplant patients Impact of a pharmacy‐
driven venous thromboembolism (VTE) prophylaxis program on post‐operative and 30‐day VTE events Impact of transition of care visits on thirty‐day hospital readmission rates Adherence to antiemetic guidelines with associated outcomes in patients receiving chemotherapy at an outpatient cancer center Date Time Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. 182 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 387962 Paul Nguyen 10‐191 387962 Paul Nguyen 12‐142 387402 Quyen Nguyen 10‐192 387402 Quyen Nguyen 12‐143 386980 Sarah Nguyen 1‐358 386290 Stephanie Nguyen 12‐063 387791 Thanh Nguyen 1‐359 Evaluation of intraoperative redosing of antibiotics in Whipple and neurosurgical procedures Evaluation of intraoperative redosing of antibiotics in Whipple and neurosurgical procedures Evaluating the impact of empiric antimicrobial treatment on hospital length of stay in patients admitted for acute bacterial skin and skin structure infection (ABSSSI) Evaluating the impact of empiric antimicrobial treatment on hospital length of stay in patients admitted for acute bacterial skin and skin structure infection (ABSSSI) Evaluating the impact of beta‐agonist use in patients with heart failure with or without pulmonary dysfunction Anticholinergic medication use and the risk of community‐acquired pneumonia in an older veteran population Evaluation of pharmacist intervention in diabetes patients identified from an electronic diabetes registry at a Veterans Affairs Medical Center Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 Wednesday, December 9 Sunday, December 6 3:45 ‐ 5:15 p.m. 3:00 p.m. ‐ 4:00 p.m. 3:45 ‐ 5:15 p.m. 183 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386093 Thomas Nguyen 11‐018 387072 WENDY UYEN 9‐305 NGUYEN 388279 Stephanie Nguyen‐
Vuong 9‐143 384807 Megan Nicklaus 10‐039 388074 Kirk Nielsen 8‐173 388925 Shelby Nielsen 11‐208 386700 Sarah Niemi 1‐360 Comparison of annualized relapse rates between oral and self‐injectable disease modifying therapies for the treatment of multiple sclerosis: a historical claims analysis Enhancing practice through the use of a clinical skills assessment program Evaluating appropriateness of granulocyte colony‐
stimulating factors (G‐CSF) for febrile neutropenia (FN) primary prophylaxis (PP) prescribing practice in high and intermediate risk patients receiving chemotherapy Evaluation of pantoprazole prescribed for stress ulcer prophylaxis Low‐dose tissue plasminogen activator (tPA) for the treatment of submassive pulmonary embolism (PE): an assessment of clinical outcomes at a community hospital Procalcitonin guidance document utilization review in an academic medical center Creation and utilization of a relative value unit system in an outpatient infusion center pharmacy Date Time Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 184 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386188 Lauren Nienas 1‐361 389466 Stephanie Nieves 9‐218 388856 Kimberly Niver 11‐077 388306 Ruby Nkwenti 10‐318 388018 Meira Nocella 8‐275 387018 Linda Nong 12‐206 389055 Kayla Nordhus 9‐306 Safety and efficacy of bivalirudin monotherapy versus unfractionated heparin (UFH) monotherapy for percutaneous coronary intervention (PCI) Evaluation of oral iron replacement therapy in geriatric patients Description of neonatal enoxaparin dosing and attainment of desired anti‐
Xa concentrations Evaluation of a pharmacy driven central line tube priming protocol to reduce central venous catheter (CVC) infections in the neonatal intensive care unit (NICU) Description of the prevalence of risk factors for hospital‐onset, healthcare facility associated Clostridium difficile infection cases at a rural community hospital Risk factors associated with immunization‐related adverse events in premature infants in a neonatal intensive care unit Implementation of a customized electronic alert for QTc prolonging medications: an evaluation of prescribing habits in the inpatient environment Date Time Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. 185 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 387367 Andrew Norman 1‐362 387909 Nikki Noroian 10‐193 387909 Nikki Noroian 12‐144 389332 Brandon Nuziale 12‐266 389632 Ucheoma Nwizu 12‐267 386814 Azuka Nwude 9‐081 385767 Ruth Nyakundi 9‐219 387385 Amber Oakes 11‐313 Follow‐up of emergency department microbiological cultures in the event of organism‐
antibiotic mismatch Determining the impact of a piperacillin‐tazobactam shortage on broad‐
spectrum antimicrobial prescribing in hospitalized adult patients Determining the impact of a piperacillin‐tazobactam shortage on broad‐
spectrum antimicrobial prescribing in hospitalized adult patients Impact of language preference on diabetes outcomes for patients referred to clinical pharmacy services Medication discrepancies in frequent users of the healthcare system: the impact and significance of frequent healthcare utilization Implementation of a discharge medication bedside delivery service Survey of West Virginia Hospital Discharge Practices for Heart Failure Patients Assessing the impact of order set utilization on clinical outcomes in patients with confirmed Clostridium difficile infection Date Time Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. 186 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386645 Eric 1‐363 Ocheretyaner 388959 Kate O'Connor 12‐064 388699 Kiernan O'Connor 1‐364 388259 Morgan Odom 9‐307 388830 Guin Ogburn 12‐065 389225 Jin Oh 10‐194 389225 Jin Oh 12‐145 386564 Janine Ohler 8‐339 Evaluation of antibiotic prescribing practices in hospitalized pediatric patients for the development of a guided pediatric antimicrobial stewardship program Evaluation of saxagliptin prescribing practices at six Veterans Affairs community‐based outpatient clinics Evaluation of renal dose checking in commercial clinical decision support (CDS) software Evaluating the efficacy and safety of probiotics for primary prevention of nosocomial Clostridium difficile infection (CDI). Protocolized versus nonprotocolized management of alcohol withdrawal syndrome utilizing lorazepam and haloperidol in critically ill trauma patients Improving patient outcomes by implementing a pharmacy driven vancomycin protocol Improving patient outcomes by implementing a pharmacy driven vancomycin protocol Daptomycin usage review and potential cost savings of ideal weight‐based Date Sunday, December 6 Wednesday, December 9 Time 3:45 ‐ 5:15 p.m. 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 187 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time dosing at a community hospital 386971 Alecia Oliver 1‐365 385382 Ashley Oliver 8‐276 389193 Katelyn Olsen 10‐110 386946 Melissa Olsommer 1‐366 387164 Kevin Omerza 10‐269 388076 Albina Ongari 10‐241 388803 Chisom Onyilofor 1‐367 Assessment of antibiotic prescribing practices for acute respiratory infections in the primary care setting within the Atlanta VA Medical Center Medication related hospital admissions at a Veterans Affairs Healthcare System Effects of initiating long‐
acting injectable antipsychotics on hospitalization rates Retrospective review in detection of error rates in admission medication reconciliation for patients at high risk of readmission to the hospital Effectiveness of three‐
factor prothrombin complex concentrate to reverse anticoagulation: clinical experience at a level I trauma center Lorazepam versus diazepam for the treatment of alcohol withdrawal syndrome in intensive care unit patients Impact of a pharmacy resident led education on 30‐day hospital readmissions in chronic obstructive pulmonary disease patients at an urban teaching hospital Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 188 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 385623 Lilian Ooi 10‐319 387313 Kelsie Ophus 8‐046 388405 Steven Orlando 1‐368 385683 Julia O'Rourke 11‐246 387630 Hillary Orr 11‐295 388697 Cristina Ortega Navarro 388704 Sharmon Osae 1‐369 388729 Theodore Osborn 1‐370 1‐371 Diagnostic performance of the methicillin‐resistant Staphylococcus aureus (MRSA) nasal swab PCR for MRSA pneumonia Growth changes in premature neonates: a retrospective analysis of human versus bovine milk fortifiers Evaluation of post‐
procedural bridging practices at a Veterans Affairs anticoagulation clinic Implementation of an oritavancin protocol for patients presenting to the emergency department with acute skin and skin structure infections Assessment of initial vancomycin dosing in a pediatric oncology patient population Intradialytic parenteral nutrition in hemodialysis patients Evaluation of adverse outcomes and appropriate use of target specific oral anticoagulants (TSOACs) in patients discharged from pharmacist monitoring at a Veterans Affairs Medical Center Evaluation of empirical treatment for outpatient community acquired pneumonia at a Veterans Affairs healthcare system: Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 189 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. a resident‐driven quality improvement project 382959 Elvis Osei Tutu 12‐268 388463 Maggie Oser 9‐144 386021 Jamie Ostrem 9‐082 388343 Alysia Osugi 11‐078 386006 Anchieh Ouyang 1‐372 389379 Ryan Owens 10‐195 Influence of European Medicine Agency/ Committee for medicinal products for humans (EMA/CHMP) Scientific Advice (SA) on Marketing Authorization Application (MAA) outcomes Impact of pharmacy services in a transitions of care clinic Preemptive therapy versus universal prophylaxis with valganciclovir for the prevention of cytomegalovirus (CMV) disease in liver transplant recipients Vancomycin dosing in pediatric patients to achieve a trough of 15 to 20 mg/L Evaluating the efficacy and safety of pharmacologic therapies for obesity in patients managed by clinical pharmacists at the San Francisco Veterans Affairs Health Care System Implementation of a new critical heparin lab alert value to enhance heparin drip protocol adherence Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. 190 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 389379 Ryan Owens 12‐146 387693 Yashira Pabon‐Padin 9‐145 388705 Puja Padalia 12‐269 384207 Daniel Padgett 10‐111 386928 Danielle Padgett 10‐112 387556 Jinsun Paek 11‐029 382550 Brittany Palasik 8‐277 389459 Megan Paleno 1‐373 Implementation of a new critical heparin lab alert value to enhance heparin drip protocol adherence Evaluating the need of a percutaneous coronary intervention (PCI) bleed risk stratification tool to facilitate appropriate antithrombotic selection Application of best practice strategies in the inpatient management of warfarin Evaluating the impact of clinical pharmacy services on The Joint Commission hospital based inpatient psychiatric services (HBIPS) core measures Medication use evaluation of vaccination after non‐
elective splenectomy or splenic embolization in trauma patients Outcomes in utilizing consolidated mail outpatient pharmacy (CMOP) for medical supplies Evaluation of antipsychotic use in elderly dementia patients Safety and efficacy of antipsychotic medications for the treatment of delirium in the intensive care unit (ICU) within a Veterans Affairs Healthcare System Date Time Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 191 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 389386 Daniel Paley 9‐052 389162 Valerie Palmer 12‐270 389391 Micaela Pamplin 12‐183 385136 Eva Pan 11‐131 384560 Bhumi Pandhi 8‐014 387337 Elizabeth Papa 1‐374 389150 Jeremy Pappacena 8‐174 388597 Julia Pardo Pastor 10‐196 388597 Julia Pardo Pastor 12‐147 Medication reconciliation: quantifying contribution to patient safety, cost avoidance, and pharmacist workload Defining and evaluating the impact of clinical pharmacy services in an ambulatory psychiatric clinic Evaluation of the appropriateness of reflex indwelling urinary catheter urine studies ordered in a community hospital Evaluation of carboplatin dosing using actual body weight compared to adjusted body weight Effect of pharmacist‐driven corticosteroid conversion in patients with COPD in a community hospital setting Interprofessional approach to safe medication injection practice changes Cost analysis, development, and implementation of a rituximab rapid infusion protocol in an academic oncology clinic Review of the use of abiraterone, enzalutamide and ketoconazole for castration resistant prostate cancer Review of the use of abiraterone, enzalutamide and ketoconazole for castration resistant Date Time Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. 192 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. prostate cancer 382620 Ae‐ryoung Park 10‐320 388540 Eun Park 12‐207 388252 Gabriel Park 12‐066 385793 Hanna Park 8‐340 387116 Jenny Park 9‐083 388592 Sarah Park 9‐308 384315 Haley Parker 1‐375 Improvement effect in patients nutrition state according to the adaptation of nutrition support teams consultation Utilizing pharmacy technicians to obtain home medication history in the emergency department Anticoagulation therapy considerations in factor VII deficiency: a case report Capturing the value of clinical pharmacy services Effectiveness of a new delirium education and treatment protocol in improving clinicians perceptions and knowledge of delirium in the intensive care unit: survey study. Comparison of unfractionated heparin dosage requirements during percutaneous coronary intervention over time Assessing A1c goal maintenance following clinical pharmacist management of veterans with type 2 diabetes 193 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388854 Michael Parks 9‐025 389305 Brittany Parmentier 8‐086 387838 Katelyn Parrish 9‐084 385257 Michelle Pasciolla 8‐175 386503 Amy Pasternak 9‐220 387411 Abhay Patel 1‐376 Comparative nephrotoxicity of vancomycin plus cefepime versus vancomycin plus piperacillin‐tazobactam in hospitalized patients Medication regimens of patients with schizophrenia and related disorders with 30 day inpatient readmissions compared to patients without 30 day inpatient readmissions Impact of pharmacist led education on nurse/pharmacist recognition and management of delirium outside of the intensive care unit Intravenous versus oral posaconazole and adherence to hospital guidelines Impact of initial intravenous tacrolimus dosage on the first tacrolimus concentration in a pediatric hematopoietic stem cell transplant population Evaluating cost savings and patient benefit from the 340B Drug Pricing Program through expansion of pediatric outpatient pharmacy services Date Time Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 194 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 389541 Amar Patel 10‐197 389541 Amar Patel 12‐148 386671 Deep Patel 9‐146 386182 Dipale Patel 1‐377 388359 Krishna Patel 1‐378 386620 Kunal Patel 11‐209 387457 Nilam Patel 9‐309 386418 Nilamben Patel 10‐288 Evaluating the Reduction in View Alerts Seen By A Patient Aligned Care Team Pharmacist In Improving Veteran Access to Primary Care Services Evaluating the Reduction in View Alerts Seen By A Patient Aligned Care Team Pharmacist In Improving Veteran Access to Primary Care Services Evaluation of maintenance Warfarin dose recommendations using Standing Stone verses Conventional dosing Evaluation of the cost associated with redispensed medications upon patient transfers Development of an online anesthesia drug reference guide Implementation of sedation vacation and titration protocols for mechanically‐ventilated intensive care unit (ICU) patients Evaluation of initial vancomycin dosing strategies and serum trough concentrations in a pediatric setting Utilization of aldosterone antagonists in veterans with heart failure on optimal therapy with reduced ejection fraction of less than 35% Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. 195 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 389353 Pooja Patel 1‐379 387056 Pritesh Patel 1‐380 387965 Puja Patel 10‐113 384981 Radha Patel 10‐321 386531 Ravi Patel 10‐114 389482 Roshni Patel 9‐147 388787 Ruben Patel 12‐303 388044 Shefali Patel 9‐221 Triple antithrombotic therapy with target specific oral anticoagulants (TSOACs) and the risk of bleeding. Enhancement of antimicrobial practices at Sells Indian Hospital Medication use evaluation of a three factor prothrombin complex concentrate in an academic medical center Evaluation of a hospital wide dosing guideline in adult patients initiated on vancomycin Evaluation of clinical outcomes in patients with healthcare‐associated pneumonia (HCAP) treated with community‐acquired pneumonia (CAP) regimens using a pneumonia risk scoring system Evaluation of a pharmacy‐
designed order set for use of blood factors to reverse oral anticoagulants Glycemic Management in the Medical Intensive Care Unit Evaluating relationship between the use of proton‐pump inhibitors and Clostridium difficile infection (CDI) and determining efficacy of probiotics in such patients. Date Time Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. 196 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386654 Udeshi Patel 11‐132 389056 Clayton Patros 1‐381 387157 Stephanie Paul 12‐018 389155 Kathleen Paulson 1‐382 388333 Julienne Pauly 1‐383 387605 Chelsey Payne 12‐271 389227 Kelly Peddy 10‐198 Medication history pharmacy technician pilot program for penicillin allergy assessment and documentation Implementation and evaluation of an algorithm‐
based order set for the outpatient treatment of urinary tract infections in the spinal cord injury population in a Veteran Affairs Medical Center Integration of pharmacy services into an outpatient specialty clinic Retrospective study comparing the morphine equivalents in chronic pain patients that are using marijuana compared to those that are not using marijuana Development and implementation of an opioid overdose education and naloxone distribution (OEND) program Evaluation of laboratory monitoring in multiple sclerosis patients treated with fingolimod Implementation and analysis of a patient‐
centered educational program: a comparison of traditional warfarin counseling versus a designed, educational audiovisual series Date Time Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 Wednesday, December 9 3:45 ‐ 5:15 p.m. 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. 197 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 389227 Kelly Peddy 12‐149 389350 Betsy Pederson 10‐199 389350 Betsy Pederson 12‐150 385128 LeeAnna Pederson 12‐272 385908 Kayla Peeler 1‐384 388314 Anita Pena 1‐385 384322 Johanna Peragine 1‐386 Implementation and analysis of a patient‐
centered educational program: a comparison of traditional warfarin counseling versus a designed, educational audiovisual series Evaluation of the dosing strategy of enoxaparin for the prevention of venous thromboembolism in morbidly obese patients Evaluation of the dosing strategy of enoxaparin for the prevention of venous thromboembolism in morbidly obese patients Differences in US rural versus non‐rural population pharmacotherapy treatment for adults with depression Mississippi Kidney Foundations renal evaluation and assessment program (REAP): assessment of resource management and targeted participant follow up Overcoming barriers to accessing a pharmacist‐run metabolic syndrome monitoring clinic Identifying risk factors among patients who discontinued hepatitis C treatment to develop a treatment‐readiness assessment tool Date Time Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 198 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 385692 Mariel Pereda 8‐176 388773 Luis Pereira 8‐341 386174 Angela Perhac 11‐170 386190 Dayna Perkins 12‐208 388218 Erika Perpich 12‐273 384484 Emily Perriello 11‐048 386664 Rosemary Persaud 10‐115 387468 Morgan Peterman 1‐387 389094 Haley Peters 11‐079 Creating a quiet, healing environment: the impact of pharmacist interventions on nighttime medication administration and patient satisfaction Monitoring metabolic adverse effects associated with atypical antipsychotic use in an outpatient psychiatric clinic Recurrent clostridium difficile infection in patients with continued proton pump inhibitor therapy Clinical and financial outcomes associated with an inpatient therapeutic interchange of insulin detemir to glargine Effectiveness of multidisciplinary post‐
transplant endocrine clinic Improper continuation of atypical antipsychotics after treatment and resolution of acute delirium in the intensive care unit Correlation of blood pressure reduction in acute intracerebral hemorrhage (COBRA‐ICH) Assessment of outcomes from a pharmacist‐run tobacco cessation clinic Impact of health‐system specialty pharmacy use on hepatitis c treatment Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. 199 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 385130 Silvia Petkova 1‐388 388311 Katie Petrone 10‐242 387298 Brittany Petrosky 8‐278 384877 Kriss Petrovskis 11‐080 386193 Stephen Petry 12‐274 386096 Shelly Pezzella 10‐116 388056 Amy Pham 9‐085 388268 Mai‐An Pham 1‐389 389020 Michelle Pham 9‐026 Assessment of initial antimicrobial prescribing in a community hospital emergency department Improving student leadership skills through a structured advisory program in an accelerated three year college of pharmacy program Weight Based Dosing of Vancomycin in the Emergency Department Evaluation of the safety of enoxaparin at a pediatric institution. Stress ulcer prophylaxis: assessment of appropriate prescribing in critically ill patients, followed with piloting of pharmacist intervention at transitions of care Impact of a care transitions team on HCAHPS survey results and readmission rates within a community health‐system. Using gap analysis and lean principles to prepare a community hospital for the arrival of USP 800 Impact of a pharmacy‐
driven education program on HCAHPS scores at an academically affiliated comprehensive cancer center Implementation of a resident facilitated observational skills‐based Date Time Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. 200 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Assessing the appropriateness of current monitoring practices for everolimus, sorafenib, and imatinib at Harris Health System Evaluating the effectiveness of treatments for patients with NAP1/027 Clostridium difficile Evaluation of emergency department empiric antibiotic selection for admitted patients Heparin infusion dosing: does one size fit all? Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Impact of a physician and pharmacist‐driven antimicrobial stewardship (AMS) program at a community hospital Impact on CDC guideline compliance after incorporating pharmacy in a pneumococcal vaccination screening process Evaluation of methylnaltrexone use at a large academic medical center Efficacy of a dihydropyridine calcium channel blocker auto‐
substitution on blood pressure control in a 445‐
bed community hospital Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. competency in a hospital pharmacy 388957 Trang Phan 10‐117 388998 John Phillips 9‐013 388389 Nicholas Phillips 10‐040 387450 Amanda Phoenix 11‐247 386766 Jennifer Pichlik 10‐289 387366 Elizabeth Pickren 8‐279 382727 Kara Piechowski 11‐314 385813 Vanessa Pierre 10‐118 201 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 385420 Chelsea Pintz 8‐047 389527 Ethan Pippin 12‐019 385662 Ameen Pirasteh 1‐390 388834 Ryan Platz 9‐222 388771 Noah Ploegman 8‐048 388880 Abby Pollander 9‐086 389377 Katelyn Pontore 9‐148 387671 Misael Porras 1‐391 Implementation of a pharmacist‐managed refill program within an adult medicine clinic Exploring the risk factors for community acquired Clostridium difficile Impact of Rapid Identification of Gram‐
Positive Organisms with the Implementation of an Antimicrobial Stewardship Approach at an Adult Community and Regional Pediatric Hospital Analysis of positive urine cultures and how they are managed in adult hospitalized patients Diltiazem in the treatment of atrial fibrillation: a single center study at CHI‐ creighton university medical center Implementation and evaluation of a delirium assessment tool in an intensive care unit Optimizing controlled substance discrepancy surveillance at a tertiary care hospital Evaluation of nurse‐driven pneumococcal and influenza vaccination protocol for appropriate patient screening, administration, and documentation at a tertiary hospital Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 202 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 384713 Amanda Porter 10‐322 388902 Blake Porter 8‐049 387106 Charrell Porter 11‐019 389290 Ed Portillo 1‐392 386695 Keith Posendek 11‐020 386935 Ashley Potter 10‐200 386935 Ashley Potter 12‐151 Retrospective evaluation of the use of statins based on the 2013 ACC/AHA guidelines in an ambulatory clinic Evaluation of the impact of pharmacist response to sepsis alerts on time to broad‐spectrum antibiotic administration at a major medical center Direct pharmacist education to enhance anticoagulant therapy initiation in patients with atrial fibrillation (DEPICT‐
AF) Meds to bed implementation in an extended care nursing facility Pharmacists' roles in patient care in an acute care urban hospital Tacrolimus dose adjustments for the prevention and treatment of graft‐versus‐host disease during concomitant posaconazole invasive fungal infection prophylaxis at Avera McKennan Hospital: a retrospective review Tacrolimus dose adjustments for the prevention and treatment of graft‐versus‐host disease during concomitant posaconazole invasive fungal infection Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. 203 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time prophylaxis at Avera McKennan Hospital: a retrospective review 385781 Anna Powers 1‐393 386780 Janelle Poyant 8‐050 389547 Hannah Pratt 8‐342 387131 Jacqueline Pratt 1‐394 388151 Lyle Pratt 11‐081 384772 Vanessa Prendergast 11‐171 386532 Brian Price 9‐149 388384 Katlin Pritchett 8‐177 Preemptive warfarin dose reduction after initiation of sulfamethoxazole‐
trimethoprim or metronidazole Evaluation of warfarin therapy management within a tertiary referral hospital Cost‐justification of a transition of care pharmacist. Automated software platform to assess pre‐
validated risk for opioid‐
induced respiratory depression to qualify patients for in‐home naloxone Effect of titrating oral diuretics prior to discharge from the hospital on the outcomes of heart failure patients Evaluation of Ertapenem Utilization in a Large Community Hospital System‐wide bowel protocol: an analysis of standardizing bowel management Design and implementation of protocols for Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 204 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. chemotherapy regimens 387170 Kristin Progar 10‐243 384712 Ali Pryne 9‐223 388331 Lukasz Przychodzien 11‐296 388883 Gina Puglisi 1‐395 385724 Benjamin Pullinger 12‐067 388695 Mitchell Purse 9‐087 387608 John Puryear 1‐396 389139 Eric Pyles 10‐119 Renal function after conversion to mTOR‐
Inhibitor in liver transplant recipients Retrospective evaluation of safety and efficacy in the treatment of cervical artery dissection at a large, multi‐site, healthcare system. Utilization of customized automated data capture and data processing for antimicrobial stewardship to increase quantity and acceptance rate of pharmacists' interventions Evaluating the effectiveness of clinical video telehealth services in the delivery of anticoagulation care for rural veterans Tolerance of enteral nutrition co‐administered with vasopressors in surgical and trauma intensive care unit patients Adherence to non‐
formulary and restricted‐
use medication consults Evaluation of an argatroban dosing protocol at a regional hospital. Dexmedetomidine medication use evaluation in adult patients in a community hospital setting Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. 205 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386683 Azhin Qadir 12‐275 387237 Lina Qasem 1‐397 386821 Andrew Quach 1‐398 385392 Stephanie Quach 8‐071 386260 Kathryn Qualls 12‐276 389398 Jennifer Quevedo 11‐082 386727 Alison Quinn 10‐323 387813 Jeydie Quinones 8‐280 Pharmacist focused approach to improve blood glucose control in patients receiving basal insulin Clinical and economic outcomes of warfarin versus direct oral anticoagulants (DOACs) following alteplase for the treatment of pulmonary embolism (PE) Comparing provider adherence to antimicrobial dosing recommendations in pediatric inpatients before and after implementation of a sequential non‐
interruptive and interruptive clinical decision support strategy Urinary tract infections caused by ESBL‐producing Enterobacteriaceae in a Medically Underserved Population Evaluation of albumin utilization in hospitalized adults Medication use evaluation of intravenous methocarbamol Effect of CYP2D6 gene variation on opiate dose requirement in sickle cell disease patients Impact of pharmacist‐led, hospital‐based discharge medication reconciliation service Date Time Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 206 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386022 Kelly Racette 10‐041 388410 Megan Radigan 10‐005 386785 Elizabeth Radloff 11‐248 382975 Andrea Rai 11‐021 387635 Karan Raja 12‐277 387193 Whitney Ralph 8‐051 389631 Kelley Ramey 8‐343 Impact of pharmacist involvement and clinical decision support on vaccination errors and missed opportunities in a pediatric primary care clinic Alcohol withdrawal treatment: outcomes in patients receiving a symptom‐triggered regimen with or without scheduled chlordiazepoxide Comparison of vasopressor treatments in the setting of severe septic shock in a mixed bed community hospital intensive care unit Impact of pharmacist interventions on readmission rates for chronic obstructive pulmonary disease (COPD) Review of medication communication scores and hospital rating on a telemetry unit without dedicated pharmacist managed discharge counseling Developing an antibiotic de‐escalation protocol at a rural community teaching hospital Evaluate the implementation of transitional care pharmacy services on key patient outcomes in a small community hospital Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 207 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 389339 Andrea Ramos 8‐344 387517 Taylor Ramsdell 11‐210 386729 Bradlee Rea 8‐178 389558 Aimrie Ream 1‐399 389084 Jacob Reaser 10‐201 389084 Jacob Reaser 12‐152 388356 Tyler Redelico 1‐400 Evaluating the use of ertapenem at a community teaching hospital Compliance with updated sepsis bundles to meet new sepsis core measure in a tertiary care hospital Retrospective analysis of histamine 2‐receptor antagonist and proton pump inhibitor use for stress ulcer prophylaxis (SUP) from patient admission through discharge Implementation and evaluation of pharmacist involvement in transitions of care services for chronic obstructive pulmonary disease (COPD) patients in a community, teaching hospital Evaluation of pharmacy education on reducing refill requests of discontinued medications at a federally qualified health center Evaluation of pharmacy education on reducing refill requests of discontinued medications at a federally qualified health center Management of bleeding using recombinant factor VIIa and 4‐factor prothrombin complex concentrate in patients with liver disease Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 208 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388615 Susana 11‐172 Redondo Capafons 385688 Brittany Reed 9‐310 385667 Ellen Reed 1‐401 389637 Lindsey Reeder 8‐345 388706 Racquel Reese 11‐112 384800 Lisa Rehs 1‐402 389604 Ashle Reid 10‐120 Pyoderma gangrenosum secondary to azacitidine in myelodysplastic syndrome Timing of antimicrobial administration in patients presenting with sepsis, severe sepsis, and septic shock Opioid overdose education and naloxone distribution to veterans admitted for detoxification at the Battle Creek Veterans Affairs Medical Center (VAMC) Drug‐induced nephrotoxicity in hospitalized patients with vancomycin in combination with piperacillin‐tazobactam or meropenem Audit of a pharmacist‐
driven piperacillin/tazobactam dosing protocol: a drug‐
use evaluation Retrospective analysis of antibiotic prescribing in the emergency department, identifying opportunities for pharmacy involvement Changes in patient demographics at a student‐run free clinic: the effects of the Affordable Care Act Date Time Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. 209 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 387673 Stefanie Reid 8‐281 387863 Ashley Reller 1‐403 386324 Adrianne Remigio 9‐311 389346 Kayla Renner 8‐282 387496 Rachel Renwick 10‐244 386571 Claire Reuter 9‐017 Use of Intravenous and Intrapulmonary Recombinant Factor VIIa for Diffuse Alveolar Hemorrhage Secondary to Disseminated Strongyloides Infection: A Case Report Evaluation of the efficacy and safety of rituximab in kidney transplant patients for the treatment of antibody mediated rejection in conjunction with plasmapheresis and intravenous immune globulin Predicting unbound phenytoin concentrations from total phenytoin concentrations using revised Winter‐Tozer (WT) equations at a large, academic medical center Prophylactic antibiotic duration and Clostridium difficile infection rates in a trauma population Physician knowledge and self‐efficacy of new anticoagulants: a targeted needs assessment Evaluation of the use of antibiotics for surgical prophylaxis among patients receiving antibiotics for active infection at a tertiary medical center Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. 210 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 387279 Jose Luis Revuelta 9‐088 389294 Caralyn Reyenga 1‐404 386745 Inmaculada Reyes 11‐173 387308 Miguel Reyes 10‐275 Malia 389035 Megan Rhoten 10‐202 389035 Megan Rhoten 12‐153 387021 Amber Rice 12‐278 387137 Emily Richards 1‐405 Off‐label use of filgrastim in the management of non‐chemotherapy drug induced neutropenia Medication use evaluation of intravenous levetiracetam at a large community hospital Neurotoxicity as dose‐
limiting factor in oxaliplatin‐based chemotherapy in a tertiary hospital EQUATION FOR THE PREDICTION OF SERUM DRUGS LEVEL OF DIGOXIN IN STEADY STATE Medication use evaluation of the diagnosis and management of asymptomatic bacteriuria in a community hospital Medication use evaluation of the diagnosis and management of asymptomatic bacteriuria in a community hospital Pain management evaluation of long‐bone fractures in the emergency department of an acute care hospital that is part of an integrated health care system Use of prophylactic ondansetron with intravenous opiates in emergency department patients Date Time Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 211 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386466 Patsy Richards 1‐406 388231 Joshua Rickard 10‐203 388231 Joshua Rickard 12‐154 386156 Taylor Rider 8‐179 385588 Krista Rieger 12‐020 387601 Jacob Rigdon 11‐174 388297 Angela Righi 11‐083 388471 Margaret Riley 11‐249 Assessment of appropriate antibiotic selection and duration of therapy for the treatment of urinary tract infections and the impact on readmission in a community hospital Adherence with monitoring guidelines for amiodarone and dofetilide in ambulatory patients Adherence with monitoring guidelines for amiodarone and dofetilide in ambulatory patients Incidence of contrast‐
induced nephropathy and the preventative effect of intravenous hydration in an at‐risk population at a large community hospital Oral antibiotics for bacteremic Enterobacteriaceae urinary tract infection Influence of documented or reported beta‐lactam allergies on clinical outcomes in patients that present with septic shock The impact of liposomal bupivacaine on efficacy and safety outcomes in the setting of cardiothoracic surgery. Vitamin A supplementation for prevention of chronic lung disease in neonates Date Time Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. 212 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 389508 Derrick Rinehart 10‐121 386689 Stephanie Ring 1‐407 386124 Lori Rio 8‐052 387142 Kyle Rising 10‐276 387545 April Risner 8‐320 387118 Karleen Ritchie 11‐084 388624 Johanna Rivera Anazagasty 1‐408 Intracerebral hemorrhage after external ventricular drain placement: an evaluation of risk factors for post‐procedural hemorrhagic complications Comparison of sustained virologic response with hepatits c virus treatments in the veteran population Assessing the impact on antimicrobial therapy for patients with bacterial pneumonia infection before and after implementation of required indications for use on all antimicrobial orders Risk of Elevated Creatine Phosphokinase with High‐
dose Daptomycin (8 mg/kg) versus Traditional Doses (6 mg/kg) Integration of a clinical pharmacy team into the patient centered medical home to improve transitions of care for Missouri Medicaid patients Beyond Cost Savings: The Impact of a Medication Assistance Program on Hemoglobin A1Cs Design of a pharmacy residency interview rubric based on the most desirable characteristics in prospective candidates identified by pharmacy residency preceptors Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 213 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 382637 Attiya Rizwan 11‐175 386248 Amy Robacheski 10‐245 389661 Shannon Robb 8‐346 389179 Taylor Roberson 1‐409 388123 Jenna Roberts 8‐321 387858 Steven Robinette 12‐279 384744 Amanda Robinson 10‐122 Modeling of Pharmacist Role In Patient Safety For Least Developed Countries ‐ Pakistan Development of a risk assessment tool to identify patients at high risk for medication related 30 day hospital readmissions Implementation of a pharmacist directed pain management stewardship program at Munson Medical Center Calcium monitoring and replacement across three phases of massive transfusion in a trauma population at a Level I Trauma Center Clinical and economic impact of antimicrobial choice and duration of therapy for inpatient, non‐
intensive care unit (ICU) community‐acquired pneumonia (CAP) Mechanical ventilation as an isolated risk factor for multi‐drug resistant organisms in respiratory cultures in intensive care units at an academic medical center Effects of a pharmacy driven preoperative antibiotic dosing protocol on surgical site infection rates and adverse drug reactions Date Time Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. 214 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 382611 Ellen Robinson 10‐246 384664 Kaitlyn Robinson 11‐085 386949 Bradley Rocco 11‐315 389137 Melissa Rock 8‐180 385738 Meghan Roddy 11‐176 388779 Brittany Rodriguez 1‐410 387110 Colleen Rogers 1‐411 Case report: Staphylococcus aureus bacteriuria as an indicator for non‐urinary infections Review of medication utilization during rapid sequence intubation in an intensive care unit Evaluation of the relationship between HbA1c reduction and primary provider encounter time versus intensive diabetes management service encounter time Evaluation of the appropriateness of ceftriaxone utilization in the emergency department for urinary tract infections Use of intravenous acetaminophen for post‐
operative pain in the neonatal intensive care unit Children's hospital retrospective review of medication discrepancies identified at the time of discharge Implementation of a pharmacist‐led discharge counseling service in a small urban teaching hospital Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 215 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 389629 Lesley Rogers 10‐290 386530 Whitney Rogers 9‐224 387611 Marissa Rogoff 1‐412 385292 Whitney Rohlman 9‐225 386197 Bertha Rojas 9‐312 388937 Glenn Roma 8‐181 387636 Konstantyn Romadin 8‐283 385207 Dana Roman 8‐347 Implementation of education plus provider prescribing reports and the effects on antipsychotic polypharmacy in children and adolescents in the outpatient setting Dexmedetomidine versus propofol for intraoperative sedation in carotid endarterectomy Pharmacist impact on patients with diabetes as part of a multidisciplinary team in a primary care setting Evaluation of automated medication dispensing machine overrides and development of policies to promote improvement Evaluation of candidemia prevalence and treatment cost comparison in a community‐based hospital Evaluation of a pharmacist driven post‐discharge education for patients following acute myocardial infarction. The effect of inhaler to nebulizer conversion on hospital readmission rates in patients with chronic obstructive pulmonary disease (COPD) Assessment of antibiotic prescribing practices in patients with penicillin allergy at a community teaching hospital Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 216 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 385754 Stephanie Romano 11‐177 387068 Rosa Maria Romero‐
Jimenez 10‐204 387068 Rosa Maria Romero‐
Jimenez 12‐155 387519 Benjamin Rosati 1‐413 388315 Philip Roszel 11‐113 389156 Nechama Rothberger 10‐123 386181 Nicole Rubio 9‐150 387117 Whitney Ruddock 9‐151 387378 Nicole Ruggiero 1‐414 Evaluation of the prevalence of intracranial hemorrhage between anticoagulants, antiplatelets, and nonsteroidal anti‐
inflammatory drugs Individualizing biological therapies dose based on patients response: cost effectiveness of moderate to severe psoriasis treatment Individualizing biological therapies dose based on patients response: cost effectiveness of moderate to severe psoriasis treatment Meds to beds: an evaluation and expansion of an existing component of transitions of care in a tertiary care hospital Impacts of a newly implemented pharmacy driven medication reconciliation protocol Ceftriaxone and SPICE: a recipe for disaster? Pharmacy resident participation in vaccination clinics in a hospital setting Assessing the appropriateness of inpatient leuprolide use at Memorial Hospital West (MHW) Evaluation of hepatitis C virus (HCV) treatment outcomes with new direct‐
Date Time Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 217 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. acting antiviral agents 386805 Diandra Ruidera 12‐068 388339 Cristina Ruiz 10‐277 383720 Abigail Russell 12‐280 389419 Gabrielle Russell 9‐226 385571 HollyAnn Russell 11‐250 389205 Lindsey Ruth 1‐415 388850 Amanda Ryan 1‐416 389323 Ann Ryan 8‐182 Safety and efficacy of anti‐
inhibitor coagulant complex in treating novel oral anticoagulant reversals Use of ipilimumab for pretreated patients with advanced melanoma Assessment of ventilator sedation practices following intubation in the emergency department Evaluation of levetiracetam for early posttraumatic seizure prophylaxis in pediatric patients with traumatic brain injury Retrospective analysis of the safety and efficacy of high dose cefepime in pediatric cystic fibrosis pulmonary exacerbations Role of fosfomycin in the treatment of acute uncomplicated cystitis caused by resistant uropathogens Development of a pharmacist‐run new patient orientation clinic in an outpatient Veterans Affairs (VA) pharmacy Evaluation of a role for pharmacists in culture follow‐up at a community hospital emergency department. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 218 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 387023 Keenan Ryan 8‐087 387342 Dimitrae Rynsburger 12‐281 386133 Ahmad Saad 1‐417 387546 Mahmoud Sabawi 11‐251 385936 Alicia Sacco 1‐418 388010 Bryan Sackey 9‐089 388470 Areeman Saed 10‐205 388470 Areeman Saed 12‐156 The Next Step in PrEP: Evaluating outcomes of a pharmacy run HIV pre‐
exposure prophylaxis (PrEP) clinic Effectiveness of liposomal bupivacaine versus standard therapy for post‐
surgical pain in patients who underwent video assisted thoracoscopy or thoracotomy Pharmacists' experience with a medication safety committee's structure, responsibilities, and roles Effect of pharmacist‐
provided clinical interventions on quality of care and cost avoidance in an emergency department Evaluating protocol adherence during anti‐
inhibitor coagulant complex administration for reversal of factor Xa inhibitors for life‐
threatening bleeding Evaluation of empiric antibiotic therapy for urosepsis in spinal cord injury patients at a Veteran Affairs medical center Pharmacist driven antimicrobial stewardship implementation in a community hospital Pharmacist driven antimicrobial stewardship implementation in a community hospital Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 Wednesday, December 9 3:45 ‐ 5:15 p.m. 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. 219 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 385199 Marla Saez 1‐419 385664 Ali Saghaian 10‐324 387700 Kelly Saha 1‐420 386045 Sarith Saju 8‐183 387338 Helin Salama 8‐284 387233 Nouran Salem 1‐421 387715 Alok Salgia 9‐313 389066 Mehrnoosh Samimi‐
Gharai 8‐184 Outcomes of anticoagulation prophylaxis in patients undergoing total knee replacement (TKR) or total hip replacement (THR) at VACHS Impact of a six‐month piperacillin/tazobactam shortage at a rural community hospital Efficacy of proton pump inhibitors in preventing gastrointestinal bleeding in patients receiving direct oral anticoagulants A cross‐sectional study ascertaining the prevalence of appropriate treatment for pre‐diabetes in the US adult population Incidence of hypotension associated with dexmedetomidine versus propofol used for sedation in mechanically ventilated adult medical intensive care unit (ICU) patients Apixaban major bleeding: patient characteristics, management and outcomes Evaluation of transition from patient controlled analgesia to oral analgesia in post surgical patients Medication use evaluation of ceftaroline fosamil in a community hospital Date Time Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 220 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 387784 Chelsea Sampadian 1‐422 388281 Jed Sana 11‐086 389209 Michelle Sandberg 1‐423 384709 Ashley Sanders 10‐247 386735 Janice Sanders 1‐424 387031 Omeka Sanders 1‐425 388715 Phillip Sanshuck 9‐314 388952 Maressa Santarossa 9‐014 Dipeptidyl‐peptidase‐IV inhibitors for treatment of type 2 diabetes mellitus: a pilot study Implementation of a billing process for inpatient clinical pharmacy services Non‐dihydropyridine calcium channel blocker use in stable heart failure patients Improving Patient Outcomes by Using Social Media to Deliver Diabetes Educational Videos in a Community Pharmacy Assessment of patient characteristics and barriers to treatment of hepatitis C in a veteran population Evaluation of the duration of antipsychotics prescribed for intensive care unit (ICU) delirium Establishing safety and efficacy of high dose unfractionated heparin compared to traditional dosing in obese patients for venous thromboembolism prophylaxis Impact of a rapid‐
diagnostic tied antimicrobial stewardship intervention on clinical outcomes in patients with bloodstream infections Date Sunday, December 6 Wednesday, December 9 Time 3:45 ‐ 5:15 p.m. 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. 221 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 387830 Melissa Santibanez 1‐426 387570 Ibinson Sarah 9‐227 385231 Nidhi Saraiya 11‐316 389109 Jonathan Sarky 11‐087 387783 Stefanie Sarratt 8‐053 388966 Gabriele Sasso 10‐325 388846 Evan Sasson 1‐427 Pharmacokinetic/pharmac
odynamic derived predictions of efficacy and clinical outcomes in obese and non‐obese patients with Enterobacteriaceae bloodstream infections Impact of therapeutic interventions on thrombocytopenia in patients on histamine‐2 receptor antagonists Evaluation of the management of positive bacterial urine cultures 2 years after guideline implementation Evaluating prescribing practices for hepatitis B immunization based on Advisory Committee on Immunization Practices(ACIP) recommendations for patients with diabetes Evaluation of safety outcomes of apixaban compared to warfarin in patients with end‐stage renal disease. Impact of an interprofessional hypoglycemia response team on prevention of recurrent insulin induced severe hypoglycemia in a 431‐bed community teaching hospital in Syracuse, NY Possible rivaroxaban induced full body rash: a Date Time Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 222 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. case report 388750 Burton Saunders 9‐228 388507 Stephen Saw 9‐315 388770 Catherine Scalley 1‐428 385704 Gianni Scappaticci 12‐209 389327 Joseph Schafer 1‐429 387321 Obadiah Scheich 12‐282 386662 Ashley Schenk 11‐317 384644 Matthew Scherrer 11‐114 Physician utilization of pediatric dosage calculators in the outpatient setting Sternal wound infection following delayed sternal closure at a large academic medical center Evaluation of naloxone use and expansion of an overdose education and naloxone distribution program (OEND) in a rural Veterans Affairs (VA) healthcare system Recurrent Clostridium difficile infection in adult hematology patients The effectiveness of ascorbic acid in the prevention of atrial fibrillation after cardiothoracic surgery Development of a standardized clinical support matrix acros a health system Utilization of intravenous tranexamic acid in total knee or total hip arthroplasty: retrospective analysis of effectiveness and safety Code sepsis: the impact of time to therapy on clinical outcomes Wednesday, December 9 Sunday, December 6 3:00 p.m. ‐ 4:00 p.m. 3:45 ‐ 5:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. 223 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 387988 Alex Schickli 1‐430 388673 Lindsay Schieb 10‐326 384277 Zachary Schlei 1‐431 386637 Lindsay Schmees 1‐432 389108 Kristen Schmerbeck 8‐185 389123 Laura Schmidt 1‐433 389376 Michael Schmidt 10‐206 Evaluation of pharmacy‐
driven dexmedetomidine stewardship and appropriate use guidelines in a community hospital setting Optimization of a vancomycin dosing and monitoring protocol in an inpatient, teaching hospital Impact of clinical pharmacists in investigational drug services at a comprehensive cancer center Comparison of the incidence of nephrotoxicity in pediatric patients receiving vancomycin with piperacillin‐tazobactam or cefepime Impact of a Collaborative Strategy to Reduce the Inappropriate Use of Stress Ulcer Prophylaxis in Hospitalized Non‐ICU Patients Evaluation of group A Streptococcal (GAS) pharyngitis treatment at a community teaching health system Characterizing Clostridium difficile infection rates, risk factors, and outcomes in hematopoietic stem cell transplant recipients Date Time Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. 224 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 389376 Michael Schmidt 12‐157 384769 Sierra Schmidt 10‐124 387125 Tanya Schmidt 10‐042 386655 Nicole Schneider 1‐434 386378 Rebecca Schoen 1‐435 387192 Sydney Schrammeck 9‐174 387192 Sydney Schrammeck 11‐202 387920 Sara Schroedl 1‐436 Characterizing Clostridium difficile infection rates, risk factors, and outcomes in hematopoietic stem cell transplant recipients Impact of time to initiation of parenteral nutrition on duration of mechanical ventilation Design and implementation of a pharmacy‐led post‐fall medication consultation service Evaluation of vitamin K dose and route on warfarin reversal in a community hospital setting Pharmacist adherence to an extended interval of international normalized ratio follow‐up protocol Evaluation of outcomes in patients with malignancy receiving direct oral anticoagulants (DOACs) Evaluation of outcomes in patients with malignancy receiving direct oral anticoagulants (DOACs) Evaluation of anticholinergic polypharmacy in the elderly population in an outpatient setting: a medication use evaluation at the Minneapolis Veterans Affairs Health Care System (MVAHCS) Date Time Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 225 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388502 Jamie Schuber 1‐437 386305 Thomas Schuetz 11‐115 388348 Courtney Schultz 1‐438 388193 Jacob Schultz 1‐439 387444 Sara Schulz 11‐088 386733 Kaitlyn Schumacher 11‐211 388434 Natalie Schwarber 11‐252 Integration and evaluation of an adherence monitoring tool for patients using target specific oral anticoagulants Evaluation of antimicrobial stewardship efforts on the utilization of piperacillin/tazobactam Influence of tyrosine kinase inhibitors on renal function and evaluation of current monitoring procedures at the Cincinnati Veterans Affairs Medical Center (VAMC) Validation of a population estimate based vancomycin kinetics calculator at the Minneapolis Veterans Affairs Medical Center (MVAMC) Effect of darbepoetin alfa on mortality and transfusion independence in critically ill trauma patients The safety and efficacy of outpatient parenteral antimicrobial therapy for the treatment of hip and knee prosthetic joint infections Outcomes of Pseudomonas aeruginosa urinary tract infections Date Sunday, December 6 Wednesday, December 9 Time 3:45 ‐ 5:15 p.m. 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. 226 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386013 Brittina Schwarz 11‐253 387479 Jaime Schwendenm
ann 385146 Caitlyn Schwirian 8‐285 388693 Abigale Scott 12‐210 387895 Rachel Scott 9‐229 387634 Jordan Sedlacek 1‐440 10‐043 387167 Ravin Seewah 11‐178 389004 Lydia Seger 11‐254 Retrospective evaluation of patients diagnosed with sepsis to determine impact of converting empiric therapy from cefepime to piperacillin‐tazobactam at a 180‐bed community hospital Reducing dual antipsychotic therapy upon patient discharge Vancomycin troughs in pediatrics: how low can you go? Incidence of major bleed and cardiovascular events in dialysis patients with newly diagnosed atrial fibrillation and the correlation with CHADS2‐
VASc and HAS‐BLED scores. Alteplase dosing for acute ischemic stroke Assessment of electronically retrievable risk factors in the outpatient setting for thirty day readmission Evaluation of acute kidney injury in patients on concurrent piperacillin‐
tazobactam and vancomycin Safety evaluation of cephalosporin and penicillin use in beta‐
lactam allergic patients: a pharmacy‐led initiative to reduce utilization of non‐
preferred antibiotics in Date Time Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. 227 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. surgery and obstetrics 387285 Nathan Seligson 12‐304 388150 Jade Senger 11‐089 386691 Kelly Sennett 9‐230 384576 Kristen Senyk 9‐152 388120 Sun Seo 9‐316 Retrospective analysis of cladribine use in acute myeloid leukemia induction treatment Implementation of pharmacist counseling to improve the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) medication‐related scores in heart surgery patients Review of dexmedetomidine usage for process improvement in alcohol withdrawal at a community level one trauma center Establishing a health system program to implement new credentialing requirements and maximize reimbursement for the Washington pharmacist provider status legislation Survey of community pharmacists opinions after implementation of a company‐wide program to help improve Medicare Part D Star Ratings quality measures 228 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386931 Roseanne Seok 12‐184 388528 Alexandra Serafino 9‐027 385627 Lianna Serbas 10‐125 387687 Jason Serna 9‐015 384502 Regan Sevinsky 10‐291 386496 Emma Sew Hoy 11‐049 388408 Jeanna Sewell 10‐044 Evaluation of the Compliance Rate of the Modified CAM‐ICU Protocol and the Appropriateness of Provider Interventions at San Francisco Veterans Affairs Healthcare System (SFVAHCS) Thromboembolism associated with the use of tranexamic acid Evaluation of fall risk in dementia patients on an atypical antipsychotic in the Veterans Affairs population. Establishing Key Antibiotic Utilization Metrics for an Antimicrobial Stewardship Dashboard Assessment of febrile neutropenia management in hospitalized adult cancer patients: a retrospective review Pharmacists' authority to furnish nicotine replacement therapy in California: evaluation of community pharmacists' impact on smoking cessation medication access and use Comparison of pharmacist‐
run to physician‐only Medicare wellness services Date Time Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. 229 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 384750 Rebecca Shaffer 8‐286 388785 Iffat Shafiq 10‐126 388497 Abhishek Shah 11‐212 389403 Ami Shah 8‐088 388213 Hiren Shah 1‐441 386892 Janki Shah 11‐050 387918 Jasmine Shah 9‐231 385950 Tanvi Shah 11‐255 384655 Suhail Shaikh 10‐248 Retrospective review of the development of acute kidney injury in patients receiving vancomycin in combination with either piperacillin/tazobactam or another broad spectrum beta‐lactam antibiotic Evaluating procalcitonin level management as a marker for antimicrobial utilization Evaluating inappropriate use of low dose statin therapy based on VA/DoD practice guidelines for the management of dyslipidemia. Evaluation of the use of liposomal bupivacaine in gynecologic oncology surgery Evaluation of bridging anticoagulation practices in critically‐ill patients with atrial fibrillation Assessment of the clinical impact of a pharmacist managed diabetes clinic Working smarter: optimizing medication batching workflow in order to reduce intravenous drug waste in a pediatric setting Evaluating the use of eptifibatide and abciximab at Loyola University Medical Center Rational use of rasburicase in the treatment and management of tumor Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. 230 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. lysis syndrome 388733 Madeline Shanko 8‐287 388600 Monica Sharma 10‐021 384208 Bethany Sharpless 11‐030 386287 Rachel Sharpton 10‐292 385854 Suhair Shawar 12‐283 386764 Kailee Shearer 11‐022 Questionnaire to assess the attitudes and perceptions of nurses and pharmacists satisfaction with pharmacy services before and after implementation of the decentralized pharmacy service model Anti‐epileptic prophylaxis in traumatic brain injury (TBI): a comparison of fosphenytoin/phenytoin vs. levetiracetam Implementation of a novel auditing report to improve compliance to joint commission therapeutic duplication standards QTc interval monitoring for chronic azithromycin therapy in patients with cystic fibrosis Derivation and validation of a predictive scoring system to identify patients at high risk of infection due to extended‐spectrum‐
beta‐lactamase‐producing Enterobacteriaceae Evaluation of empiric antibiotic use and subsequent de‐escalation as a proponent for developing a pharmacist managed antimicrobial stewardship de‐escalation protocol 231 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388969 Jeffrey Shearin 10‐327 388194 Sara Shearin 9‐317 388045 Amrit Sheena 11‐090 384312 Shelby Shemanski 12‐069 387202 Stephanie Sheng 1‐442 387400 Liliana Sherman 10‐022 384643 Sahil Sheth 8‐288 Implementation of a procalcitonin protocol at a community hospital to aid in the de‐escalation of vancomycin in intensive care unit (ICU) patients presenting with sepsis. Expansion of an antimicrobial stewardship program in a 135 bed community hospital, with a focus on intravenous to oral conversion of antimicrobial therapy Evaluation of empiric antimicrobial therapy for urinary tract infections in the emergency department Evaluation of clinical efficacy utilizing adjusted body weight for daptomycin dosing Appropriate target‐specific oral anticoagulant utilization within a community hospital Number of encounters required to achieve blood pressure (BP) control in hypertensive patients: a retrospective study Incidence of acute kidney injury after treatment with vancomycin in combination with piperacillin‐tazobactam or cefepime for non‐ICU patients at a community hospital Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 232 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 389395 Samantha Shi 1‐443 389249 Yi Shi 1‐444 386613 Olga Shimunova 10‐207 386613 Olga Shimunova 12‐158 386815 Jae Shin 1‐445 386359 Naon Shin 11‐256 385702 Denver Shipman 9‐090 386651 Clare 10‐249 Siebenberger Impact of pharmacist involvement in an interdisciplinary palliative care team at an acute care hospital Pilot Project to Investigate Role of Clinical Pharmacist in Screening High‐risk Hypoglycemic Patients at the San Francisco Veterans Affairs Health Care System (SFVAHCS) Evaluation of micafungin and tigecycline use: a pre‐
post analysis Evaluation of micafungin and tigecycline use: a pre‐
post analysis Evaluation of vaccine standardization compliance throughout medical group offices within a community health system Development and implementation of a sleep protocol for mechanically ventilated patients in the critical care unit Embedding pharmacists in primary care clinics: factors increasing provider acceptance and utilization of newly‐established collaborative drug therapy management (CDTM) services Utilization of sodium ferric gluconate at a community hospital Date Time Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. 233 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386167 Kelsey Siebold 10‐250 385884 Sarah Sienko 12‐284 387231 Alison Sigler 10‐251 389355 Amanda Sihabout 1‐446 388225 Francisco Silva 9‐016 387264 Katelyn Simmons 9‐053 388412 Samuel Simon 11‐318 387258 Brent Simpkins 9‐232 Duration of anticoagulation after provoked VTE: a review of current practices Characterization of tranexamic acid use in trauma and surgery Evaluating the impact of an emergency medicine pharmacist (EMP) in a community hospital with an existing pharmacy technician led medication reconciliation pilot program Evaluating perioperative antibiotic prescribing patterns for transurethral resection of prostate (TURP) and bladder resection procedures at a VA healthcare facility Impact of bariatric surgery on chronic disease, healthcare costs, and quality of life in a native american population Review of the management of the hepatitis C population being treated with ledipasvir/sofosbuvir in an ambulatory setting Ceftazidime/avibactam for carbapenem resistant hospital acquired pneumonia: a case series Evaluation of an insulin infusion protocol for diabetic ketoacidosis at a rural, community teaching Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. 234 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. hospital 385217 Rachel Simpkins 8‐289 385756 Amrita Singh 12‐070 382643 Amanda Singrey 8‐089 385858 Alyssa Sinkov 9‐153 387078 Heather Sirek 1‐447 389535 Dennis Sison 9‐318 386833 Danny Situ 12‐021 Comparing fracture risk assessment tool (FRAX) prediction with and without bone mineral density (BMD) in male veterans with previous fracture Evaluation of the appropriate use of eculizumab at two academic medical centers Access to breathing medications in an uninsured and underinsured patient population Discordance between aPTT and anti‐Xa levels during heparin infusion: outcomes in cirrhotic and renal failure patients Comparison of ceftriaxone plus either doxycycline or azithromycin in the treatment of non‐ICU Veteran patients with community‐acquired pneumonia: a non‐
inferiority study Evaluation of the Impact of Medication Therapy Management on Opioid Overutilization Characterization of liposomal bupivacaine's impact upon orthopedic surgery outcomes 235 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 387476 Nicholas Skezas 8‐072 389499 Mark Skildum 11‐091 389385 Melissa Slattery 11‐257 389005 Aaron Sloan 1‐448 383298 Lindsey Slusher 9‐319 385214 Stephen Small 10‐127 386684 Bethany Smith 12‐071 384383 Danielle Smith 9‐233 ACE inhibitor induced angioedema: selecting appropriate therapies Impact of the presence of a pharmacist in the emergency department on ischemic stroke outcomes in patients receiving tissue plasminogen activator (tPA). Developing an assessment tool and protocol to decrease the rates of Clostridium difficile infection in a community hospital setting Clinical outcomes of generic warfarin manufacturer substitution in the Department of Veterans Affairs Retrospective analysis of extended infusion piperacillin‐tazobactam in morbidly obese patients in a community hospital Comparison of adverse effects and efficacy of two continuous nafcillin infusion regimens Impact of a critical care pharmacist in a multidisciplinary ventilator optimization initiative in a community hospital intensive care unit Evaluation of the efficacy and safety of tolvaptan in adult patients with refractory SIADH secondary to traumatic Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. 236 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. brain injury or non‐
traumatic intracranial hemorrhage. 384388 Hilary Smith 8‐186 387785 Katherine Smith 1‐449 388438 Matthew Smith 10‐208 388438 Matthew Smith 12‐159 389284 Megan Smith 10‐209 389284 Megan Smith 12‐160 388898 Melissa Smith 10‐278 388097 Sean Smithgall 8‐187 Pharmacist Involvement in Pre‐operative and Post‐
operative Optimization of Medication Therapy Interruption of warfarin therapy in patients undergoing procedures: a quality improvement project Evaluation of the impact of pharmacist‐driven utilization of oritavancin in a community hospital emergency department Evaluation of the impact of pharmacist‐driven utilization of oritavancin in a community hospital emergency department Development and reliability of a comprehensive medication review evaluation tool Development and reliability of a comprehensive medication review evaluation tool Implementation of barcode verification for sterile product compounding Influence on readmission rates after participation in an interprofessional transitional care clinic 237 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 385566 Julie Smithson 1‐450 386366 Jessica Snead 10‐293 385904 Andy Snyder 1‐451 388032 Shirley So 9‐154 387950 Jennifer Sobeck 1‐452 385801 minoosh sobhanian 11‐297 387792 Kristine Sobolewski 9‐234 387726 Loriel Solodokin 1‐453 Comprehensive review of the utilization of IV unfractioned heparin Evaluation of mycophenolate dosing for orthotopic heart transplant recipients Incorporation of a novel vancomycin nomogram into a standard vancomycin dosing protocol at a community hospital: effect on vancomycin utilization and safety Impact of pharmacy services on discharge medication reconciliation and improving transitions of care for pneumonia and COPD patients Design and implementation of a pre‐
diabetes pathway to assist in diabetes diagnosis prevention and proper alignment of care Risk factors for the development of venous thromboembolisms in neurocritical care patients Implementation of antibiotic stewardship practices targeting urinary tract infections through a real time reporting system Safety profile of carfilzomib when infused over 10 minutes versus 30 minutes: a cohort study Date Time Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 238 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 389242 Cassandra Song 1‐454 387760 Matthew Song 1‐455 387507 Vincent Soriano 12‐072 385690 Cindi Sounthoneva
t 1‐456 386170 Elizabeth Spears 9‐155 386039 Samantha Spishock 9‐156 389169 Stevan Squires 1‐457 Impact of implementing the CHA2DS2‐VASc for stroke risk evaluation in veterans with atrial fibrillation in a Veterans Administration anticoagulation clinic Analgesia, sedation, and delirium monitoring practices and patient outcomes following the implementation of an order set and provider education: a clinical practice improvement project Characterization of free phenytoin concentrations in end stage renal disease using the modified Winter‐
Tozer equation Utilization of therapeutic interchanges to improve access to medications in a low‐income uninsured population Effect of maintenance intravenous fluids on new‐
onset atrial fibrillation in critically ill adults Comparison of pediatric outpatient antibiotic prescribing patterns for specified indications in primary care practices Pharmacist implementation of a chronic heart failure pharmacotherapy clinic using 2013 ACCF/AHA guidelines to optimize Date Time Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 239 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. medication therapy 389331 Kirbie St. James 10‐210 389331 Kirbie St. James 12‐161 385580 Martin St. John 11‐179 386649 Brooke Stanton 9‐157 389181 Kelly Starman 1‐458 388644 Lauren Stauffer 11‐258 384389 Kenneth Stearns 1‐459 386713 Kathryn Stecklein 11‐051 Effects of a medication history process refinement using pharmacy technicians in the emergency department Effects of a medication history process refinement using pharmacy technicians in the emergency department Effects of pharmacist intervention on post‐
discharge antibiotic therapy and pneumonia readmission rates Utilization of iron dextran and iron sucrose at a community hospital Evaluation of the Boise VAMC pharmacist‐
managed smoking cessation clinic Evaluation of the efficiency of a pharmacy‐managed admission medication reconciliation program Implementation and evaluation of an antimicrobial stewardship program (ASP) at Claremore Comprehensive Indian Health Care Facility. Impact of rapid detection of respiratory viruses in adult inpatients on anti‐
infective use Wednesday, December 9 Sunday, December 6 Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. 3:45 ‐ 5:15 p.m. 1:45 p.m. ‐ 2:45 p.m. 240 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 387253 Katie Steele 8‐348 388893 Kevin Steele 8‐188 385642 Molly Steen 12‐305 388877 Teodora Cristina Stefan 1‐460 386698 Caitlin Stehling 8‐189 386948 Matthew Stephens 11‐092 388985 James Stergios III 12‐285 Development of a pharmacy technician training program to incorporate walk‐in immunizations into the workflow of a community pharmacy Medication use Evaluation: Assessing prescribing patterns and infusion methods at a large community hospital system. Pharmacy and behavioral health: assessing the impact of interdisciplinary collaboration and pharmacy‐driven informatics interventions on a subset of the American Indian/Alaska Native population Evaluation of use of benzodiazepines in the treatment of post‐
traumatic stress disorder The use of intravenous proton pump inhibitors for stress ulcer prophylaxis in pediatric intensive care patients Emergency department and urgent care antibiotic prescribing patterns for children with acute otitis media Evaluation of antibiotic therapy duration in complicated intra‐
abdominal infections Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. 241 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 389538 Diana Stewart 10‐294 387480 Melanie Stewart 1‐461 386375 Zachary Stewart 9‐158 389145 Cassandra Stith 10‐128 384330 Ashley Stocker 1‐462 385933 Robyn Stoianovici 8‐290 388606 Nicole Stone 11‐259 Knowledge, skills and attitudes regarding medication management in patients with advanced illnesses: an educational needs assessment for surveyors in the state of Maryland Addition of a proton pump inhibitor restriction protocol to the antimicrobial stewardship program to reduce clostridium difficile infections in a community hospital Evaluation of the safety and efficacy of bolus three percent sodium chloride in the management of cerebral edema in adults with stroke Implementation of clinical pharmacy services at a healthcare for the homeless clinic Effect of pharmacist‐led Medicare annual wellness visits (AWV) on health maintenance personal prevention plans, medication discrepancies, and health care utilization Evaluation of a vancomycin dosing protocol in adult inpatients with renal impairment Clinical outcomes of 3 different dosing schemes of dabigatran in adults 75 years of age or older: Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. 242 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. hospital based cohort study 387665 Carly Stoneman 9‐235 385604 Carolyn Stout 11‐023 388718 Samantha Straits 11‐052 386184 Micheal Strein 8‐291 386258 Melissa Striglio 1‐463 388595 Matthew Stryker 8‐190 386716 Candi Sturges 10‐052 388607 Samantha Su 9‐236 Effect of vancomycin versus linezolid on hospital length of stay in patients with influenza and bacterial pneumonia Assessing clinical outcomes after a 12‐week pharmacist‐driven, interdisciplinary health and wellness program Efficacy of pharmacist facilitated transitions of care Evaluation of appropriate analgesia and sedation pre versus post implementation of an analgosedation protocol in critically ill patients Evaluating inpatient empiric antibiotic selection for the treatment of skin and soft tissue infections Evaluating the off‐label use of once‐weekly exenatide in combination with basal insulin therapy in patients with type 2 diabetes mellitus Medication use evaluation of the pediatric asthma protocol in the emergency department Albuterol versus levalbuterol in patients with a history of atrial fibrillation 243 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 384333 Jenny Suen 8‐191 386543 Brandi Sugonis 1‐464 384630 Christina Suguitan 1‐465 387236 Rand Sulaiman 10‐211 387236 Rand Sulaiman 12‐162 388745 Danine Sullinger 11‐260 389132 Nataliya Sulyk 10‐129 Inpatient pharmacy pain consult to improve patient outcome Workflow redesign in a VA outpatient pharmacy to improve prescription wait times and veteran satisfaction Evaluation of anti‐
methicillin‐resistant Staphylococcus aureus therapy continuation and discontinuation based on MRSA nares testing in Veteran patients admitted with pneumonia Evaluation of de‐escalation of empirically initiated broad‐spectrum antibiotics in patients diagnosed with healthcare‐associated pneumonia Evaluation of de‐escalation of empirically initiated broad‐spectrum antibiotics in patients diagnosed with healthcare‐associated pneumonia Development and implementation of a delirium protocol in the surgical trauma intensive care unit Evaluation of the clinical and economic impact of ideal body weight dosing for intravenous immune globulin in idiopathic thrombocytopenic purpura (ITP) Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. 244 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388817 Michele Summerville 10‐130 385365 Jacob Sumner 9‐091 387297 Yihan Sun 12‐286 388245 Hanna Sung 10‐045 386895 Emily Supenia 10‐212 386895 Emily Supenia 12‐163 385685 Steven Swank 12‐287 387548 Gary Sweet 8‐292 Nephrogenic diabetes insipidus as a result of historic lithium use precipitated by poor oral intake Improving appropriate proton‐pump inhibitor use in patients on dual antiplatelet therapy Optimization of renal sparing immunosuppression to prevent renal failure in liver transplant patients Clinical outcomes of NPH/regular 70/30 versus insulin glargine in insulin‐
naive type 2 patients with diabetes uncontrolled by oral antidiabetics in the outpatient setting Evaluation of pharmacist impact on an emergency department culture follow‐
up program Evaluation of pharmacist impact on an emergency department culture follow‐
up program Competency outcome evaluation before and after international exchanges of pharmacy faculty and practicing pharmacists from developing countries Effects of home psychotropic medication reinitiation in ICU patients with a history of mental illness Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 245 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 385888 Michelle Sweet 8‐192 388813 Alexa Szelc 9‐159 386797 Michael Ta 9‐320 386582 Thanh Ta 11‐213 384771 Menilik Tadesse 8‐193 384721 Khalid Taher 11‐193 386106 Lindsey Takara 8‐322 Thrombus risk reduction in antiphospholipid syndrome patients monitored by factor II activity assay Retrospective review of patients receiving intravenous acyclovir and the incidence of nephrotoxicity Effect of morphine and hydromorphone on blood pressure after a single intravenous dose in critically ill patients Assessing the impact of pre‐discharge bundle on reducing 30‐day readmissions of patients with chronic obstructive pulmonary disease (COPD) Impact of pharmacist‐led medication education on the pharmacy care experience of high‐risk hospitalized patients Impact of restrictive ciprofloxacin susceptibility reporting on resistance and utilization in gram‐
negative bacteria in a tertiary care hospital Intravenous heparin therapy for full dose and cardiac protocols: dose optimization in elderly and obese patients Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 246 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 387933 Bryson Tamanaha 1‐466 389579 Diana Tamer 8‐194 387524 Kathy Tang 1‐467 389666 Shidie Tang 12‐073 389357 Stephanie Tang 8‐195 387511 Heather Tanner 1‐468 388743 Natalie Tapley 9‐237 385429 Christopher Tassen 11‐261 Assessing provider adherence to recommendations against the use of combination angiotensin‐converting enzyme inhibitor and angiotensin receptor blocker therapy at a Veterans Affairs medical center Impact of time to antibiotic initiation on mortality in septic patients admitted through the emergency department at a community hospital system Managing albumin use in the ICU: using a collaborative approach Acquired methemoglobinemia secondary to lidocaine injection Development of a pharmacist‐driven transitions of care model in an acute care community hospital Evaluation of diabetes outcomes in a pharmacist‐
managed insulin titration program Evaluating the appropriateness of dosing for select novel oral anticoagulants and risk of complications in an inpatient setting Use of electronic tracking system to decrease Date Time Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. 247 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. missing medications 386491 Morgan Taylor 10‐328 387966 Sarah Teasdale 1‐469 387108 Shannon Tellier 11‐262 389194 Gene Terkoski 10‐295 384720 Erin Terranova 11‐319 387172 Salma Tewfik 9‐238 387152 Khushbu Thaker 12‐211 Evaluation of current prescribing patterns for Clostridium difficile infection and the implementation of an order‐set. Enhancing antibiotic stewardship in a private not‐for‐profit tertiary care hospital Baseline characteristics of oral anticoagulant use in an urban academic medical center Return on investment (ROI) analysis for medication therapy management (MTM) services provided within a commercial patient population Incidence of Acute Kidney Injury Before and After the Implementation of an Extended Interval Infusion for Zosyn and a CHI Health standardized Vancomycin Dosing Protocol Utilizing lean principles to implement a pharmacist‐
led discharge counseling program Evaluation of physician and nursing adherence to a sedation and analgesia protocol in mechanically ventilated patients Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. 248 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388931 Alexis Thayer 8‐349 384715 Samantha Themas 8‐293 385677 Meghan Thibeaux 1‐470 384292 Kaci Thiessen 8‐323 387754 Ryan Thimes 12‐074 385676 Ashley Thomas 1‐471 383592 Kama Thomas 1‐472 386040 Lindsey Thomas 8‐196 Perioperative factors associated with surgical site infection in patients undergoing peripheral vascular bypass surgery Use of oritavancin for treatment of acute bacterial skin and skin structure infections (ABSSSIs) in outpatients: a retrospective quality analysis Comparison of a multi‐
modal blood glucose control plan before and after initiation in diabetic open vascular surgery patients Prescribing practices for community‐acquired pneumonia in the Sooner Health Access Network Medicaid population: identifying opportunities for antimicrobial stewardship Implementation of the blue ocean leadership strategy in the pharmacy setting and the impact on employee engagement and satisfaction Limiting warfarin tablet strengths in veterans The Impact of Irregular Urinary Drug Screens on Chronic Opioid Therapy Management Evaluation of suspected heparin‐induced thrombocytopenia (HIT) Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 249 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. management in a community hospital 389010 Sarah Thomas 10‐329 388920 Shanada Thomas 1‐473 387325 Rebecca Thompson 10‐252 387884 Tonisha Thompson 8‐197 385134 Kyle Thorner 8‐324 388004 Megan Tibbitts 9‐321 385934 Elizabeth Tien 12‐075 Real‐world effectiveness of an 8‐week course of fixed‐
dose ledipasvir and sofosbuvir therapy for the treatment of Hepatitis C in a specialty pharmacy setting Evaluation of physician led oral chemotherapy management within a large health‐systems outpatient cancer center Outcomes from implementation of rapid identification test for detection of gram‐positive and gram‐negative bacteria into a pharmacist‐
directed antimicrobial stewardship protocol for pediatric patients Pharmacists impact on increasing cure rates among hepatitis C patients in an outpatient setting Evaluation of a warfarin dosing nomogram at a large community hospital Evaluating antibiotic administration times in the emergency department at an academic medical center Implementation and promotion of Better Health Pharmacy: a county medication repository program 250 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388873 Matthew Timmons 9‐322 384575 Samad Tirmizi 8‐090 387166 Lauren Titterington 12‐288 386138 Krystal Titus‐
Rains 1‐474 388990 Allison Todd 11‐263 387181 Matthew Todd 12‐076 385300 Alec Toews 10‐296 Evaluation of clinician utilization of a respiratory PCR panel in conjunction with procalcitonin and BNP to guide antimicrobial therapy in hospitalized patients with suspected respiratory tract infections: A before and after study. Evaluation of interactions with anti‐infective agents and immunosuppressive therapy in a tertiary care center Induced hypothermia and shivering: an evaluation of two management strategies in an urban health system Durations of treatment response in veterans with multiple myeloma at the Durham Veteran's Administration Medical Center Implementation of a pharmacy pain management service to improve patient safety and overall pain outcomes Development of a Dynamic Drug Procurement Process in a Closed System Dispensing Pharmacy Comparison of acute kidney injury in the neonatal population between treatment with piperacillin/tazobactam or piperacillin/tazobactam Date Time Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. 251 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. plus vancomycin 385872 Tara Tokar 10‐131 386120 Rebecca Tokarski 1‐475 388396 Diem Ton 8‐198 386213 Nicholas Torney 11‐264 385425 Annie Torosyan 8‐199 387094 Meghan Toth 10‐213 387094 Meghan Toth 12‐164 Safety and efficacy of rapid intravenous titration of sodium nitroprusside to oral vasodilators in advanced low‐output heart failure Evaluation of Pharmacy Services in the Emergency Department at Magee‐
Womens Hospital of UPMC Impact of pharmacists providing bedside discharge prescription service at a pediatric hospital Implementation of a pharmacist‐managed penicillin skin testing service at a community teaching hospital Pharmacist‐managed bacteremia treatment compared to the historical standard of care in a community hospital emergency department Evaluation of meropenem use in a free‐standing pediatric hospital: a retrospective chart review Evaluation of meropenem use in a free‐standing pediatric hospital: a retrospective chart review 252 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 384781 Maria Tovar 8‐200 387128 Caroline Townley 11‐180 388603 Aaron Tran 1‐476 383709 Ann Tran 10‐046 387956 Emmeline Tran 9‐175 387956 Emmeline Tran 11‐203 387802 Hai Quyen Tran 9‐028 387574 Jennifer Tran 12‐306 Prostate specific antigen as predictive factor of response to abiraterone in real‐life conditions Comparison of grade IV neutropenia with pegfilgrastim administered by two delivery methods: on‐body injector and manual injection with a prefilled syringe Antipsychotic‐induced urinary incontinence with a focus on risperidone The effect of cefepime intravenous push versus intravenous piggyback on time to administration of vancomycin in the emergency department Prescribing accuracy of novel oral anticoagulant (NOAC) dosing for venous thromboembolism (VTE) treatment and prophylaxis Prescribing accuracy of novel oral anticoagulant (NOAC) dosing for venous thromboembolism (VTE) treatment and prophylaxis Safety and efficacy of liposomal bupivacaine for postoperative pain management in pediatric patients undergoing spinal surgery Evaluation of procalcitonin for antibiotic streamlining in critically ill patients Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. 253 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386304 Loan Tran 11‐265 386642 Nhi Tran 10‐214 386642 Nhi Tran 12‐165 389091 Tam Tran 10‐297 389282 Trang Tran 1‐477 386504 Victor Tran 8‐201 386693 Gregory Trietley 10‐330 Utilization of lean six sigma methodology to improve pharmacy workflow in an oncology clinic Design of a pilot pharmacist‐driven inpatient pain consult service and opioid stewardship program at a Veterans Affairs (VA) medical center Design of a pilot pharmacist‐driven inpatient pain consult service and opioid stewardship program at a Veterans Affairs (VA) medical center Assessment of albuterol metered‐dose inhaler versus albuterol nebulizer in pediatric patients with asthma Case of cardiomyopathy likely induced by clozapine Integration of medication therapy management into a complex care management program at a federally qualified health center Prevalence of drug therapy problems related to urinary tract infection treatment after positive urinalysis in the emergency department Date Time Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. 254 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388372 Ken Trinh 12‐077 388178 TUAN TRINH 1‐478 387245 Gia Troisi 1‐479 386828 Deni Trone 9‐323 386412 Carly Trowbridge 11‐320 387622 Sabrina Truc 1‐480 388682 Lance Trujillo 10‐132 Evaluation of a Heparin Infusion Protocol Dosed Using Adjusted Body Weight in Acute Patients with Venous Thromboembolism or Cardiovascular Indications Implementation of a nursing education program to improve patient satisfaction with pain management in a community teaching hospital Implementation of a Guideline for PPI Use on the General Medical Floors of a Community Health System Analysis of predictive factors leading to delayed clearance in pediatric patients who received high dose methotrexate Comparing time to readmission or mortality in inpatients with dementia: antipsychotic use versus no antipsychotic use for behavioral disturbances Comprehensive review of the perioperative bridge protocol utilized at the Veterans Affairs Western New York (VA WNY) Healthcare System Evaluation of time to first antibiotic dose administered in patients presenting to the emergency department at Date Time Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. 255 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. a community hospital 385225 Elaine Truong 8‐325 386912 Huong Truong 1‐481 388635 Sean Truong 1‐482 386112 Stacy Tse 12‐185 389014 Melissa Tsiu 10‐133 387011 Mandi Tsoi 8‐202 Cardiovascular outcomes related to testosterone supplementation in a male veteran population (CORTS) Development of an evidence‐based, cost‐
effective, step‐wise practice guideline for mucositis assessment, prevention and management Impact of an interventional group appointment regarding opioid safety and distribution of naloxone kits in a veteran population Evaluating the efficacy, appropriateness, and tolerability of saxagliptin in patients with type 2 diabetes mellitus in an outpatient setting Effect of adequate fluid resuscitation and appropriate antibiotic therapy on mortality and length of stay in patients with sepsis Evaluating the use of intrathecal chemotherapy to achieve remission and transplant eligibility in patients with neoplastic meningitis Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 256 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386672 Patrick Tu 1‐483 387169 Brittany Turner 10‐263 389551 Jazmin Turner 9‐029 386585 Kyle Turner 11‐024 389261 Alyssa Tuttle 8‐350 385716 June Twiggs 1‐484 388768 Kelsey Tyson 8‐294 387589 Kathleen Ubina 11‐266 Avoidance of double anaerobic coverage while improving outcomes in clostridium difficile infections at a veterans affairs medical center Evaluation of symptom management and patient outcomes following total hip and knee arthroplasties Impact of a pharmacist on reducing use of proton pump inhibitors in high risk elderly populations in an ambulatory care setting A multiple health system approach to improve the quality of care transitions through medication management Impact of a pharmacy driven protocol for methicillin resistant Staphylococcus aureus nucleic acid amplification nasal swab test on the duration of therapy with vancomycin Conservative versus moderate intensity blood glucose management in postoperative cardiac surgery patients Efficacy and safety of basal bolus insulin order set in non‐critically ill hospitalized patients Impact of pharmacist‐led diabetic education on 30 day‐readmission rates Date Time Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. 257 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388363 Stepan Uhlyar 8‐295 387718 Brantley Underwood 10‐253 387470 Kelsi Upmann 11‐267 387379 Priyasha Uppal 10‐047 385880 Amulya Uppala 9‐324 387874 Lourie Ann Urbano 1‐485 387923 Eric Urnoski 12‐078 385140 Natalia Uzal 1‐486 Implementation of a pharmacy driven hyperglycemia optimization for diabetic patients in an acute care inpatient psychiatric setting Medication adherence rates utilizing a community pharmacy‐based mobile application Assessment of impact for patients who are concurrently on antiretroviral therapy (ART) and a P2Y12 inhibitor Assessment of the appropriateness and safety of dual alpha‐blocker therapy Cost‐savings associated with pharmacist‐driven intravenous to oral interchange policy Evaluation of antimicrobial prophylaxis for preventing surgical site infection at a Veterans Affairs hospital Impact of oral vancomycin prophylaxis on the occurrence of Clostridium difficile infection in allogeneic hematopoietic stem cell transplant recipients Pharmacists Impact on Discharge Medication Reconciliation and Patient Satisfaction Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 Sunday, December 6 3:00 p.m. ‐ 4:00 p.m. 3:45 ‐ 5:15 p.m. 258 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386286 Nina Vadiei 9‐239 389325 Dreana Valenciano 9‐333 388455 Natalie Valentino 1‐487 386886 Anuja Vallabh 9‐030 385887 Kelsey Van Gorkom 1‐488 388070 Michael Van Sistine 9‐092 387377 Brenden Van Slyke 9‐160 Impact of norepinephrine weight‐based dosing compared to non‐weight‐
based dosing in achieving time to goal mean arterial pressure in obese patients with septic shock Evaluation of a cost‐
savings initiative for use of lipoglycopeptide antibiotics in the emergency department (ED) Increasing utilization of overdose education and naloxone distribution (OEND) in a Veterans Affairs (VA) primary care clinic Improving transitions of care through pharmacist led discharge counseling on an acute inpatient psychiatric unit Risk of bleeding and systemic embolism: a comparison of target‐
specific oral anticoagulants and warfarin in a setting with increased time in therapeutic range Effects of sedative selection and dose for emergency department procedural sedation on adverse events and length of stay Evaluation of a pharmacy resident impact on venous thromboembolism prophylaxis and treatment Date Time Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. 259 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. in a community teaching hospital 387816 Jocelyn Van Vickle 10‐279 387383 Derek VanderHorst 12‐289 385606 Jennifer Vanderploeg 11‐093 386701 Lauren VanHook 12‐079 388170 Erin VanMeter 10‐254 385749 Valana Vannoy 11‐268 389130 Jocelyn VanOpdorp 9‐093 Management of diabetic ketoacidosis (DKA) in the emergency department: a retrospective analysis Implementation of a health‐system wide antimicrobial stewardship program at two remote community hospitals Use of sub‐dissociative dose ketamine to reduce opioid use in the emergency department for patients with moderate‐to‐
severe pain Evaluation of a newly implemented pharmacist driven warfarin collaborative practice: assessing uptake, quality, and outcomes in an inpatient setting Expansion of pharmacy services through implementation of an interdisciplinary diabetes shared medical appointment Retrospective evaluation of initial maintenance caffeine dose and successful first‐time extubation Patient reported outcomes from a ritonavir to cobicistat simplification study. 260 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 389073 Alexandra Varga 11‐298 386563 Yhanique Vassell, PharmD 11‐025 388242 Allie Vecchiet 10‐255 387278 Evan Venturella 12‐022 385837 Martein Vernon 1‐489 389045 Egor Veselov 12‐307 389526 Katherine Viale 8‐351 Impact of the implementation of matrix‐
assisted laser desorption ionization time‐of‐flight (MALDI‐TOF) mass spectrometry on time to effective and optimal antimicrobial therapy in gram‐positive bacteremias Utilization of a Pharmacist on geriatric rounds to evaluate and assess the dispensing of inappropriate mediations and 30 day readmissions. Measuring the impact of in‐house specialty pharmacy services on medication adherence in a cystic fibrosis population Efficacy of fosfomycin for the treatment of vancomycin‐resistant enterococci urinary tract infections. Effectiveness and safety of hepatitis C treatment with direct‐acting antivirals (DAAs) in a veteran population Implementation of a resident‐led pharmacy technician certification program in a teaching hospital Medication reconciliation and discharge counseling for patients on the cardiac step‐down unit: expansion of transitions of care services at PeaceHealth Date Time Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 261 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Southwest Medical Center 387859 Laine Vicarel 8‐054 385591 Katherine Vicinanza 1‐490 386680 Jennifer Vidal 11‐056 387607 Jessica Vigneau 8‐203 387262 Isabel Viguera‐
Guerra 8‐352 Peri‐procedural international normalized ratio (INR) control in patients receiving continuous warfarin therapy for catheter ablation of atrial fibrillation A retrospective evaluation of iron supplementation practices in an outpatient pharmacy‐run Erythropoietin Clinic at a VA facility Multicenter evaluation of the impact of weight estimations on anticoagulation reversal with 4‐factor prothrombin complex concentrate (PCC) in the emergency department Warfarin overlap with parenteral anticoagulation for venous thromboembolism: a targeted intervention to improve measure compliance Influence of ribavirin on peginterferon‐free direct‐
acting antiviral based regimens in nave patients chronically infected by hepatitis C virus genotype 1: a systematic review and Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 262 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time meta‐analysis. 388529 Juan Villanueva 1‐491 389600 Jill Anne Villarosa 10‐215 389600 Jill Anne Villarosa 12‐166 387147 Alexis Villarreal 11‐181 385238 Zakarri Vinson 11‐299 387208 Jennifer Vipond 8‐296 Evaluation of the appropriate use of posaconazole at an academic medical center following the implementation of criteria to guide use Impact on adherence to sepsis bundles following implementation of a revised sepsis order set and multidisciplinary education Impact on adherence to sepsis bundles following implementation of a revised sepsis order set and multidisciplinary education Evaluating transitions of care services performed by pharmacists in high risk patients Evaluation of MIC data to determine the potential benefit of double coverage of Pseudomonas aeruginosa and other gram negative bacilli at a large academic center Impact of adverse events related to the co‐
administration of diazepam with protease inhibitors or cobicistat Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 263 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 389596 Cassandra Vo 9‐054 389033 Kim Vo 12‐186 387976 Ngoc (Kathy) Vo 9‐094 384764 Trang Vo 8‐297 387539 Calla Vodoor 12‐290 386043 Tiffany Vogeler 11‐182 389625 Julia Vorotnikova 11‐116 Evaluation of fixed‐dose scheme for 4‐factor prothrombin complex concentrate (4F‐PCC) on urgent warfarin reversal Initiation of target‐specific oral anticoagulants for atrial fibrillation and venous thromboembolism: impact on time to hospital discharge Efficacy of a pharmacist driven vancomycin dosing service in a community hospital Impact of a clinical decision support system (CDSS) on time to ordered appropriate antibiotic therapy in gram negative bacteremia Clinical outcomes and costs associated with pre and post initiation of cystic fibrosis transmembrane conductance regulator potentiating agents in managed care medicaid plans Proton pump inhibitor (PPI) use: impact of in‐
service education to health care providers on prescribing patterns Improving assessment of pain management in patients receiving intravenous patient‐
controlled analgesia (PCA) at a community hospital. Date Time Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. 264 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388051 Betty Vu 8‐055 385163 khanh vu 12‐291 387826 Lamanh Vu 9‐240 386560 Vera Vulaj 9‐325 389401 Alexa Vyain 10‐134 386850 Rose Wade 1‐492 385583 Nicolle Waetjen 10‐135 388266 Lauren Wagner 1‐493 Medication use evaluation of daptomycin: streamlining therapy in an academic medical center Improving human immunodeficiency virus (HIV) screening at Gallup Service Unit Optimization of empiric therapy for urinary tract infections in the emergency department: striking the balance between appropriate therapy while avoiding unnecessary exposures Electrolyte abnormalities in ICU patients receiving parenteral nutrition: incidence and associated outcomes Assessment of prescribing habits for the treatment of hepatitis B virus (HBV) in patients co‐infected with human immunodeficiency virus (HIV) and evaluation of renal decline Evaluation of outpatient and inpatient treatment of skin and soft tissue infections in a veteran population Reducing congestive heart failure and chronic obstructive pulmonary disease readmission rates by pharmacist directed education and counseling Pharmacist interventions to reduce the risk of Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 265 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time UF Health Personalized Medicine Program: value of preemptive pharmacogenetic testing Credentialing and privileging pharmacists in a community medical center Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Evaluation of blood factor prescribing and monitoring in patients with hemophilia Clinical outcomes of extended spectrum beta‐
lactamase‐producing Enterobacteriaceae among levofloxacin, cefepime, and carbapenems Clinical outcomes of extended spectrum beta‐
lactamase‐producing Enterobacteriaceae among levofloxacin, cefepime, and carbapenems Evaluation of the efficacy and safety of bosentan in infants with chronic pulmonary hypertension Monitoring of proton pump inhibitor (PPI) use in an outpatient clinic setting Evaluating the impact of the pharmacists patient care process on medication adherence in the pharmacist‐led geriatric evaluation and management (GEM) clinic Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Clostridium difficile infection 388378 Dyson Wake 9‐095 385375 Amber Walker 10‐136 387512 Elizabeth Walker 1‐494 388135 Kristy Walker 10‐216 388135 Kristy Walker 12‐167 386775 Jessica Wallace 12‐292 386606 Takova Wallace 11‐053 384670 Stephanie Walters 12‐187 266 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 382630 Nan Wang 12‐293 388163 Stanley Wang 10‐256 386113 Yuchen Wang 8‐353 386809 Sheena Wanke 8‐056 387598 Victor Warne 10‐270 386189 Caleb Warner 1‐495 389081 Ryan Warren 9‐241 Conspiracy theory: Are our SPaCE bugs really a thing to be feared? Retrospective analysis of estimated cost avoidance from pharmacist interventions in a pharmacist‐led ambulatory care clinic over a one‐year period Evaluation of overlapping pro re nata (PRN) medications based on indication in psychiatric patients Evaluation of collection of lactate levels and the administration of resuscitation fluids in patients with severe sepsis or septic shock Effects of a nursing‐driven emergency department pain protocol on number of doses of pain medication received, degree of pain reduction, and length of stay Institution of a pharmacy‐
led basal/bolus insulin protocol and rates of within range blood glucose readings in hospitalized patients Evaluating the appropriateness of target‐
specific oral anticoagulant (TSOAC) prescribing in the outpatient setting Date Time Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. 267 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 389471 Staci Warren 8‐354 386688 Melissa Waterhouse 1‐496 386183 Kacie Waters 10‐217 386183 Kacie Waters 12‐168 387618 Kristin Waters 12‐080 388519 Lori Watkins 9‐242 388129 Lucas Watson 1‐497 Neonatal early‐onset sepsis risk calculator validation and assessment of current guideline adherence within two tertiary healthcare centers Efficacy and Tolerability of Every‐Other‐Day Statin Administration in Patients with Previous Statin Intolerance: A Retrospective Chart Review Evaluation of 4‐factor prothrombin complex concentrate (PCC) in hospitalized patients Evaluation of 4‐factor prothrombin complex concentrate (PCC) in hospitalized patients Utilization of as‐needed haloperidol, risperidone, olanzapine, quetiapine, lorazepam, or alprazolam in patients not taking these medications prior to admission to a hospitalist service Evaluating the management of candidemia at four community hospitals: a comparison of micafungin versus fluconazole The concurrent use of three or more antidepressant agents in the Iowa City VA Healthcare System Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 268 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 387374 Troy Watson 1‐498 385307 Bethany Wattles 9‐326 386520 Ashley Weber 11‐117 386746 Kathy Weekes‐
Plante 11‐321 388504 Erica Wegrzyn 1‐499 388023 Jarod Weidner 11‐094 386756 Kylie Weigel 10‐331 Retrospective review of antithrombotic therapy post‐percutaneous coronary intervention Evaluation of risk factors for high vancomycin troughs in pediatric patients Assessing the treatment of active mycobacteria infections with rifabutin in HIV patients receiving pharmacokinetic‐boosted anti‐retroviral therapy (ART) Lacosamide vs. Levetiracetam for Primary Prophylaxis of Early Seizures in Neurocritical Care Patients Evaluation of a pharmacist co‐managed interdisciplinary education of emergency department providers and nurses for the implementation of a naloxone layperson education program Implementation of a computerized surveillance program among clinical pharmacy staff to improve antimicrobial prescribing practices at Mercy Medical Center‐‐North Iowa Evaluation of low molecular weight heparin dosing and risk of bleeding in a lung transplant population Date Time Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. 269 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 386413 Julie Weiner 12‐023 386858 Rachel Weingartner 1‐500 386132 Kevin Welch 10‐048 386891 Eric Weldon 12‐294 387877 Keith Wellman 1‐501 386239 Dominique Werge 9‐327 384739 Jessica Wesolek 1‐502 Clinical and economic evaluation of multimodal pain management implementation in the surgical setting Effect of multidisciplinary group classes and telephone follow‐up on congestive heart failure (CHF) exacerbations in Veterans with CHF Evaluation of modified del Nido versus Buckberg solution for cardioplegia during coronary artery bypass graft surgery Appropriateness the use of intravenous iron sucrose in treatment of iron deficiency anemia in pregnancy Implementation of a symptom‐triggered alcohol withdrawal treatment protocol and the effect on duration of therapy at a Veterans Affairs hospital Evaluation of the appropriate use of piperacillin‐tazobactam and metronidazole used simultaneously to treat infections at a rural community hospital Implementation of a code sepsis pathway in the emergency department to improve early treatment of severe sepsis and septic shock Date Time Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 270 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 387183 Marissa West 11‐183 388143 Christy Westbrook 8‐204 387743 Sara Wettergreen 9‐055 384765 Allyson Wexler 1‐503 388661 William Wheeler, IV 11‐095 384336 Taylor White 11‐322 389013 Lauren Whitfield 1‐504 Steroid‐Induced Hyperglycemia in Patients Receiving EPOCH‐
containing Chemotherapy Regimens: A Medication Use Evaluation Development and implementation of a sepsis protocol and algorithm to facilitate early goal directed therapy in a small community hospital Comparison of faculty assessment and students self‐assessment of performance during clinical case discussions in a capstone course Alvimopan medication use evaluation and pharmacist impact on appropriate discontinuation Impact of demographics and comorbidities on inpatient warfarin sensitivity for patients admitted on warfarin therapy Assessment of the effect of reduced dose novel oral anticoagulants (NOACs) on ischemic events in patients with nonvalvular atrial fibrillation Effect of capped heparin dosing on time to exceed lower limit of therapeutic activated partial thromboplastin time (aPTT) threshold for treatment of venous Date Time Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 271 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. thromboembolism (VTE) 389111 Jennifer Wiafe 11‐096 385409 Julie Wiechert 10‐023 385574 Emily Wiener 12‐024 386860 Micah Wilcox 10‐049 388189 Michael Wilcox 9‐328 382628 Kent Wilin 10‐218 Blood cultures and broad‐
spectrum antibiotics: evaluation of compliance to surviving sepsis campaign bundle in a community health system Development and evaluation of a pharmacist managed culture and sensitivity review practice for discharged emergency department patients Improving time to antibiotic administration in sepsis patients in the emergency department Management and Transition of Care for the Hospitalized Type 2 Diabetic Patient: Pharmacist's Role Implementation of process improvement strategies to optimize medication inventory in a pharmacy carousel system at a large academic medical center Heparin induced thrombocytopenia: a retrospective assessment of patient evaluation and management at an academic medical center 272 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 382628 Kent Wilin 12‐169 388550 Holly Wilkerson 12‐081 387096 Samantha Will 8‐073 384414 Chelsea Williams 10‐271 388531 Germaine Williams 9‐329 386004 Krista Williams 12‐082 388488 Whitney Williams 9‐243 387878 Sarah Williford 8‐298 Heparin induced thrombocytopenia: a retrospective assessment of patient evaluation and management at an academic medical center Influence of an educational intervention designed to enhance participants' knowledge of and self‐
efficacy towards enrolling in medicare part d drug plans Evaluation of a pharmacist‐led monitoring program for renally dose adjusted medications in a patient‐centered medical home Treatment of delirium in critically ill pediatric patients with second generation antipsychotics Impact of a mental health pharmacist on primary care in a Federally Qualified Health Center Effect of prolonged postoperative antibiotic utilization on patient outcomes An Evaluation of a Pharmacist Driven Hematology/Oncology Stewardship Program Hyperosmotic Therapy in Severe Traumatic Brain Injury Date Time Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 273 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 388556 Austin Wilson 8‐205 389326 Kaitlyn Wilson 10‐257 384572 Lindsay Wilson 9‐161 388790 Mark Wilson 10‐137 386001 Bradly Winter 9‐244 384657 Sara Winters 9‐096 387219 Andrea Winterswyk 8‐355 386793 Bethany Withycombe 8‐299 Evaluating the effect of an expanded discharge medication reconciliation process on discharge medication discrepancy rates and types Efficacy of dementia medications in controlling behavior symptoms and reducing use of psychotropic medications in dementia patients Serotonin‐modulating antidepressants and risk of bleeding after trauma Impact of early identification using a rapid PCR test with antimicrobial stewardship intervention in patients with blood cultures contaminated by coagulase‐negative staphylococci Assessing the need and opportunity for clinical pharmacist involvement in dosing of direct oral anticoagulants (DOACs) Evaluation of the use of rivaroxaban for non‐FDA approved indications Evaluation of concurrent oral antipsychotic use in patients treated with long‐
acting injectable antipsychotics Implementation and quality analysis of a standardized chemotherapy verification and centralized product Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 274 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. check workflow process 387148 Kurt Wittig 12‐212 385678 Lisa Wohlford 1‐505 385601 Kirre Wold 9‐330 385250 Anna Wolf 10‐332 384748 Lauren Wolf 12‐083 386032 Lauren Wolfe 9‐331 Retrospective review of drug therapy opportunities in HIV patients within an ambulatory care setting Differences in opioid analgesic prescribing trends by patient characteristics in adults presenting to US emergency departments for injury Implementation and evaluation of a formal antimicrobial stewardship committee at Mercy Medical Center ‐ North Iowa Evaluation and implementation of statewide antimicrobial stewardship initiatives at two community‐based hospitals Evaluation of the appropriateness of antibiotic and anticoagulant discharge prescription practices in a community hospital emergency department Evaluation of the impact of pharmacist‐led tobacco cessation classes on abstinence rates in patients of a Patient‐
Centered Medical Home (PCMH) practice Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. 275 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 387256 Sujin Wolff 1‐506 383724 Daniel Wolverton 12‐084 389638 Anthony Wong 12‐085 383168 Cecilia Wong 10‐333 385560 Courtney Wong 1‐507 387026 Edward Wong 11‐269 384340 jenny wong 11‐194 Impact of inpatient discharge counseling by trained pharmacists on 30‐
day and 90‐day hospital and emergency department readmission rates Impact of transition of care pharmacy interventions on orthopedic hospital readmissions Initiation of a computerized insulin drip dosing recommendation tool in the emergency department for the management of adult hyperglycemic emergencies The impact of pharmacist‐
initiated interventions at discharge on 30 day readmission rates Use of probiotics in the prevention of Clostridium difficile infection associated with broad‐
spectrum antibiotics Visual assessment tool to evaluate performance and improve pharmacy quality and productivity: operational and educational measures Comparison of a value based insurance design and healthcare utilization against a fixed copay formulary insurance design within a large integrated healthcare organization Date Sunday, December 6 Time 3:45 ‐ 5:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. 276 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 385699 Kong Wong 8‐206 388827 Shan Wong 8‐207 385901 Robert Woods 8‐300 385750 Jessica Wooster 9‐097 384387 Kelsi Worthy 11‐323 387572 Margaret Wovkulich 12‐188 389436 Crystal Wright 8‐356 The relationship between antipsychotic polypharmacy and hospital readmissions at the Washington DC, Veterans Affairs Medical Center (DC VAMC) Evaluation of albumin utilization before and after implementation of an electronic ordering restriction within a community health system Evaluation of the clinical outcomes associated with concomitant use of ketamine and dexmedetomidine for adult procedural sedation and analgesia in the emergency department Impact of community pharmacist‐performed medication reconciliations in Medicare patients post‐
discharge on 30‐day hospital readmission rates Impact of pharmacists within a multidisciplinary team on sepsis management in the emergency department Evaluation of a newly implemented 7‐day automatic stop‐order for parenteral antibiotics Prescribing and deprescribing of potentially inappropriate medications in older adults in an advanced urgent care Date Time Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 277 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. setting: a retrospective before‐and‐after analysis 387562 Dana Wright 10‐219 387562 Dana Wright 12‐170 388444 Emily Wright 12‐086 385686 Jordan Wright 8‐301 386763 Laurie Wright 11‐270 388587 Robert Wright 9‐162 388317 Sarah Wright 9‐163 386008 Jessica Cho Kiu Wu 1‐508 Cost effective analysis of regadenoson versus adenosine in an outpatient stress test lab Cost effective analysis of regadenoson versus adenosine in an outpatient stress test lab Long‐acting injectable antipsychotics versus oral therapy in adult behavioral health patients Combate la diabetes: a community pharmacist's approach to diabetes education among the Hispanic population in rural Tennessee Efficacy of a pharmacist‐
managed epoetin alfa protocol for anemia of prematurity Pharmacist Impact on Pain Management in Long‐Bone Fractures Intravenous versus oral acetaminophen for elderly trauma patients with rib fractures Adverse cardiac events associated with patients receiving trimethoprim‐
sulfamethoxazole and renin‐angiotensin‐
aldosterone‐system inhibitors 278 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 385863 Matthew Wu 11‐184 385621 Timothy Wu 1‐509 386941 Yunuo Wu 11‐118 385252 Stephanie Wuerffel 8‐057 387528 Jenny Wulf 12‐087 385979 Jordan Wulz 1‐510 384711 Pin Xiang 11‐185 Polymerase chain reaction (PCR) testing and antimicrobial stewardship among hospitalized patients with staphylococcus bacteremia Impact of a pharmacist led concierge/bedside encounter service on medication‐related Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores Implementing a medication synchronization program in community pharmacies Pharmacist‐supported implementation of a protocol for low‐dose ketamine analgesia by a paramedic level rural emergency medical service Evaluating the impact of pharmacist intervention within transitions of care roles on patients admitted with chronic obstructive pulmonary disease Does health literacy‐
directed pharmacist‐led diabetes education improve educational outcomes? Outcomes and cost impacts of a pharmacist‐
led medication management program for high risk diabetic patients in Central Texas Date Time Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Sunday, December 6 Wednesday, December 9 3:45 ‐ 5:15 p.m. 1:45 p.m. ‐ 2:45 p.m. 279 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 387643 Kevin Xie 11‐026 389276 Jenny Xiong 8‐208 384528 Fuwang Xu 12‐189 386581 David Yabusaki 12‐213 388249 Mina Yacoub 10‐258 385263 Lily Yam 1‐511 387764 Amy Yan 11‐119 387868 Eric Yancey 9‐245 Retrospective study of patient outcomes and process adherence in diabetic ketoacidosis Medication use evaluation of direct oral anticoagulants at a large 425‐bed community hospital Decentralized pharmacy technicians to improve medication delivery and nursing satisfaction Effect of skilled nursing facility (SNF) to home medication reconciliation on hospital readmission rates as part of a multicomponent care model redesign MRSA nasal cultures in patients diagnosed with cellulitis: current utility & role in antimicrobial stewardship Assessment of enoxaparin thromboprophylaxis dosing and anti‐factor Xa levels in low‐weight patients Assessing impact of opioid use for the treatment of chronic nonmalignant pain on COPD readmission rates at a teaching hospital Tolerance rates for intraperitoneal taxane/platinum doublet for ovarian and peritoneal cancer: a single center retrospective analysis. Date Time Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. 280 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 385637 Linda Yang 1‐512 386555 Pamela Yang 10‐050 388012 Sendra Yang 1‐513 388942 Arsheena Yassin 1‐514 387762 Stanislav Yavid 12‐308 386285 Nastaran Yazdi 386159 Julianne Yeary 11‐271 11‐097 384770 Bo Young Yen 1‐515 Evaluation of the appropriateness of empiric community acquired pneumonia (CAP) regimens in a heterogeneous population Impact of pharmacist intervention on the appropriateness of therapeutic monitoring of vancomycin in a veteran population Outcomes of pharmacy‐led hepatitis C direct‐acting antiviral (DAA) utilization management at a Veterans Affairs Medical Center Clinical and cost comparison of extended versus standard piperacillin‐tazobactam infusion Impact of evidence based therapy on unscheduled healthcare contacts in acute coronary syndrome patients treated with percutaneous coronary intervention Heart failure transition of care Utilization of IV loop diuretics in systolic heart failure with volume overload Characterization of IV erythromycin use as a prokinetic agent in the treatment of post‐
operative delayed gastric emptying Date Time Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. 281 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 385403 Alannah Yoder 11‐272 387531 Carol Yoon 1‐516 386675 Jessica Yost 10‐138 388271 Nicole Young 10‐298 384647 Tramaine Young 11‐186 387695 Benjamin Yu 9‐164 387566 Chi Fai Yuen 11‐273 Evaluation of the non‐
formulary use of codeine and codeine‐containing products in pediatric patients in an academic pediatric hospital Implementation of a medication management telephone clinic for veterans newly entering the VA healthcare system prior to their initial primary care physician visit Multicenter retrospective review of characteristics associated with bleeding secondary to the direct oral anticoagulants Implementation and evaluation of the effects of an oral hypoglycemic to insulin protocol for glucose management in hospitalized patients with type 2 diabetes mellitus Methodological Study of Vancomycin Dosing in Elderly Patients using Actual Serum Creatinine versus Rounded Serum Creatinine Evaluation of the use of emergency department services Retrospective evaluation of procalcitonin utilization in reducing antibiotic exposure and adverse clinical outcomes in patients with lower respiratory tract infections Date Time Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. 282 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 383307 Justin Zacharias 10‐051 389317 Jessica Zacher 11‐324 386547 Maryam Zaeem 8‐209 387606 Michelle Zaepfel 8‐302 388081 Veronica Zafonte 8‐210 388633 Dalia Zall 8‐303 389270 Bin Zang 11‐274 388121 Tanya Zapolskaya 8‐357 Impact of medication education service by pharmacy interns on HCAHPS scores in a pediatric hospital Retrospective review of INR management by pharmacist versus non‐
pharmacist providers in post‐operative total hip and total knee arthroplasty patients Impact of a pharmacist driven insulin education program to enhance patient safety and healthcare provider knowledge Characterization of reported vaccine‐related errors at UR Medicine Treatment of asymptomatic bacteriuria in transplant patients Health plan strategies for improving medication adherence in Medicare Part D beneficiaries: the implementation and evaluation of a mail order medication synchronization program Evaluation of stress ulcer prophylaxis in the intensive care settings of a tertiary care teaching institution Utility of carboplatin intradermal testing in gynecology‐oncology patients Date Time Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. 283 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number 389102 Htet Htet W Zaw 9‐098 388071 Lindsey Zawierucha 12‐295 385816 Yelena Zaychik 9‐165 387707 Renjbar Zebari 8‐211 388620 Julia Zecchini 9‐246 386100 Amanda Zeek 1‐517 389453 Qian Ya Zeng 8‐212 386784 Sonya Zhan 9‐332 384321 Chloe Zhang 12‐088 Impact of pharmacist‐led discharge counseling and medication reconciliation on high‐risk patients in the emergency department Impact of pharmacy‐led patient education on pneumococcal and influenza vaccination rates in the inpatient setting Efficacy of and adherence to diabetic ketoacidosis protocol in the Medical Intensive Care Unit The Impact of Pharmacy Resident Interventions on Drug Related Costs in a Community Teaching Hospital Quality improvement of vancomycin trough level collection Evaluating the change in body weight and risk factors for heart disease in patients treated with low‐
dose quetiapine for sleep Optimizing therapy: pharmacist involvement versus usual care in a heart failure population Evaluation of pharmacist order verification changes between medical residents, mid‐level practitioners, and hospitalists Implementation of inhaled epoprostenol for acute pulmonary hypertension after cardiac surgery and Date Time Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. 284 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time acute respiratory distress syndrome 383718 Junyu Zhang 1‐518 386973 Crystal Zhou 10‐334 389608 Julia Zhu 9‐056 386686 Weiyun Zhu 11‐187 386191 Kelsea Ziegler 8‐304 386322 Brianna Zinser 12‐309 386589 Olga Zirka 12‐025 Rate of nephrotoxicity in morbidly obese and obese patients using an adjusted body weight vancomycin dosing protocol Comparison of outcomes between Veterans with and without mental illness enrolled in a pharmacist managed telephone tobacco cessation clinic Evaluation of treatment adherence, severity of illness, and incidence of adverse events in deep vein thrombosis treated in the inpatient compared to the outpatient setting. Implementation of a proton pump inhibitor monitoring protocol in a community hospital and its impact on hospital acquired Clostridium difficile infection Analysis of cholesterol management in a pharmacist‐run clinic Evaluating the Utilization of the Confusion Assessment Method for the Intensive Care Units on Delirium Management Implementation of a pharmacist‐driven pain management service for patients at high risk for Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 12:30 p.m. ‐ 1:30 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. Wednesday, December 9 1:45 p.m. ‐ 2:45 p.m. Wednesday, December 9 10:00 ‐ 11:00 a.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. 285 | P a g e
2015 ASHP MIDYEAR CLINICAL MEETING RESIDENT POSTER LISTING BY PRIMARY AUTHOR LAST NAME Submission ID PA Full Name Session‐ Title Board Number Date Time Wednesday, December 9 3:00 p.m. ‐ 4:00 p.m. respiratory depression 386028 Kimberly Zitko 12‐026 389040 Emily Zoelle 1‐519 387944 Antoine Zogbi 9‐166 Evaluating non‐insulin dual therapy of individuals with type 2 diabetes mellitus in a primary care clinic Retrospective review of psychiatrist response to pharmacist recommendations regarding treatment of dyslipidemia in psychiatric inpatients Retrospective quality assurance analysis of chronic concomitant use of opioids and benzodiazepines in the Veteran Affairs Portland Health Care System Sunday, December 6 3:45 ‐ 5:15 p.m. Wednesday, December 9 11:15 a.m. ‐ 12:15 p.m. 286 | P a g e